{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:10:48Z","timestamp":1794348648397,"version":"4.9.0"},"reference-count":1297,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","award":["WE.03-2019-05"],"award-info":[{"award-number":["WE.03-2019-05"]}],"id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","award":["50199468"],"award-info":[{"award-number":["50199468"]}],"id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2018-04312"],"award-info":[{"award-number":["RGPIN-2018-04312"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007555","name":"Foundation for Cardiovascular Research","doi-asserted-by":"publisher","award":["19CVD02"],"award-info":[{"award-number":["19CVD02"]}],"id":[{"id":"10.13039\/100007555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007555","name":"Foundation for Cardiovascular Research","doi-asserted-by":"publisher","award":["ANR-23-CE14-0027-01"],"award-info":[{"award-number":["ANR-23-CE14-0027-01"]}],"id":[{"id":"10.13039\/100007555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/18\/3\/34214"],"award-info":[{"award-number":["RE\/18\/3\/34214"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/17\/6\/32944"],"award-info":[{"award-number":["RG\/17\/6\/32944"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA029798"],"award-info":[{"award-number":["R01AA029798"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AG061200"],"award-info":[{"award-number":["R01AG061200"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01067836"],"award-info":[{"award-number":["R01067836"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["PG\/17\/26\/32881CAMS"],"award-info":[{"award-number":["PG\/17\/26\/32881CAMS"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT 152904"],"award-info":[{"award-number":["PJT 152904"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT 190230"],"award-info":[{"award-number":["PJT 190230"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","award":["215850"],"award-info":[{"award-number":["215850"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["ZonMw01142042330003"],"award-info":[{"award-number":["ZonMw01142042330003"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["NMSS RG 4544A1"],"award-info":[{"award-number":["NMSS RG 4544A1"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","award":["EMCLSH23035"],"award-info":[{"award-number":["EMCLSH23035"]}],"id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2021082"],"award-info":[{"award-number":["2021082"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","award":["R01EY033403"],"award-info":[{"award-number":["R01EY033403"]}],"id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["NI 1301\/7-1"],"award-info":[{"award-number":["NI 1301\/7-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1328"],"award-info":[{"award-number":["SFB1328"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1525"],"award-info":[{"award-number":["SFB1525"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["IRTG1874\/DIAMICON-SP2"],"award-info":[{"award-number":["IRTG1874\/DIAMICON-SP2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA238514"],"award-info":[{"award-number":["R01CA238514"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA254197"],"award-info":[{"award-number":["R01CA254197"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010173","name":"Smart Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35-HL135827"],"award-info":[{"award-number":["R35-HL135827"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35-HL166565"],"award-info":[{"award-number":["R35-HL166565"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.pharmr.2025.100042","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T02:53:39Z","timestamp":1737514419000},"page":"100042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Cyclic nucleotide phosphodiesterases as drug targets"],"prefix":"10.1016","volume":"77","author":[{"given":"Michy P.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7529-5179","authenticated-orcid":false,"given":"Viacheslav O.","family":"Nikolaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8912-1834","authenticated-orcid":false,"given":"Leila","family":"Gobejishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Lugnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hesslinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nickolaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Kass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walma","family":"Pereira de Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolphe","family":"Fischmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Brocke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0681-8236","authenticated-orcid":false,"given":"Paul M.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4418-887X","authenticated-orcid":false,"given":"Gary A.","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam B.","family":"Keeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8967-114X","authenticated-orcid":false,"given":"Gang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1326-4219","authenticated-orcid":false,"given":"Mohammad","family":"Abdel-Halim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf H.","family":"Abadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George S.","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Giembycz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-7792","authenticated-orcid":false,"given":"Graeme","family":"Bolger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4749-686X","authenticated-orcid":false,"given":"Gretchen","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjetil","family":"Tasken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6427-6813","authenticated-orcid":false,"given":"Nathaniel E.B.","family":"Saidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3075-0630","authenticated-orcid":false,"given":"Martina","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Zaccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph T.","family":"Schermuly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengming","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1573-6526","authenticated-orcid":false,"given":"Rick H.","family":"Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroush","family":"Mohammadi Jouabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7155-1756","authenticated-orcid":false,"given":"Anton J.M.","family":"Roks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmr.2025.100042_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-023-00881-3","article-title":"Hallmarks of cardiovascular ageing","volume":"20","author":"Abdellatif","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/CIRCRESAHA.109.197947","article-title":"Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on \u00df-adrenergic cAMP signals","volume":"105","author":"Abi-Gerges","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib3","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1073\/pnas.1902651116","article-title":"Genomic correlates of clinical outcome in advanced prostate cancer","volume":"116","author":"Abida","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib4","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.4049\/jimmunol.173.8.4847","article-title":"TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling","volume":"173","author":"Abrahamsen","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cellsig.2010.08.015","article-title":"Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis","volume":"23","author":"Abusnina","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1160\/TH14-05-0454","article-title":"Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition","volume":"113","author":"Abusnina","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pharmr.2025.100042_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13024-019-0326-4","article-title":"Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade","volume":"14","author":"Acquarone","year":"2019","journal-title":"Mol Neurodegen"},{"key":"10.1016\/j.pharmr.2025.100042_bib8","doi-asserted-by":"crossref","DOI":"10.5812\/ijpr-136131","article-title":"Co-treatment of naringenin and ketoprofen-RGD suppresses cell proliferation via calmodulin\/PDE\/cAMP\/PKA axis pathway in leukemia and ovarian cancer cells","volume":"22","author":"Afshari","year":"2023","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/BJ20090842","article-title":"Differential regulation of adipocyte PDE3B in distinct membrane compartments by insulin and the beta3-adrenergic receptor agonist CL316243: effects of caveolin-1 knockdown on formation\/maintenance of macromolecular signalling complexes","volume":"424","author":"Ahmad","year":"2009","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmr.2025.100042_bib10","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1111\/odi.12275","article-title":"Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets","volume":"21","author":"Ahmad","year":"2015","journal-title":"Oral Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1212\/WNL.0000000000000037","article-title":"PET imaging shows loss of striatal PDE10A in patients with Huntington disease","volume":"82","author":"Ahmad","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.pharmr.2025.100042_bib12","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3390\/cells11132020","article-title":"cAMP signaling in cancer: a PKA-CREB and EPAC-centric approach","volume":"11","author":"Ahmed","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.pharmr.2025.100042_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111128","article-title":"Phosphodiesterase 5 (PDE5): structure-function regulation and therapeutic applications of inhibitors","volume":"134","author":"Ahmed","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharmr.2025.100042_bib14","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmr.2025.100042_bib15","article-title":"Epidemiology, pathogenesis, and clinical approach in group 5 pulmonary hypertension","volume":"7","author":"Al-Qadi","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.pharmr.2025.100042_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1478-811X-11-47","article-title":"Phosphodiesterase activity is regulated by CC2D1A that is implicated in non-syndromic intellectual disability","volume":"11","author":"Al-Tawashi","year":"2013","journal-title":"Cell Commun Signal: CCS"},{"key":"10.1016\/j.pharmr.2025.100042_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1515\/jtim-2017-0021","article-title":"Effect of pentoxifylline on histological activity and fibrosis of nonalcoholic steatohepatitis patients: a one year randomized control trial","volume":"5","author":"Alam","year":"2017","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib18","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.bbrc.2006.07.136","article-title":"Subcellular dynamics of protein kinase A activity visualized by FRET-based reporters","volume":"348","author":"Allen","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2025.100042_bib19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.euf.2017.05.010","article-title":"Validation of cyclic adenosine monophosphate phosphodiesterase-4D7 for its independent contribution to risk stratification in a prostate cancer patient cohort with longitudinal biological outcomes","volume":"4","author":"Alves de Inda","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.pharmr.2025.100042_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/bs.mie.2015.09.001","article-title":"Probing biased signaling in chemokine receptors","volume":"570","author":"Amarandi","year":"2016","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.pharmr.2025.100042_bib21","article-title":"Phosphodiesterase III inhibitors for heart failure","volume":"2005","author":"Amsallem","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib22","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1172\/JCI124725","article-title":"microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance","volume":"129","author":"Anandagoda","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmr.2025.100042_bib23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0021-9258(18)48336-6","article-title":"In vivo differential prenylation of retinal cyclic GMP phosphodiesterase catalytic subunits","volume":"267","author":"Anant","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib24","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/bph.14205","article-title":"PDE5 inhibitors\u2014pharmacology and clinical applications 20 years after sildenafil discovery","volume":"175","author":"Andersson","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.neurobiolaging.2016.02.016","article-title":"Association of genetic risk factors with cognitive decline: the PATH through life project","volume":"41","author":"Andrews","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmr.2025.100042_bib26","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cell.2022.02.011","article-title":"Receptor-associated independent cAMP nanodomains mediate spatiotemporal specificity of GPCR signaling","volume":"185","author":"Anton","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib27","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/rccm.202306-0944OC","article-title":"Ensifentrine, a novel phosphodiesterase 3 and 4 inhibitor for the treatment of chronic obstructive pulmonary disease: randomized, double-blind, placebo-controlled, multicenter phase III trials (the ENHANCE trials)","volume":"208","author":"Anzueto","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib28","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0022-3565(24)29484-2","article-title":"Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor","volume":"298","author":"Aoki","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1385\/CRIAI:27:1:035","article-title":"Differences in airway remodeling between asthma and chronic obstructive pulmonary disease","volume":"27","author":"Aoshiba","year":"2004","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bcp.2017.06.116","article-title":"Neurogenesis in the aging brain","volume":"141","author":"Apple","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/JGP.0b013e31819431ea","article-title":"A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study","volume":"17","author":"Arai","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100042_bib32","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0968-0004(97)01148-1","article-title":"The GAF domain: an evolutionary link between diverse phototransducing proteins","volume":"22","author":"Aravind","year":"1997","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/gut.2004.061432","article-title":"Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study","volume":"55","author":"Arber","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.pharmr.2025.100042_bib34","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/jm401549m","article-title":"Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases","volume":"57","author":"Armani","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib35","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib36","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1128\/MCB.23.22.8042-8057.2003","article-title":"Regulation of T-cell activation by phosphodiesterase 4B2 requires its dynamic redistribution during immunological synapse formation","volume":"23","author":"Arp","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib37","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.1167\/iovs.13-13281","article-title":"Timing is everything: GTPase regulation in phototransduction","volume":"54","author":"Arshavsky","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib38","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0006-291X(63)90566-7","article-title":"Isolation of adenosine 3', 5'-monophosphate and guanosine 3', 5'-monophosphate from rat urine","volume":"11","author":"Ashman","year":"1963","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2025.100042_bib39","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.4049\/jimmunol.173.8.4806","article-title":"A-kinase anchoring proteins interact with phosphodiesterases in T lymphocyte cell lines","volume":"173","author":"Asirvatham","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib40","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/HYPERTENSIONAHA.120.15856","article-title":"Nitric oxide-cGMP signaling in hypertension: current and future options for pharmacotherapy","volume":"76","author":"Ataei Ataabadi","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmr.2025.100042_bib41","article-title":"Soluble guanylate cyclase activator BAY 54\u20136544 improves vasomotor function and survival in an accelerated ageing mouse model","volume":"00","author":"Ataei Ataabadi","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2308317","article-title":"Vascular ageing features caused by selective dna damage in smooth muscle cell","volume":"2021","author":"Ataei Ataabadi","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.pharmr.2025.100042_bib43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijc.11681","article-title":"MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma","volume":"109","author":"Atkins","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharmr.2025.100042_bib44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/path.4760","article-title":"Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis","volume":"240","author":"Avila","year":"2016","journal-title":"J Pathol"},{"key":"10.1016\/j.pharmr.2025.100042_bib45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3797\/scipharm.1404-08","article-title":"Selective phosphodiesterase 4B inhibitors: a review","volume":"82","author":"Azam","year":"2014","journal-title":"Sci Pharm"},{"key":"10.1016\/j.pharmr.2025.100042_bib46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/er.2013-1053","article-title":"Clinical and molecular genetics of the phosphodiesterases (PDEs)","volume":"35","author":"Azevedo","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib47","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1073\/pnas.96.9.5280","article-title":"Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway","volume":"96","author":"Bach","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib48","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1016\/j.xphs.2016.08.014","article-title":"Lung retention by lysosomal trapping of inhaled drugs can be predicted in vitro with lung slices","volume":"105","author":"B\u00e4ckstr\u00f6m","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib49","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cell.2018.07.034","article-title":"Comprehensive characterization of cancer driver genes and mutations","volume":"174","author":"Bailey","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib50","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.1742-4658.2009.06926.x","article-title":"Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases","volume":"276","author":"Baillie","year":"2009","journal-title":"FEBS J"},{"key":"10.1016\/j.pharmr.2025.100042_bib51","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.bjp.0703636","article-title":"Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases","volume":"131","author":"Baillie","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib52","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41573-019-0033-4","article-title":"Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond","volume":"18","author":"Baillie","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmr.2025.100042_bib53","series-title":"Bifunctional Quinoline Derivatives","author":"Baker","year":"2011"},{"key":"10.1016\/j.pharmr.2025.100042_bib54","first-page":"13","article-title":"Vinpocetine's immunomodulating, anti-oxidant, anti-inflammatory, ant-ifibrotic, and PDE inhibiting potencies ameliorate bleomycin-induced pulmonary fibrosis","volume":"26","author":"Balaha","year":"2023","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib55","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1532-5415.1987.tb04664.x","article-title":"A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction","volume":"35","author":"Balestreri","year":"1987","journal-title":"J Am Geriat Soc"},{"key":"10.1016\/j.pharmr.2025.100042_bib56","doi-asserted-by":"crossref","first-page":"E7428","DOI":"10.1073\/pnas.1800996115","article-title":"Phosphodiesterase 2 inhibition preferentially promotes NO\/guanylyl cyclase\/cGMP signaling to reverse the development of heart failure","volume":"115","author":"Baliga","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib57","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/S0022-5347(01)63299-3","article-title":"Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes","volume":"159","author":"Ballard","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.pharmr.2025.100042_bib58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/nbdi.2002.0492","article-title":"Beta-amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cells","volume":"10","author":"Baltrons","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib59","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.nbd.2004.07.022","article-title":"Reduced expression of NO-sensitive guanylyl cyclase in reactive astrocytes of Alzheimer disease, Creutzfeldt-Jakob disease, and multiple sclerosis brains","volume":"17","author":"Baltrons","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib60","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1016\/j.bmcl.2012.07.077","article-title":"Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson's disease model","volume":"22","author":"Banerjee","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib61","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1476-5381.2009.00170.x","article-title":"Dual PDE3\/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease","volume":"157","author":"Banner","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib62","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1073\/pnas.95.25.15020","article-title":"Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory","volume":"95","author":"Barad","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib63","doi-asserted-by":"crossref","first-page":"L332","DOI":"10.1152\/ajplung.00384.2003","article-title":"Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokers","volume":"287","author":"Barber","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib64","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2125.1998.t01-1-00689.x","article-title":"Effect of selective phosphodiesterase 3 inhibition on the early and late asthmatic responses to inhaled allergen","volume":"45","author":"Bardin","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib65","first-page":"433","article-title":"The effect of thymic humoral factor on intracellular lymphocyte cyclic AMP in alcoholic liver disease","volume":"5","author":"Barlas","year":"1983","journal-title":"Thymus"},{"key":"10.1016\/j.pharmr.2025.100042_bib66","article-title":"Phosphodiesterase 5 inhibitors for pulmonary hypertension","volume":"1","author":"Barnes","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib67","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1124\/pr.56.4.2","article-title":"Mediators of chronic obstructive pulmonary disease","volume":"56","author":"Barnes","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib68","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nri2254","article-title":"Immunology of asthma and chronic obstructive pulmonary disease","volume":"8","author":"Barnes","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib69","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/all.13760","article-title":"Inflammatory endotypes in COPD","volume":"74","author":"Barnes","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.pharmr.2025.100042_bib70","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0022-3565(24)37221-0","article-title":"SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions","volume":"284","author":"Barnette","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib71","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13195-018-0352-4","article-title":"Amyloid beta-induced impairments on mitochondrial dynamics, hippocampal neurogenesis, and memory are restored by phosphodiesterase 7 inhibition","volume":"10","author":"Bartolome","year":"2018","journal-title":"Alzheimer's Res Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib72","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3390\/cells11040660","article-title":"Treatment of experimental autoimmune encephalomyelitis with an inhibitor of phosphodiesterase-8 (PDE8)","volume":"11","author":"Basole","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.pharmr.2025.100042_bib73","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cellsig.2017.08.007","article-title":"PDE8 controls CD4(+) T cell motility through the PDE8A-Raf-1 kinase signaling complex","volume":"40","author":"Basole","year":"2017","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000088192","article-title":"Neonatal persistent pulmonary hypertension treated with milrinone: four case reports","volume":"89","author":"Bassler","year":"2006","journal-title":"Biol Neonate"},{"key":"10.1016\/j.pharmr.2025.100042_bib75","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/cvr\/cvy221","article-title":"Heart failure leads to altered beta2-adrenoceptor\/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman\/Na,K ATPase microdomain","volume":"115","author":"Bastug-\u00d6zel","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib76","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1038\/s41598-018-22193-0","article-title":"PDE4D regulates spine plasticity and memory in the retrosplenial cortex","volume":"8","author":"Baumgartel","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2025.100042_bib77","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1042\/CS20140753","article-title":"Phosphodiesterase 1 regulation is a key mechanism in vascular aging","volume":"129","author":"Bautista Ni\u00f1o","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pharmr.2025.100042_bib78","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.molimm.2009.10.032","article-title":"Distinct metabolism of cyclic adenosine monophosphate in regulatory and helper CD4+ T cells","volume":"47","author":"Bazhin","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib79","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1074\/jbc.275.14.10349","article-title":"UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions","volume":"275","author":"Beard","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib80","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuron.2016.10.064","article-title":"Phosphodiesterase 10A inhibition improves cortico-basal ganglia function in Huntington's disease models","volume":"92","author":"Beaumont","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2025.100042_bib81","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","article-title":"Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms","volume":"75","author":"Beavo","year":"1995","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib82","doi-asserted-by":"crossref","first-page":"E6240","DOI":"10.1073\/pnas.1703939114","article-title":"Analyses of PDE-regulated phosphoproteomes reveal unique and specific cAMP-signaling modules in T cells","volume":"114","author":"Beltejar","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib83","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","article-title":"Developmental relationships of four exhausted CD8(+) T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms","volume":"52","author":"Beltra","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.pharmr.2025.100042_bib84","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib85","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1073\/pnas.0408535102","article-title":"Selective up-regulation of PDE1B2 upon monocyte-to-macrophage differentiation","volume":"102","author":"Bender","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib86","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/CIRCRESAHA.120.318234","article-title":"cAMP imaging at ryanodine receptors reveals beta(2)-adrenoceptor driven arrhythmias","volume":"129","author":"Berisha","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib87","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib88","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.cellsig.2012.12.007","article-title":"Specific interactions between Epac1, \u03b2-arrestin2 and PDE4D5 regulate \u03b2-adrenergic receptor subtypes differential effects on cardiac hypertrophic signaling","volume":"25","author":"Berthouze-Duquesnes","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib89","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/ehf2.13327","article-title":"Evaluation of phosphodiesterase 9A as a novel biomarker in heart failure with preserved ejection fraction","volume":"8","author":"Besler","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.pharmr.2025.100042_bib90","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3389\/fphar.2020.00470","article-title":"PDE3 Inhibition reduces epithelial mast cell numbers in allergic airway inflammation and attenuates degranulation of basophils and mast cells","volume":"11","author":"Beute","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib91","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94888","article-title":"A pathophysiological role of PDE3 in allergic airway inflammation","volume":"3","author":"Beute","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmr.2025.100042_bib92","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.4049\/jimmunol.164.2.1117","article-title":"Therapeutic potential of phosphodiesterase-4 and -3 inhibitors in Th1-mediated autoimmune diseases","volume":"164","author":"Bielekova","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib93","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/jmg.10.3.253","article-title":"Hereditary brachydactyly associated with hypertension","volume":"10","author":"Bilginturan","year":"1973","journal-title":"J Med Genet"},{"key":"10.1016\/j.pharmr.2025.100042_bib94","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1124\/mol.114.093393","article-title":"Superiority of combined phosphodiesterase PDE3\/PDE4 inhibition over PDE4 inhibition alone on glucocorticoid- and long-acting \u03b22-adrenoceptor agonist-induced gene expression in human airway epithelial cells","volume":"87","author":"BinMahfouz","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib95","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/01.WCB.0000143536.22131.D7","article-title":"The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow","volume":"24","author":"Birk","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmr.2025.100042_bib96","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/andr.12695","article-title":"Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma","volume":"8","author":"Bisegna","year":"2020","journal-title":"Andrology"},{"key":"10.1016\/j.pharmr.2025.100042_bib97","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00415-008-5005-2","article-title":"Genes associated with Parkinson syndrome","volume":"255","author":"Biskup","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.pharmr.2025.100042_bib98","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1615\/CritRevImmunol.v26.i5.40","article-title":"Role of cAMP phosphodiesterase 4 in regulation of T-cell function","volume":"26","author":"Bjorgo","year":"2006","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib99","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1042\/BST20190252","article-title":"Reshaping cAMP nanodomains through targeted disruption of compartmentalised phosphodiesterase signalosomes","volume":"47","author":"Blair","year":"2019","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pharmr.2025.100042_bib100","first-page":"237","article-title":"ERAP1 and PDE8A Are Downregulated in Cattle Protected against Bovine Tuberculosis","volume":"27","author":"Blanco","year":"2017","journal-title":"J Mol Microbiol Biotechnol"},{"key":"10.1016\/j.pharmr.2025.100042_bib101","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bjp.0701833","article-title":"Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4","volume":"124","author":"Blease","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib102","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.tips.2019.10.006","article-title":"Phosphodiesterase type 4 inhibition in CNS diseases","volume":"40","author":"Blokland","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib103","doi-asserted-by":"crossref","first-page":"14188","DOI":"10.1073\/pnas.93.24.14188","article-title":"Identification and tissue-specific expression of PDE7 phosphodiesterase splice variants","volume":"93","author":"Bloom","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib104","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.acvd.2016.02.004","article-title":"Cyclic nucleotide phosphodiesterases in heart and vessels: a therapeutic perspective","volume":"109","author":"Bobin","year":"2016","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2006.09.035","article-title":"Inhibition of phosphodiesterase type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with cardiovascular risk factors and erectile dysfunction","volume":"196","author":"Bocchio","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmr.2025.100042_bib106","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.cell.2020.07.035","article-title":"Optical mapping of camp signaling at the nanometer scale","volume":"182","author":"Bock","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115809","article-title":"Andrographolide suppresses cisplatin-induced endothelial hyperpermeability through activation of PI3K\/Akt and eNOS -derived nitric oxide","volume":"28","author":"Bodiga","year":"2020","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib108","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.neuropharm.2004.07.040","article-title":"Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance","volume":"47","author":"Boess","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib109","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/jcbfm.2013.234","article-title":"C-type natriuretic peptide modulates permeability of the blood-brain barrier","volume":"34","author":"Bohara","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmr.2025.100042_bib110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-2008-1076694","article-title":"Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions","volume":"40","author":"Boikos","year":"2008","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib111","first-page":"6558","article-title":"A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs","volume":"13","author":"Bolger","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib112","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0898-6568(94)90018-3","article-title":"Molecular biology of the cyclic AMP-specific cyclic nucleotide phosphodiesterases: a diverse family of regulatory enzymes","volume":"6","author":"Bolger","year":"1994","journal-title":"Cellular signalling"},{"key":"10.1016\/j.pharmr.2025.100042_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1024423","article-title":"The cAMP-signaling cancers: Clinically-divergent disorders with a common central pathway","volume":"13","author":"Bolger","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.pharmr.2025.100042_bib114","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cellsig.2014.12.009","article-title":"Dimerization of cAMP phosphodiesterase-4 (PDE4) in living cells requires interfaces located in both the UCR1 and catalytic unit domains","volume":"27","author":"Bolger","year":"2015","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0378-1119(94)90155-4","article-title":"Differential CNS expression of alternative mRNA isoforms of the mammalian genes encoding cAMP-specific phosphodiesterases","volume":"149","author":"Bolger","year":"1994","journal-title":"Gene"},{"key":"10.1016\/j.pharmr.2025.100042_bib116","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.3390\/ijms21165704","article-title":"Dominant-negative attenuation of cAMP-selective phosphodiesterase PDE4D action affects learning and behavior","volume":"21","author":"Bolger","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib117","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(95)11323-O","article-title":"Reduced nitric oxide responsive soluble guanylyl cyclase activity in the superior temporal cortex of patients with Alzheimer's disease","volume":"187","author":"Bonkale","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib118","first-page":"47","article-title":"Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction","volume":"8","author":"Boolell","year":"1996","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib119","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.18632\/oncotarget.13640","article-title":"PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide","volume":"8","author":"Booth","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmr.2025.100042_bib120","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/jcp.24977","article-title":"OSU-03012 and viagra treatment inhibits the activity of multiple chaperone proteins and disrupts the blood\u2013brain barrier: implications for anti-cancer therapies","volume":"230","author":"Booth","year":"2015","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib121","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.20062129","article-title":"Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression","volume":"204","author":"Bopp","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib122","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.4049\/jimmunol.0803310","article-title":"Inhibition of cAMP degradation improves regulatory T cell-mediated suppression","volume":"182","author":"Bopp","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib123","doi-asserted-by":"crossref","first-page":"23s","DOI":"10.1002\/j.1552-4604.1981.tb02569.x","article-title":"Phylogenic and neurologic aspects of the vomiting process","volume":"21","author":"Borison","year":"1981","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib124","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCHEARTFAILURE.114.001915","article-title":"Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction","volume":"8","author":"Borlaug","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pharmr.2025.100042_bib125","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13048-022-01050-9","article-title":"Phosphodiesterase 10A (PDE10A) as a novel target to suppress \u03b2-catenin and RAS signaling in epithelial ovarian cancer","volume":"15","author":"Borneman","year":"2022","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib126","first-page":"4682","article-title":"ras oncogenes in human cancer: a review","volume":"49","author":"Bos","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib127","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1124\/jpet.105.099192","volume":"318","author":"Boswell-Smith","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib128","doi-asserted-by":"crossref","first-page":"70669","DOI":"10.18632\/oncotarget.12204","article-title":"Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases","volume":"7","author":"Bottcher","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmr.2025.100042_bib129","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/bjc.2015.335","article-title":"Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progression","volume":"113","author":"Bottcher","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pharmr.2025.100042_bib130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1126\/science.184.4132.19","article-title":"Modulation of inflammation and immunity by cyclic AMP","volume":"184","author":"Bourne","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2025.100042_bib131","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1101\/lm.5.4.365","article-title":"Different training procedures recruit either one or two critical periods for contextual memory consolidation, each of which requires protein synthesis and PKA","volume":"5","author":"Bourtchouladze","year":"1998","journal-title":"Lear Mem"},{"key":"10.1016\/j.pharmr.2025.100042_bib132","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.40.6.927","article-title":"Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease","volume":"40","author":"Boyce","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.pharmr.2025.100042_bib133","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmr.2025.100042_bib134","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1164\/rccm.201007-1099OC","article-title":"Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases","volume":"183","author":"Brassard","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib135","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1158\/1535-7163.MCT-20-0462","article-title":"The KRAS(G12C) inhibitor MRTX849 reconditions the tumor immune microenvironment and sensitizes tumors to checkpoint inhibitor therapy","volume":"20","author":"Briere","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib136","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1183\/09031936.00153108","article-title":"Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study","volume":"35","author":"Briggs","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmr.2025.100042_bib137","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1073\/pnas.96.12.6896","article-title":"Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment","volume":"96","author":"Brocke","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib138","doi-asserted-by":"crossref","first-page":"E1533","DOI":"10.1073\/pnas.1303004110","article-title":"Phosphodiesterase-8A binds to and regulates Raf-1 kinase","volume":"110","author":"Brown","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib139","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1183\/09031936.93.05080982","article-title":"Bronchodilatory effect of inhaled zardaverine, a phosphodiesterase III and IV inhibitor, in patients with asthma","volume":"5","author":"Brunn\u00e9e","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmr.2025.100042_bib140","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1177\/2050640620944140","article-title":"Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats","volume":"8","author":"Brusilovskaya","year":"2020","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.pharmr.2025.100042_bib141","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3390\/cells8121473","article-title":"An EPAC1\/PDE1C-signaling axis regulates formation of leading-edge protrusion in polarized human arterial vascular smooth muscle cells","volume":"8","author":"Brzezinska","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.pharmr.2025.100042_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100606","article-title":"Phosphodiesterase 1C integrates store-operated calcium entry and cAMP signaling in leading-edge protrusions of migrating human arterial myocytes","volume":"296","author":"Brzezinska","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib143","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/CIRCULATIONAHA.114.009751","article-title":"Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension","volume":"130","author":"Bubb","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib144","first-page":"151","article-title":"Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: safety, tolerability, and efficacy","volume":"2","author":"Buckley","year":"2010","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.pharmr.2025.100042_bib145","series-title":"Seminars in Oncology","first-page":"87","article-title":"Preclinical and clinical studies of docetaxel and exisulind in the treatment of human lung cancer","author":"Bunn","year":"2002"},{"key":"10.1016\/j.pharmr.2025.100042_bib146","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nbt.1598","article-title":"Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety","volume":"28","author":"Burgin","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmr.2025.100042_bib147","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40256-018-0272-5","article-title":"Pulmonary arterial hypertension: combination therapy in practice","volume":"18","author":"Burks","year":"2018","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.pharmr.2025.100042_bib148","first-page":"663","article-title":"Phosphodiesterase 3A expression is modulated by nitric oxide in rat pulmonary artery smooth muscle cells","volume":"61","author":"Busch","year":"2010","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib149","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0021-9258(18)60316-3","article-title":"Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine","volume":"237","author":"Butcher","year":"1962","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib150","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCRESAHA.122.322031","article-title":"CNP promotes antiarrhythmic effects via phosphodiesterase 2","volume":"132","author":"Cachorro","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib151","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1161\/CIRCRESAHA.116.304408","article-title":"Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia","volume":"116","author":"Cai","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib152","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1523\/JNEUROSCI.19-07-02489.1999","article-title":"A critical role of the nitric oxide\/cGMP pathway in corticostriatal long-term depression","volume":"19","author":"Calabresi","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib153","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s41465-017-0061-0","article-title":"A combination of nootropic ingredients (CAF++) is not better than caffeine in improving cognitive functions","volume":"2","author":"Caldenhove","year":"2017","journal-title":"J Cog Enhanc"},{"key":"10.1016\/j.pharmr.2025.100042_bib154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000172","article-title":"Persistent cAMP-signals triggered by internalized G-protein-coupled receptors","volume":"7","author":"Calebiro","year":"2009","journal-title":"PLoS Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JME-10-0014","article-title":"Imaging of persistent cAMP signaling by internalized G protein-coupled receptors","volume":"45","author":"Calebiro","year":"2010","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.pharmr.2025.100042_bib156","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1078-0432.CCR-14-1716","article-title":"Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma","volume":"21","author":"Califano","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib157","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(09)61255-1","article-title":"Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials","volume":"374","author":"Calverley","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pharmr.2025.100042_bib158","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1164\/rccm.200610-1563OC","article-title":"Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease","volume":"176","author":"Calverley","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib159","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pupt.2015.03.007","article-title":"Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3\/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways","volume":"32","author":"Calzetta","year":"2015","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib160","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/jpet.113.204644","article-title":"Effect of the mixed phosphodiesterase 3\/4 inhibitor RPL554 on human isolated bronchial smooth muscle tone","volume":"346","author":"Calzetta","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib161","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12868-017-0396-6","article-title":"Altered phosphorylation, electrophysiology, and behavior on attenuation of PDE4B action in hippocampus","volume":"18","author":"Campbell","year":"2017","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib162","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100042_bib163","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijcard.2018.09.043","article-title":"Pulmonary vasodilator therapies are of no benefit in pulmonary hypertension due to left heart disease: a meta-analysis","volume":"273","author":"Cao","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib164","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.1471-4159.1995.65031085.x","article-title":"The mammalian pineal expresses the cone but not the rod cyclic GMP phosphodiesterase","volume":"65","author":"Carcamo","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100042_bib165","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1152\/jn.1988.59.2.358","article-title":"Excitation of area postrema neurons by transmitters, peptides, and cyclic nucleotides","volume":"59","author":"Carpenter","year":"1988","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib166","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/CIRCULATIONAHA.105.599241","article-title":"Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes","volume":"113","author":"Castro","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib167","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1158\/1078-0432.CCR-15-1900","article-title":"Expression and function of phosphodiesterase type 5 in human breast cancer cell lines and tissues: implications for targeted therapy","volume":"22","author":"Catalano","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib168","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.2337\/db21-0100","article-title":"Increased energy expenditure and protection from diet-induced obesity in mice lacking the cGMP-specific phosphodiesterase PDE9","volume":"70","author":"Ceddia","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmr.2025.100042_bib169","doi-asserted-by":"crossref","first-page":"E1414","DOI":"10.1073\/pnas.1419906112","article-title":"Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4","volume":"112","author":"Cedervall","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.chembiol.2011.12.010","article-title":"Identification of biologically active PDE11-selective inhibitors using a yeast-based high-throughput screen","volume":"19","author":"Ceyhan","year":"2012","journal-title":"Chem Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib171","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02815117","article-title":"Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid beta peptide","volume":"35","author":"Chalimoniuk","year":"1998","journal-title":"Mol Chem Neuropathol"},{"key":"10.1016\/j.pharmr.2025.100042_bib172","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/sctm.21-0022","article-title":"Current concepts on endothelial stem cells definition, location, and markers","volume":"10","author":"Chambers","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib173","first-page":"904","article-title":"Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors","volume":"8","author":"Chan","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib174","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1253\/circj.72.825","article-title":"Cilostazol therapy attenuates monocrotaline-induced pulmonary arterial hypertension in rat model","volume":"72","author":"Chang","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.pharmr.2025.100042_bib175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4292\/wjgpt.v8.i1.47","article-title":"Plecanatide-mediated activation of guanylate cyclase-C suppresses inflammation-induced colorectal carcinogenesis in Apc(+\/Min-FCCC) mice","volume":"8","author":"Chang","year":"2017","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib176","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.actbio.2023.11.040","article-title":"Neutrophil-targeted combinatorial nanosystems for suppressing bacteremia-associated hyperinflammation and MRSA infection to improve survival rates","volume":"174","author":"Chang","year":"2024","journal-title":"Acta Biomater"},{"key":"10.1016\/j.pharmr.2025.100042_bib177","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"The Lancet Neurol"},{"key":"10.1016\/j.pharmr.2025.100042_bib178","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1203\/PDR.0b013e3181bce574","article-title":"Regulation of phosphodiesterase 3 in the pulmonary arteries during the perinatal period in sheep","volume":"66","author":"Chen","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib179","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/molehr\/gap035","article-title":"PDE8A genetic variation, polycystic ovary syndrome and androgen levels in women","volume":"15","author":"Chen","year":"2009","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.pharmr.2025.100042_bib180","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.vph.2012.09.001","article-title":"Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension","volume":"58","author":"Chen","year":"2013","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib181","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0003-4975(97)00011-8","article-title":"Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension","volume":"63","author":"Chen","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.pharmr.2025.100042_bib182","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00262-017-2005-z","article-title":"KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma","volume":"66","author":"Chen","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.pharmr.2025.100042_bib183","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCRESAHA.122.322264","article-title":"PDE10A inactivation prevents doxorubicin-induced cardiotoxicity and tumor growth","volume":"133","author":"Chen","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib184","article-title":"Roles of PDE1 in pathological cardiac remodeling and dysfunction","volume":"5","author":"Chen","year":"2018","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib185","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/17460441.2020.1821643","article-title":"An update of cyclic nucleotide phosphodiesterase as a target for cardiac diseases","volume":"16","author":"Chen","year":"2021","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.pharmr.2025.100042_bib186","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.119.042178","article-title":"A novel role of cyclic nucleotide phosphodiesterase 10A in pathological cardiac remodeling and dysfunction","volume":"141","author":"Chen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib187","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/5\/4\/046006","article-title":"A mathematical analysis of second messenger compartmentalization","volume":"5","author":"Chen","year":"2008","journal-title":"Phys Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108694","article-title":"Phosphodiesterase 7 (PDE7): a unique drug target for central nervous system diseases","volume":"196","author":"Chen","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib189","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.canlet.2019.01.013","article-title":"Kras(G12D) mutation contributes to regulatory T cell conversion through activation of the MEK\/ERK pathway in pancreatic cancer","volume":"446","author":"Cheng","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib190","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1021\/acs.jmedchem.0c00929","article-title":"Discovery of novel PDEdelta degraders for the treatment of KRAS mutant colorectal cancer","volume":"63","author":"Cheng","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib191","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/(SICI)1096-9861(19990503)407:2<287::AID-CNE9>3.0.CO;2-R","article-title":"Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect","volume":"407","author":"Cherry","year":"1999","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pharmr.2025.100042_bib192","first-page":"62","article-title":"The role of endothelin-1 in pulmonary arterial hypertension","volume":"2014","author":"Chester","year":"2014","journal-title":"Glob Cardiol Sci Pract"},{"key":"10.1016\/j.pharmr.2025.100042_bib193","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41398-018-0331-3","article-title":"Brain region-specific alterations of RNA editing in PDE8A mRNA in suicide decedents","volume":"9","author":"Chimienti","year":"2019","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100042_bib194","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.833832","article-title":"PDE4B is a homeostatic regulator of cyclic AMP in dendritic cells","volume":"13","author":"Chinn","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib195","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1128\/MCB.00365-16","article-title":"AMPK and endothelial nitric oxide synthase signaling regulates K-ras plasma membrane interactions via cyclic GMP-dependent protein kinase 2","volume":"36","author":"Cho","year":"2016","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib196","first-page":"641","article-title":"Effect of udenafil on portal venous pressure and hepatic fibrosis in rats. A novel therapeutic option for portal hypertension","volume":"59","author":"Choi","year":"2009","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.pharmr.2025.100042_bib197","doi-asserted-by":"crossref","first-page":"E2253","DOI":"10.1073\/pnas.1416230112","article-title":"Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia\/reperfusion injury","volume":"112","author":"Chung","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib198","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.3892\/etm.2017.4256","article-title":"Pharmacological management of non-alcoholic fatty liver disease: atorvastatin versus pentoxifylline","volume":"13","author":"Cioboata","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib199","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1124\/jpet.103.064691","volume":"310","author":"Claveau","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib200","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1161\/HYPERTENSIONAHA.123.21392","article-title":"Cellular senescence contributes to large elastic artery stiffening and endothelial dysfunction with aging: amelioration with senolytic treatment","volume":"80","author":"Clayton","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmr.2025.100042_bib201","unstructured":"Clinical_Trials_Arena (2003) Ariflo (Cilomilast)\u2014Oral PDE-IV Inhibitor for COPD."},{"key":"10.1016\/j.pharmr.2025.100042_bib202","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.immuni.2017.11.016","article-title":"Oncogenic RAS signaling promotes tumor immunoresistance by stabilizing PD-L1 mRNA","volume":"47","author":"Coelho","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.pharmr.2025.100042_bib203","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","article-title":"Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure","volume":"311","author":"Cohn","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib204","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: an update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.pharmr.2025.100042_bib205","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/ijnp\/pyad042","article-title":"Rolipram ameliorates memory deficits and depression-like behavior in APP\/PS1\/tau triple transgenic mice: involvement of neuroinflammation and apoptosis via cAMP signaling","volume":"26","author":"Cong","year":"2023","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib206","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1210\/mend.14.9.0534","article-title":"Phosphodiesterases and cyclic nucleotide signaling in endocrine cells","volume":"14","author":"Conti","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmr.2025.100042_bib207","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","article-title":"Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling","volume":"76","author":"Conti","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.pharmr.2025.100042_bib208","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/ejhf.2527","article-title":"Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo-controlled multicentre trial","volume":"24","author":"Cooper","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.pharmr.2025.100042_bib209","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/neuonc\/noz094","article-title":"Genetic variants and cognitive functions in patients with brain tumors","volume":"21","author":"Correa","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.pharmr.2025.100042_bib210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0300-2896(10)70052-1","article-title":"[Pharmacological profile of roflumilast]","volume":"46","author":"Cortijo Gimeno","year":"2010","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.pharmr.2025.100042_bib211","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1476-5381.2008.00041.x","article-title":"Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury","volume":"156","author":"Cortijo","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib212","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00424-021-02562-x","article-title":"Photoreceptor phosphodiesterase (PDE6): activation and inactivation mechanisms during visual transduction in rods and cones","volume":"473","author":"Cote","year":"2021","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.pharmr.2025.100042_bib213","first-page":"33","article-title":"Photoreceptor Phosphodiesterase (PDE6): structure, regulatory mechanisms, and implications for treatment of retinal diseases","volume":"Volume 22","author":"Cote","year":"2022"},{"key":"10.1016\/j.pharmr.2025.100042_bib214","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0100-2018","article-title":"Fibrosing interstitial lung diseases: knowns and unknowns","volume":"28","author":"Cottin","year":"2019","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib215","doi-asserted-by":"crossref","first-page":"13812","DOI":"10.1074\/jbc.275.18.13812","article-title":"Activated 3',5'-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line","volume":"275","author":"Cox","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib216","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.111.00676","article-title":"Inhibition of phosphodiesterase-1 attenuates cold-induced pulmonary hypertension","volume":"61","author":"Crosswhite","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmr.2025.100042_bib217","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/j.1476-5381.2011.01517.x","article-title":"Sildenafil restores cognitive function without affecting beta-amyloid burden in a mouse model of Alzheimer's disease","volume":"164","author":"Cuadrado-Tejedor","year":"2011","journal-title":"British J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib218","first-page":"290","article-title":"Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitis","volume":"39","author":"Culafic","year":"2020","journal-title":"J Med Biochem"},{"key":"10.1016\/j.pharmr.2025.100042_bib219","doi-asserted-by":"crossref","first-page":"32","DOI":"10.9740\/mhc.2022.01.032","article-title":"Istradefylline: a novel agent in the treatment of \"off\" episodes associated with levodopa\/carbidopa use in Parkinson disease","volume":"12","author":"Cummins","year":"2022","journal-title":"Ment Health Clin"},{"key":"10.1016\/j.pharmr.2025.100042_bib220","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1183\/09059180.00004712","article-title":"Pulmonary arterial hypertension associated with congenital heart disease","volume":"21","author":"D'Alto","year":"2012","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib221","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1460-9568.2005.04321.x","article-title":"Differential expression and regulation of the cAMP-selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration","volume":"22","author":"D'Sa","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib222","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1074\/jbc.RA119.007420","article-title":"Phosphorylation of HSP90 by protein kinase A is essential for the nuclear translocation of androgen receptor","volume":"294","author":"Dagar","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib223","doi-asserted-by":"crossref","first-page":"18202","DOI":"10.1073\/pnas.1006965107","article-title":"Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction","volume":"107","author":"Das","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib224","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/PAF.0b013e31822a644a","article-title":"Subarachnoid hemorrhage during sexual activity after sildenafil intake: an accidental association?","volume":"32","author":"De-Giorgio","year":"2011","journal-title":"Am J Forensic Med Pathol"},{"key":"10.1016\/j.pharmr.2025.100042_bib225","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1530\/ERC-15-0134","article-title":"Phosphodiesterase sequence variants may predispose to prostate cancer","volume":"22","author":"de Alexandre","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.pharmr.2025.100042_bib226","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1096\/fj.07-098921","article-title":"Protective effects of phosphodiesterase-4 (PDE-4) inhibition in the early phase of pulmonary arterial hypertension in transgenic sickle cell mice","volume":"22","author":"De Franceschi","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmr.2025.100042_bib227","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainres.2009.11.009","article-title":"Dopamine D1, D2 and mu-opioid receptors are co-expressed with adenylyl cyclase 5 and phosphodiesterase 7B mRNAs in striatal rat cells","volume":"1310","author":"De Gortari","year":"2010","journal-title":"Brain research"},{"key":"10.1016\/j.pharmr.2025.100042_bib228","doi-asserted-by":"crossref","first-page":"1017.e1011","DOI":"10.1016\/j.neurobiolaging.2011.09.033","article-title":"A genome-wide scan for common variants affecting the rate of age-related cognitive decline","volume":"33","author":"De Jager","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmr.2025.100042_bib229","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuropharm.2008.06.025","article-title":"Amelioration of recognition memory impairment associated with iron loading or aging by the type 4-specific phosphodiesterase inhibitor rolipram in rats","volume":"55","author":"de Lima","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cellsig.2017.08.011","article-title":"Identification and characterization of a potent and biologically-active PDE4\/7 inhibitor via fission yeast-based assays","volume":"40","author":"de Medeiros","year":"2017","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib231","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/COPD.S31236","article-title":"The association between COPD and heart failure risk: a review","volume":"8","author":"de Miguel D\u00edez","year":"2013","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib232","first-page":"1224","article-title":"Apremilast for discoid lupus erythematosus: results of a phase 2, open-label, single-arm, pilot study","volume":"11","author":"De Souza","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.pharmr.2025.100042_bib233","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cnur.2017.04.009","article-title":"Impaired sleep: a multifaceted geriatric syndrome","volume":"52","author":"Dean","year":"2017","journal-title":"Nurs Clin North Am"},{"key":"10.1016\/j.pharmr.2025.100042_bib234","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib235","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/jth.15844","article-title":"The NO\/cGMP\/PKG pathway in platelets: the therapeutic potential of PDE5 inhibitors in platelet disorders","volume":"20","author":"Degjoni","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.pharmr.2025.100042_bib236","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3748\/wjg.v24.i3.438","article-title":"Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: a case report with 8 years follow-up","volume":"24","author":"Deibert","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pharmr.2025.100042_bib237","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071279","article-title":"A yeast-based chemical screen identifies a PDE inhibitor that elevates steroidogenesis in mouse Leydig cells via PDE8 and PDE4 inhibition","volume":"8","author":"Demirbas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2025.100042_bib238","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1016\/j.bmcl.2011.03.022","article-title":"1,5-Substituted nipecotic amides: selective PDE8 inhibitors displaying diastereomer-dependent microsomal stability","volume":"21","author":"DeNinno","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib239","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ijc.24806","article-title":"Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A","volume":"126","author":"Desiniotis","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pharmr.2025.100042_bib240","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0168-8278(99)80192-5","article-title":"Effect of pentoxifylline on early proliferation and phenotypic modulation of fibrogenic cells in two rat models of liver fibrosis and on cultured hepatic stellate cells","volume":"30","author":"Desmouliere","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.pharmr.2025.100042_bib241","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/NRE-131022","article-title":"Phosphodiesterase inhibition facilitates cognitive restoration in rodent models of age-related memory decline","volume":"34","author":"Devan","year":"2014","journal-title":"NeuroRehabilitation"},{"key":"10.1016\/j.pharmr.2025.100042_bib242","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jaci.2010.06.051","article-title":"PDE11A associations with asthma: results of a genome-wide association scan","volume":"126","author":"DeWan","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib243","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.543727","article-title":"Selective phosphodiesterase 1 inhibitor BTTQ reduces blood pressure in spontaneously hypertensive and dahl salt sensitive rats: role of peripheral vasodilation","volume":"11","author":"Dey","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib244","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fped.2019.00246","article-title":"Epidemiology of asthma in children and adults","volume":"7","author":"Dharmage","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.pharmr.2025.100042_bib245","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/CIRCRESAHA.108.174813","article-title":"Protein kinase A type I and type II define distinct intracellular signaling compartments","volume":"103","author":"Di Benedetto","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib246","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1073\/pnas.84.5.1413","article-title":"Basal and adenosine receptor-stimulated levels of cAMP are reduced in lymphocytes from alcoholic patients","volume":"84","author":"Diamond","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib247","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.yjmcc.2011.11.007","article-title":"Guanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte","volume":"52","author":"Dickey","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib248","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/CIRCRESAHA.109.196592","article-title":"Phosphodiesterase 2 mediates redox-sensitive endothelial cell proliferation and angiogenesis by thrombin via Rac1 and NADPH oxidase 2","volume":"104","author":"Diebold","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib249","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14559","article-title":"Nitric oxide activates AMPK by modulating PDE3A in human pulmonary artery smooth muscle cells","volume":"8","author":"Dillard","year":"2020","journal-title":"Physiol Rep"},{"key":"10.1016\/j.pharmr.2025.100042_bib250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019329","article-title":"The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1\/P-glycoprotein transporter","volume":"6","author":"Ding","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2025.100042_bib251","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2147\/COPD.S347588","article-title":"Efficacy of ICS versus non-ICS combination therapy in COPD: a meta-analysis of randomised controlled trials","volume":"17","author":"Ding","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib252","doi-asserted-by":"crossref","first-page":"16513","DOI":"10.1073\/pnas.0405973101","article-title":"Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signalling within discrete subcellular compartments","volume":"101","author":"DiPilato","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib253","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Disease","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.pharmr.2025.100042_bib254","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/emboj\/20.8.1921","article-title":"mAKAP assembles a protein kinase A\/PDE4 phosphodiesterase cAMP signaling module","volume":"20","author":"Dodge","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmr.2025.100042_bib255","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainres.2008.02.108","article-title":"The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging","volume":"1216","author":"Domek-Lopacinska","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib256","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/jpet.116.232819","article-title":"Treatment of skin inflammation with benzoxaborole phosphodiesterase inhibitors: selectivity, cellular activity, and effect on cytokines associated with skin inflammation and skin architecture changes","volume":"358","author":"Dong","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib257","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10549-015-3445-9","article-title":"Inhibition of breast cancer cell migration by activation of cAMP signaling","volume":"152","author":"Dong","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.pharmr.2025.100042_bib258","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bbrc.2006.04.143","article-title":"Phosphodiesterase 8 (PDE8) regulates chemotaxis of activated lymphocytes","volume":"345","author":"Dong","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2025.100042_bib259","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bcp.2009.09.001","article-title":"Inhibition of PDE3, PDE4 and PDE7 potentiates glucocorticoid-induced apoptosis and overcomes glucocorticoid resistance in CEM T leukemic cells","volume":"79","author":"Dong","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib260","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2147\/COPD.S413436","article-title":"Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD","volume":"18","author":"Donohue","year":"2023","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib261","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1183\/09031936.00002007","article-title":"Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3\/4 inhibition","volume":"31","author":"Dony","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmr.2025.100042_bib262","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01527-2017","article-title":"Challenging the concept of adding more drugs in pulmonary arterial hypertension","volume":"50","author":"Dos Santos Fernandes","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmr.2025.100042_bib263","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1523-1755.1999.00233.x","article-title":"Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney","volume":"55","author":"Dousa","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharmr.2025.100042_bib264","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejphar.2010.02.036","article-title":"Etazolate improves performance in a foraging and homing task in aged rats","volume":"634","author":"Drott","year":"2010","journal-title":"European journal of pharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib265","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.4155\/fmc-2023-0101","article-title":"PDE4 inhibitors for disease therapy: advances and future perspective","volume":"15","author":"Du","year":"2023","journal-title":"Future Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib266","first-page":"1","article-title":"Granulocyte colony-stimulating factor plus pentoxifylline increases short-term survival in patients with severe alcoholic hepatitis: a network meta-analysis","author":"Duan","year":"2023","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.pharmr.2025.100042_bib267","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/08923978209031077","article-title":"Inhibition of lymphocyte-mediated cytolysis and cyclic AMP phosphodiesterase by erythro-9-(2-hydroxy-3-nonyl)adenine","volume":"4","author":"Duncan","year":"1982","journal-title":"J Immunopharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib268","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202101169","article-title":"Single serine on TSC2 exerts biased control over mTORC1 activation mediated by ERK1\/2 but not Akt","volume":"5","author":"Dunkerly-Eyring","year":"2022","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.pharmr.2025.100042_bib269","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2007.06.036","article-title":"Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase","volume":"572","author":"Dunkern","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib270","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1111\/j.1742-4658.2007.06001.x","article-title":"Characterization of inhibitors of phosphodiesterase 1C on a human cellular system","volume":"274","author":"Dunkern","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.pharmr.2025.100042_bib271","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/thx.24.2.176","article-title":"A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema","volume":"24","author":"Dunnill","year":"1969","journal-title":"Thorax"},{"key":"10.1016\/j.pharmr.2025.100042_bib272","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1021\/acs.jmedchem.7b00302","article-title":"Discovery of selective phosphodiesterase 1 inhibitors with memory enhancing properties","volume":"60","author":"Dyck","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib273","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1510\/icvts.2009.205849A","article-title":"eComment: acute aortic dissection in children and young adults\u2014the role of sildenafil","volume":"9","author":"Edwin","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.pharmr.2025.100042_bib274","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1601-183X.2006.00209.x","article-title":"Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice","volume":"5","author":"Ehrman","year":"2006","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.pharmr.2025.100042_bib275","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.4049\/jimmunol.159.3.1520","article-title":"Differential expression of cyclic nucleotide phosphodiesterase 3 and 4 activities in human T cell clones specific for myelin basic protein","volume":"159","author":"Ekholm","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib276","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10741-008-9132-8","article-title":"\u03b2-adrenergic stimulation and myocardial function in the failing heart","volume":"14","author":"El-Armouche","year":"2009","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib277","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/fcp.12530","article-title":"Comparative effectiveness of phosphodiesterase 3, 4, and 5 inhibitors in amelioration of high-fat diet-induced nonalcoholic fatty liver in rats","volume":"34","author":"El-Deen","year":"2020","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib278","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.molimm.2013.11.020","article-title":"Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes","volume":"58","author":"El-Jawhari","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib279","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/biom10101433","article-title":"cAMP signaling in pathobiology of alcohol associated liver disease","volume":"10","author":"Elnagdy","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.pharmr.2025.100042_bib280","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/path.6194","article-title":"Increased expression of phosphodiesterase 4 in activated hepatic stellate cells promotes cytoskeleton remodeling and cell migration","volume":"261","author":"Elnagdy","year":"2023","journal-title":"J Pathol"},{"key":"10.1016\/j.pharmr.2025.100042_bib281","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173183","article-title":"A novel phosphodiesterase 1 inhibitor reverses L-dopa-induced dyskinesia, but not motivation deficits, in monkeys","volume":"205","author":"Enomoto","year":"2021","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmr.2025.100042_bib282","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/meth.1997.0562","article-title":"Antisense inhibition of phosphodiesterase expression","volume":"14","author":"Epstein","year":"1998","journal-title":"Methods"},{"key":"10.1016\/j.pharmr.2025.100042_bib283","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/0006-291X(82)91089-0","article-title":"Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin","volume":"105","author":"Epstein","year":"1982","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2025.100042_bib284","first-page":"303","article-title":"Cyclic nucleotide phosphodiesterase in normal and leukemic human lymphocytes and lymphoblasts","volume":"16","author":"Epstein","year":"1984","journal-title":"Adv Cyclic Nucleotide Protein Phosphorylation Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib285","first-page":"379","article-title":"Activation of cyclic nucleotide phosphodiesterase from isolated human peripheral blood lymphocytes by mitogenic agents","volume":"40","author":"Epstein","year":"1980","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib286","first-page":"4016","article-title":"Increased cyclic nucleotide phosphodiesterase activity associated with proliferation and cancer in human and murine lymphoid cells","volume":"37","author":"Epstein","year":"1977","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib287","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1042\/bj2430533","article-title":"Identification and characterization of a Ca2+-calmodulin-sensitive cyclic nucleotide phosphodiesterase in a human lymphoblastoid cell line","volume":"243","author":"Epstein","year":"1987","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmr.2025.100042_bib288","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1161\/CIRCULATIONAHA.122.060210","article-title":"Mutant phosphodiesterase 3A protects from hypertension-induced cardiac damage","volume":"146","author":"Ercu","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib289","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/HYPERTENSIONAHA.122.19433","article-title":"Mutations in phosphodiesterase 3A (PDE3A) cause hypertension without cardiac damage","volume":"80","author":"Ercu","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmr.2025.100042_bib290","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1042\/bj3210165","volume":"321","author":"Erdogan","year":"1997","journal-title":"Biochemical J"},{"key":"10.1016\/j.pharmr.2025.100042_bib291","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1164\/rccm.200611-1630OC","article-title":"Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia","volume":"176","author":"Ernst","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib292","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.lfs.2019.03.014","article-title":"Phosphodiestrase-1 and 4 inhibitors ameliorate liver fibrosis in rats: Modulation of cAMP\/CREB\/TLR4 inflammatory and fibrogenic pathways","volume":"222","author":"Essam","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib293","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03957-2020","article-title":"Endothelial cells in the pathogenesis of pulmonary arterial hypertension","volume":"58","author":"Evans","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmr.2025.100042_bib294","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S2213-2600(15)00544-5","article-title":"BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis","volume":"4","author":"Evans","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib295","doi-asserted-by":"crossref","first-page":"L723","DOI":"10.1152\/ajplung.00485.2004","article-title":"Inhibition of phosphodiesterase 1 augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs with acute pulmonary hypertension","volume":"290","author":"Evgenov","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib296","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0140-6736(09)61252-6","article-title":"Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with long-acting bronchodilators: two randomised clinical trials","volume":"374","author":"Fabbri","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pharmr.2025.100042_bib297","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.740803","article-title":"Tanimilast, a novel inhaled Pde4 inhibitor for the treatment of asthma and chronic obstructive pulmonary disease","volume":"12","author":"Facchinetti","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib298","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109592","article-title":"Phosphodiesterases PDE2A and PDE10A both change mRNA expression in the human brain with age, but only PDE2A changes in a region-specific manner with psychiatric disease","volume":"70","author":"Farmer","year":"2020","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib299","first-page":"19","article-title":"Value of sildenafil treatment for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction following aneurysmal subarachnoid hemorrhage","volume":"3","author":"Faropoulos","year":"2023","journal-title":"Med Int (Lond)"},{"key":"10.1016\/j.pharmr.2025.100042_bib300","doi-asserted-by":"crossref","first-page":"E135","DOI":"10.1210\/jc.2010-1655","article-title":"Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer","volume":"96","author":"Faucz","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmr.2025.100042_bib301","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1160\/TH03-12-0768","article-title":"Modulation of VEGF-induced endothelial cell cycle protein expression through cyclic AMP hydrolysis by PDE2 and PDE4","volume":"92","author":"Favot","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pharmr.2025.100042_bib302","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1073\/pnas.97.7.3702","article-title":"Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A","volume":"97","author":"Fawcett","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib303","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/mds.27963","article-title":"PET Molecular imaging of phosphodiesterase 10A: an early biomarker of Huntington's disease progression","volume":"35","author":"Fazio","year":"2020","journal-title":"Move Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib304","doi-asserted-by":"crossref","first-page":"C839","DOI":"10.1152\/ajpcell.00361.2011","article-title":"Assessment of cellular mechanisms contributing to cAMP compartmentalization in pulmonary microvascular endothelial cells","volume":"302","author":"Feinstein","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib305","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11011-018-0374-4","article-title":"Roflumilast ameliorates cognitive impairment in APP\/PS1 mice via cAMP\/CREB\/BDNF signaling and anti-neuroinflammatory effects","volume":"34","author":"Feng","year":"2019","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib306","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nchembio.206","article-title":"Sustained cyclic AMP production by parathyroid hormone receptor endocytosis","volume":"5","author":"Ferrandon","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib307","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrneurol.2016.200","article-title":"The psychosis spectrum in Parkinson disease","volume":"13","author":"Ffytche","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.pharmr.2025.100042_bib308","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/jamp.2017.1369","article-title":"Investigation of lung pharmacokinetic of the novel PDE4 inhibitor CHF6001 in preclinical models: evaluation of the preciseinhale technology","volume":"31","author":"Fioni","year":"2018","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.pharmr.2025.100042_bib309","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejmech.2012.12.009","article-title":"Synthesis of quinoline derivatives: discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease","volume":"60","author":"Fiorito","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib310","doi-asserted-by":"crossref","first-page":"15559","DOI":"10.1074\/jbc.273.25.15559","article-title":"Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase","volume":"273","author":"Fisher","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib311","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1074\/jbc.M112.403279","article-title":"Type 10 soluble adenylyl cyclase is overexpressed in prostate carcinoma and controls proliferation of prostate cancer cells","volume":"288","author":"Flacke","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib312","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1743-6109.2008.01014.x","article-title":"The PDE5 inhibitor sildenafil increases circulating endothelial progenitor cells and CXCR4 expression","volume":"6","author":"Foresta","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib313","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2125.2005.02553.x","article-title":"Tadalafil pharmacokinetics in healthy subjects","volume":"61","author":"Forgue","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib314","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1465-9921-10-39","article-title":"A multi-target antisense approach against PDE4 and PDE7 reduces smoke-induced lung inflammation in mice","volume":"10","author":"Fortin","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib315","first-page":"7449","article-title":"A randomized controlled trial comparing the effects of Vitamin E, Ursodeoxycholic acid and Pentoxifylline on Egyptian non-alcoholic steatohepatitis patients","volume":"25","author":"Fouda","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib316","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cellsig.2013.12.003","article-title":"Structural basis for the design of selective phosphodiesterase 4B inhibitors","volume":"26","author":"Fox","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib317","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mad.2006.11.016","article-title":"Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans","volume":"128","author":"Franceschi","year":"2007","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.pharmr.2025.100042_bib318","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2213-2600(13)70187-5","article-title":"Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials","volume":"1","author":"Franciosi","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib319","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00030.2010","article-title":"Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions","volume":"91","author":"Francis","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib320","series-title":"Cyclic Nucleotide Phosphodiesterases in Health and Disease","first-page":"131","article-title":"Phosphodiesterase 5: molecular characteristics relating to structure, function, and regulation","author":"Francis","year":"2006"},{"key":"10.1016\/j.pharmr.2025.100042_bib321","article-title":"Inflammation, immunity, and vascular remodeling in pulmonary hypertension; Evidence for complement involvement?","volume":"2020","author":"Frid","year":"2020","journal-title":"Glob Cardiol Sci Pract"},{"key":"10.1016\/j.pharmr.2025.100042_bib322","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13195-019-0467-2","article-title":"Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease","volume":"11","author":"Frolich","year":"2019","journal-title":"Alzheimer's Res Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib323","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000237698","article-title":"Effect of a phosphodiesterase 3 inhibitor, cilostazol, on bronchial hyperresponsiveness in elderly patients with asthma","volume":"114","author":"Fujimura","year":"1997","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib324","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1164\/ajrccm.151.1.7812559","article-title":"Bronchodilator and bronchoprotective effects of cilostazol in humans in vivo","volume":"151","author":"Fujimura","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib325","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000023948","article-title":"Bronchoprotective effect of an intrabronchial administration of cilostazol powder and a nebulized PDE1 and PDE4 inhibitor KF19514 in guinea pigs","volume":"116","author":"Fujimura","year":"1998","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib326","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1046\/j.1432-1327.2000.01661.x","article-title":"The human phosphodiesterase PDE10A gene genomic organization and evolutionary relatedness with other PDEs containing GAF domains","volume":"267","author":"Fujishige","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.pharmr.2025.100042_bib327","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jacbts.2019.12.009","article-title":"Estrogen receptor-\u03b1 non-nuclear signaling confers cardioprotection and is essential to cGMP-PDE5 inhibition efficacy","volume":"5","author":"Fukuma","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib328","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1002\/cam4.1500","article-title":"Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer","volume":"7","author":"Fusco","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib329","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Galie","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib330","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib331","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmr.2025.100042_bib332","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0898-6568(02)00146-8","article-title":"Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans","volume":"15","author":"Gamanuma","year":"2003","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib333","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sj.bjp.0701688","article-title":"Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation","volume":"123","author":"Gantner","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib334","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/sj.bjp.0701124","article-title":"In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors","volume":"121","author":"Gantner","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib335","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-3565(24)36389-X","article-title":"Protection from T cell-mediated murine liver failure by phosphodiesterase inhibitors","volume":"280","author":"Gantner","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib336","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/pupt.1999.0220","article-title":"Characterization of the phosphodiesterase (PDE) pattern of in vitro-generated human dendritic cells (DC) and the influence of PDE inhibitors on DC function","volume":"12","author":"Gantner","year":"1999","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib337","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0091-6749(97)70146-5","article-title":"Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative study","volume":"100","author":"Gantner","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib338","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s12276-022-00815-y","article-title":"Phosphodiesterase 4D contributes to angiotensin II-induced abdominal aortic aneurysm through smooth muscle cell apoptosis","volume":"54","author":"Gao","year":"2022","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib339","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuropharm.2012.06.052","article-title":"Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD","volume":"64","author":"Garcia-Barroso","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib340","doi-asserted-by":"crossref","first-page":"8590","DOI":"10.1021\/jm501090m","article-title":"Modulation of cAMP-specific PDE without emetogenic activity: new sulfide-like PDE7 inhibitors","volume":"57","author":"Garcia","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib341","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12931-023-02531-1","article-title":"Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry","volume":"24","author":"Garcia","year":"2023","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib342","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/cvr\/cvab208","article-title":"Efficacy and limitations of senolysis in atherosclerosis","volume":"118","author":"Garrido","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib343","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1165\/rcmb.2012-0262OC","article-title":"Reversal of myofibroblast differentiation by prostaglandin E(2)","volume":"48","author":"Garrison","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib344","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nature05543","article-title":"Foxp3-dependent programme of regulatory T-cell differentiation","volume":"445","author":"Gavin","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100042_bib345","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/14737175.2017.1268531","article-title":"Phosphodiesterase 10 inhibitors in clinical development for CNS disorders","volume":"17","author":"Geerts","year":"2017","journal-title":"Expert review of neurotherapeutics"},{"key":"10.1016\/j.pharmr.2025.100042_bib346","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/abbi.2000.2252","article-title":"Characterization of an in vivo hormonally regulated phosphodiesterase 3 (PDE3) associated with a liver Golgi-endosomal fraction","volume":"387","author":"Geoffroy","year":"2001","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pharmr.2025.100042_bib347","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106293","article-title":"Interventional and pharmacological management of chronic thromboembolic pulmonary hypertension","volume":"177","author":"Ghofrani","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib348","doi-asserted-by":"crossref","first-page":"68S","DOI":"10.1016\/j.jacc.2004.02.031","article-title":"Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension","volume":"43","author":"Ghofrani","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib349","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0735-1097(03)00555-2","article-title":"Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension","volume":"42","author":"Ghofrani","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib350","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1097\/00003246-200211000-00014","article-title":"Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in severe pulmonary hypertension","volume":"30","author":"Ghofrani","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib351","first-page":"1488","article-title":"Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study","volume":"44","author":"Ghofrani","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib352","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013417","article-title":"Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6\/2 mouse model of Huntington's disease","volume":"5","author":"Giampa","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.pharmr.2025.100042_bib353","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.nbd.2009.02.014","article-title":"Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease","volume":"34","author":"Giampa","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib354","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM199305063281805","article-title":"Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis","volume":"328","author":"Giardiello","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib355","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/0006-2952(92)90160-K","article-title":"Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma?","volume":"43","author":"Giembycz","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib356","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0165-6147(96)10039-0","article-title":"Phosphodiesterase 4 and tolerance to beta 2-adrenoceptor agonists in asthma","volume":"17","author":"Giembycz","year":"1996","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib357","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1517\/13543784.10.7.1361","article-title":"Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease","volume":"10","author":"Giembycz","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmr.2025.100042_bib358","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0165-6147(02)02089-8","article-title":"4D or not 4D\u2014the emetogenic basis of PDE4 inhibitors uncovered?","volume":"23","author":"Giembycz","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib359","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.coph.2005.04.001","article-title":"Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors","volume":"5","author":"Giembycz","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib360","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1513\/pats.200504-041SR","article-title":"Phosphodiesterase-4: selective and dual-specificity inhibitors for the therapy of chronic obstructive pulmonary disease","volume":"2","author":"Giembycz","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.pharmr.2025.100042_bib361","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2125.2006.02640.x","article-title":"An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease","volume":"62","author":"Giembycz","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib362","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/bjp.2008.297","article-title":"Can the anti-inflammatory potential of PDE4 inhibitors be realized: guarded optimism or wishful thinking?","volume":"155","author":"Giembycz","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib363","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1476-5381.2009.00277.x","article-title":"An estimation of \u03b22-adrenoceptor reserve on human bronchial smooth muscle for some sympathomimetic bronchodilators","volume":"158","author":"Giembycz","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib364","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0006-2952(91)90330-8","article-title":"Selective inhibition of a high affinity type IV cyclic AMP phosphodiesterase in bovine trachealis by AH 21\u2013132. Relevance to the spasmolytic and anti-spasmogenic actions of AH 21-132 in the intact tissue","volume":"42","author":"Giembycz","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib365","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1476-5381.1996.tb15629.x","article-title":"Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2","volume":"118","author":"Giembycz","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib366","first-page":"147","article-title":"Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD","volume":"4","author":"Giembycz","year":"2010","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib367","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/sj.bjp.0707627","article-title":"A Holy Grail of asthma management: toward understanding how long-acting \u03b22-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids","volume":"153","author":"Giembycz","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib368","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coph.2014.04.001","article-title":"Cyclic nucleotide-based therapeutics for chronic obstructive pulmonary disease","volume":"16","author":"Giembycz","year":"2014","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib369","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/978-3-642-17969-3_18","article-title":"Harnessing the clinical efficacy of phosphodiesterase 4 inhibitors in inflammatory lung diseases: dual-selective phosphodiesterase inhibitors and novel combination therapies","volume":"204","author":"Giembycz","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib370","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ccm.2013.09.007","article-title":"How phosphodiesterase 4 inhibitors work in patients with chronic obstructive pulmonary disease of the severe, bronchitic, frequent exacerbator phenotype","volume":"35","author":"Giembycz","year":"2014","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib371","doi-asserted-by":"crossref","first-page":"16","DOI":"10.12703\/P7-16","article-title":"Potential mechanisms to explain how LABAs and PDE4 inhibitors enhance the clinical efficacy of glucocorticoids in inflammatory lung diseases","volume":"7","author":"Giembycz","year":"2015","journal-title":"F1000Prime Rep"},{"key":"10.1016\/j.pharmr.2025.100042_bib372","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1358\/dof.2006.031.03.966246","article-title":"Phosphodiesterase 7 as a therapeutic target","volume":"31","author":"Giembycz","year":"2006","journal-title":"Drug Future"},{"key":"10.1016\/j.pharmr.2025.100042_bib373","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.2174\/138161206778194123","article-title":"Phosphodiesterase 7A: a new therapeutic target for alleviating chronic inflammation?","volume":"12","author":"Giembycz","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmr.2025.100042_bib374","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/tera.1420160108","article-title":"The effects of methylxanthines on catecholamine-stimulated and normal chick embryos","volume":"16","author":"Gilbert","year":"1977","journal-title":"Teratology"},{"key":"10.1016\/j.pharmr.2025.100042_bib375","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008236","article-title":"Acute hemodynamic effects and tolerability of phosphodiesterase-1 inhibition with ITI-214 in human systolic heart failure","volume":"14","author":"Gilotra","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pharmr.2025.100042_bib376","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmr.2025.100042_bib377","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1460-9568.2008.06387.x","article-title":"Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms","volume":"28","author":"Giorgi","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib378","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/hipo.22128","article-title":"PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model","volume":"23","author":"Giralt","year":"2013","journal-title":"Hippocampus"},{"key":"10.1016\/j.pharmr.2025.100042_bib379","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1073\/pnas.101131098","article-title":"T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3","volume":"98","author":"Glavas","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib380","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1124\/jpet.110.174268","article-title":"S-adenosylmethionine decreases lipopolysaccharide-induced phosphodiesterase 4B2 and attenuates tumor necrosis factor expression via cAMP\/protein kinase A pathway","volume":"337","author":"Gobejishvili","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib381","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/jpet.113.204933","article-title":"Rolipram attenuates bile duct ligation-induced liver injury in rats: a potential pathogenic role of PDE4","volume":"347","author":"Gobejishvili","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib382","doi-asserted-by":"crossref","first-page":"G718","DOI":"10.1152\/ajpgi.90232.2008","article-title":"Enhanced PDE4B expression augments LPS-inducible TNF expression in ethanol-primed monocytes: relevance to alcoholic liver disease","volume":"295","author":"Gobejishvili","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib383","doi-asserted-by":"crossref","first-page":"G681","DOI":"10.1152\/ajpgi.00098.2006","article-title":"Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-kappaB activity and TNF expression: relevance to alcoholic liver disease","volume":"291","author":"Gobejishvili","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib384","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00213-008-1278-5","article-title":"A placebo-controlled study of sildenafil effects on cognition in schizophrenia","volume":"202","author":"Goff","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib385","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0165-0173(99)00045-4","article-title":"D1 receptors in prefrontal cells and circuits","volume":"31","author":"Goldman-Rakic","year":"2000","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib386","article-title":"The effects of acute and chronic selective phosphodiesterase 1 inhibition on smooth muscle cell-associated aging features","volume":"12","author":"Golshiri","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib387","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.3390\/ijms21134667","article-title":"Chronic sildenafil treatment improves vasomotor function in a mouse model of accelerated aging","volume":"21","author":"Golshiri","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib388","first-page":"14","article-title":"The importance of the nitric oxide-cGMP pathway in age-related cardiovascular disease: focus on phosphodiesterase-1 and soluble guanylate cyclase","volume":"127","author":"Golshiri","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.pharmr.2025.100042_bib389","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/jpet.121.000628","article-title":"Selective PDE1 inhibition ameliorates vascular function, reduces inflammatory response, and lowers blood pressure in ageing animals","volume":"378","author":"Golshiri","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib390","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109927","article-title":"Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer's-like pathology and symptoms through multiple targeting actions in aged T2D rats","volume":"117","author":"Gomaa","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib391","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1016\/j.bmcl.2013.10.014","article-title":"PDE2 inhibition: potential for the treatment of cognitive disorders","volume":"23","author":"Gomez","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib392","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2009.08.008","article-title":"The flavonoid dioclein is a selective inhibitor of cyclic nucleotide phosphodiesterase type 1 (PDE1) and a cGMP-dependent protein kinase (PKG) vasorelaxant in human vascular tissue","volume":"620","author":"Goncalves","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib393","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41586-020-2315-8","article-title":"Phase and context shape the function of composite oncogenic mutations","volume":"582","author":"Gorelick","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100042_bib394","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cellimm.2009.04.005","article-title":"Phosphodiesterase 7A inhibitor ASB16165 suppresses proliferation and cytokine production of NKT cells","volume":"258","author":"Goto","year":"2009","journal-title":"Cell Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib395","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1093\/eurheartj\/ehad086","article-title":"Phosphodiesterase 8 governs cAMP\/PKA-dependent reduction of L-type calcium current in human atrial fibrillation: a novel arrhythmogenic mechanism","author":"Grammatika Pavlidou","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmr.2025.100042_bib396","doi-asserted-by":"crossref","first-page":"33379","DOI":"10.1074\/jbc.M006329200","article-title":"The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site","volume":"275","author":"Grange","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib397","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1023\/A:1017573722074","article-title":"Sildenafil (Viagra): is there an influence on psychological performance?","volume":"32","author":"Grass","year":"2001","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.pharmr.2025.100042_bib398","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/bph.14979","article-title":"Pulmonary hypertension in chronic obstructive pulmonary disease","volume":"178","author":"Gredic","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib399","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0896-6273(00)80798-9","article-title":"Beyond the dopamine receptor: the DARPP-32\/protein phosphatase-1 cascade","volume":"23","author":"Greengard","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2025.100042_bib400","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"Greenman","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100042_bib401","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1124\/jpet.113.206284","article-title":"Concurrent agonism of adenosine A2B and glucocorticoid receptors in human airway epithelial cells cooperatively induces genes with anti-inflammatory potential: a novel approach to treat chronic obstructive pulmonary disease","volume":"346","author":"Greer","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib402","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1245","article-title":"The gene encoding phosphodiesterase 4D confers risk of ischemic stroke","volume":"35","author":"Gretarsdottir","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmr.2025.100042_bib403","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.52.4.771","article-title":"D1 receptor blockade improves L-dopa\u2013induced dyskinesia but worsens parkinsonism in MPTP monkeys","volume":"52","author":"Grondin","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pharmr.2025.100042_bib404","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1094-5539(02)00172-4","article-title":"Does a single dose of the phosphodiesterase 4 inhibitor, cilomilast (15 mg), induce bronchodilation in patients with chronic obstructive pulmonary disease?","volume":"16","author":"Grootendorst","year":"2003","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib405","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1074\/jbc.M511468200","article-title":"cAMP is a ligand for the tandem GAF domain of human phosphodiesterase 10 and cGMP for the tandem GAF domain of phosphodiesterase 11","volume":"281","author":"Gross-Langenhoff","year":"2006","journal-title":"J Biolog Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib406","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/15412551003758304","article-title":"Treatment of chronic obstructive pulmonary disease with roflumilast, a new phosphodiesterase 4 inhibitor","volume":"7","author":"Gross","year":"2010","journal-title":"Copd"},{"key":"10.1016\/j.pharmr.2025.100042_bib407","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1465-9921-7-9","article-title":"Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells","volume":"7","author":"Growcott","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib408","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00424-014-1515-1","article-title":"Cyclic AMP synthesis and hydrolysis in the normal and failing heart","volume":"466","author":"Guellich","year":"2014","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.pharmr.2025.100042_bib409","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4322","article-title":"Cryo-EM structure of phosphodiesterase 6 reveals insights into the allosteric regulation of type I phosphodiesterases","volume":"5","author":"Gulati","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.pharmr.2025.100042_bib410","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/cancers15010262","article-title":"The CAPRA&PDE4D5\/7\/9 prognostic model is significantly associated with adverse post-surgical pathology outcomes","volume":"15","author":"Gulliver","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pharmr.2025.100042_bib411","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/s41416-023-02417-5","article-title":"Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategies","volume":"129","author":"Gulliver","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pharmr.2025.100042_bib412","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.bmcl.2009.02.060","article-title":"Identification of potent pyrimidine inhibitors of phosphodiesterase 7 (PDE7) and their ability to inhibit T cell proliferation","volume":"19","author":"Guo","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib413","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-642-17969-3_7","article-title":"Small molecule allosteric modulators of phosphodiesterase 4","volume":"204","author":"Gurney","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib414","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15028-x","article-title":"Multiple behavior phenotypes of the fragile-X syndrome mouse model respond to chronic inhibition of phosphodiesterase-4D (PDE4D)","volume":"7","author":"Gurney","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2025.100042_bib415","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1021\/acs.jmedchem.9b00193","article-title":"Design and synthesis of selective phosphodiesterase 4D (PDE4D) allosteric inhibitors for the treatment of fragile X syndrome and other brain disorders","volume":"62","author":"Gurney","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib416","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1158\/1078-0432.CCR-13-1573","article-title":"NSAIDs inhibit tumorigenesis, but how?","volume":"20","author":"Gurpinar","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib417","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/sj.bjp.0705317","article-title":"VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal","volume":"139","author":"Gutierrez-Canas","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib418","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/259321a0","article-title":"Increased cyclic nucleotide phosphodiesterase activity in leukaemic lymphocytes","volume":"259","author":"Hait","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100042_bib419","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib420","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib421","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202154315","article-title":"A cAMP signalosome in primary cilia drives gene expression and kidney cyst formation","volume":"23","author":"Hansen","year":"2022","journal-title":"EMBO Rep"},{"key":"10.1016\/j.pharmr.2025.100042_bib422","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1007\/s00213-014-3480-y","article-title":"Mice deficient in phosphodiesterase-4A display anxiogenic-like behavior","volume":"231","author":"Hansen","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib423","article-title":"Why rats can't vomit","author":"Hanson","year":"2003","journal-title":"Rat Behav Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib424","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/jpet.116.237388","article-title":"TAK-063, a novel phosphodiesterase 10A inhibitor, protects from striatal neurodegeneration and ameliorates behavioral deficits in the R6\/2 mouse model of Huntington's disease","volume":"360","author":"Harada","year":"2017","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.pharmr.2025.100042_bib425","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/syn.10067","article-title":"Age differences in phosphodiesterase type-IV and its functional response to dopamine D1 receptor modulation in the living brain: a PET study in conscious monkeys","volume":"44","author":"Harada","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.pharmr.2025.100042_bib426","series-title":"Struct Activ Enzymes Fed Eur Biochem Soc Symp 1st","article-title":"The structure and activity of chymotrypsin","author":"Hartley","year":"1964"},{"key":"10.1016\/j.pharmr.2025.100042_bib427","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","article-title":"Neurohormonal activation in heart failure with reduced ejection fraction","volume":"14","author":"Hartupee","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib428","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12640-022-00482-x","article-title":"Roflumilast reduces pathological symptoms of sporadic Alzheimer's disease in rats produced by intracerebroventricular streptozotocin by inhibiting NF-kappaB\/BACE-1 mediated abeta production in the hippocampus and activating the cAMP\/BDNF signalling pathway","volume":"40","author":"Hasan","year":"2022","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib429","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.atherosclerosis.2006.01.022","article-title":"Activation of endothelial nitric oxide synthase by cilostazol via a cAMP\/protein kinase A- and phosphatidylinositol 3-kinase\/Akt-dependent mechanism","volume":"189","author":"Hashimoto","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmr.2025.100042_bib430","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1161\/CIRCULATIONAHA.117.030490","article-title":"Acute enhancement of cardiac function by phosphodiesterase type 1 inhibition","volume":"138","author":"Hashimoto","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib431","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1326440","article-title":"Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)","volume":"6","author":"Hassel","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.pharmr.2025.100042_bib432","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pupt.2010.03.011","article-title":"The preclinical pharmacology of roflumilast\u2014a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease","volume":"23","author":"Hatzelmann","year":"2010","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib433","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0022-3565(24)29537-9","article-title":"Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro","volume":"297","author":"Hatzelmann","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib434","doi-asserted-by":"crossref","first-page":"8936","DOI":"10.1523\/JNEUROSCI.0248-16.2016","article-title":"Compartmentalized PDE4A5 signaling impairs hippocampal synaptic plasticity and long-term memory","volume":"36","author":"Havekes","year":"2016","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib435","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.13424","article-title":"Sleep deprivation causes memory deficits by negatively impacting neuronal connectivity in hippocampal area CA1","volume":"5","author":"Havekes","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.pharmr.2025.100042_bib436","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1006\/bbrc.1998.9379","article-title":"Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isozyme of 3',5'-cyclic nucleotide phosphodiesterase","volume":"250","author":"Hayashi","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2025.100042_bib437","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1016\/S0021-9258(19)70757-1","article-title":"Selective activation of particulate cAMP-dependent protein kinase by isoproterenol and prostaglandin E1","volume":"255","author":"Hayes","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib438","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0022-3565(25)12354-9","article-title":"Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3',5'-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung","volume":"276","author":"Haynes","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib439","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2174\/1389450116666151001112710","article-title":"Sphingosine-1-phosphate receptors in the central nervous and immune systems","volume":"17","author":"Healy","year":"2016","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.pharmr.2025.100042_bib440","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuroscience.2003.11.009","article-title":"Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms","volume":"123","author":"Hebb","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmr.2025.100042_bib441","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neubiorev.2018.02.007","article-title":"Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: clinical overview and translational considerations","volume":"87","author":"Heckman","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib442","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00213-017-4770-y","article-title":"Acute administration of roflumilast enhances sensory gating in healthy young humans in a randomized trial","volume":"235","author":"Heckman","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib443","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bbi.2017.04.015","article-title":"The isozyme selective phosphodiesterase-4 inhibitor, ABI-4, attenuates the effects of lipopolysaccharide in human cells and rodent models of peripheral and CNS inflammation","volume":"64","author":"Hedde","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.pharmr.2025.100042_bib444","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1038\/npp.2016.106","article-title":"Phosphodiesterase 11A (PDE11A), enriched in ventral hippocampus neurons, is required for consolidation of social but not nonsocial memories in mice","volume":"41","author":"Hegde","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib445","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.str.2009.07.019","article-title":"Cyclic nucleotide binding GAF domains from phosphodiesterases: structural and mechanistic insights","volume":"17","author":"Heikaus","year":"2009","journal-title":"Structure"},{"key":"10.1016\/j.pharmr.2025.100042_bib446","doi-asserted-by":"crossref","first-page":"22749","DOI":"10.1074\/jbc.M801577200","article-title":"Solution structure of the cGMP binding GAF domain from phosphodiesterase 5: insights into nucleotide specificity, dimerization, and cGMP-dependent conformational change","volume":"283","author":"Heikaus","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib447","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/bjc.2014.22","article-title":"The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells","volume":"110","author":"Henderson","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pharmr.2025.100042_bib448","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1042\/CS20180519","article-title":"Creating a potential diagnostic for prostate cancer risk stratification (InformMDx) by translating novel scientific discoveries concerning cAMP degrading phosphodiesterase-4D7 (PDE4D7)","volume":"133","author":"Henderson","year":"2019","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pharmr.2025.100042_bib449","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41589-022-00971-2","article-title":"Deubiquitinase-targeting chimeras for targeted protein stabilization","volume":"18","author":"Henning","year":"2022","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib450","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.cellsig.2008.03.011","article-title":"Real-time monitoring of phosphodiesterase inhibition in intact cells","volume":"20","author":"Herget","year":"2008","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib451","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.838449","article-title":"BI 1015550 is a pde4b inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis","volume":"13","author":"Herrmann","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib452","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM200006013422201","article-title":"Hemodynamic effects of sildenafil in men with severe coronary artery disease","volume":"342","author":"Herrmann","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib453","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-3-642-17969-3_16","article-title":"Cyclic nucleotides and phosphodiesterases in monocytic differentiation","author":"Hertz","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib454","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","article-title":"Inflammation and immunity in IPF pathogenesis and treatment","volume":"147","author":"Heukels","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib455","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/intimm\/dxg079","article-title":"Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity","volume":"15","author":"Heystek","year":"2003","journal-title":"Int Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib456","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0022-3565(25)31785-4","article-title":"Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation","volume":"211","author":"Hidaka","year":"1979","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib457","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004850-199100610-00005","article-title":"Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes","volume":"6","author":"Hindmarch","year":"1991","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib458","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.cellsig.2014.03.031","article-title":"Role of phosphodiesterase 2 in growth and invasion of human malignant melanoma cells","volume":"26","author":"Hiramoto","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib459","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1164\/ajrccm\/153.6_Pt_2.S16","article-title":"Airway behavior and its regulation: how do structural changes affect airway behavior?","volume":"153","author":"Hogg","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib460","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(04)16900-6","article-title":"Pathophysiology of airflow limitation in chronic obstructive pulmonary disease","volume":"364","author":"Hogg","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pharmr.2025.100042_bib461","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib462","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.pathol.4.110807.092145","article-title":"The pathology of chronic obstructive pulmonary disease","volume":"4","author":"Hogg","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.pharmr.2025.100042_bib463","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1055\/s-0043-1770059","article-title":"The pulmonary vasculature","volume":"44","author":"Hopkins","year":"2023","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib464","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/1c75cd5d-9dde-4ace-8524-a4980745e804","article-title":"Why can't rodents vomit? A comparative behavioral, anatomical, and physiological study","volume":"8","author":"Horn","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2025.100042_bib465","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0031-6997(25)07154-6","article-title":"Dopamine (3-hydroxytyramine) and brain function","volume":"18","author":"Hornykiewicz","year":"1966","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib466","doi-asserted-by":"crossref","first-page":"11571","DOI":"10.1158\/0008-5472.CAN-06-2914","article-title":"Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population","volume":"66","author":"Horvath","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib467","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1158\/0008-5472.CAN-09-0884","article-title":"Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumors","volume":"69","author":"Horvath","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib468","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/path.1711010212","article-title":"Hyperplasia of bronchial muscle in chronic bronchitis","volume":"101","author":"Hossain","year":"1970","journal-title":"J Pathol"},{"key":"10.1016\/j.pharmr.2025.100042_bib469","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1172\/JCI119291","article-title":"Proliferation of hepatic stellate cells is inhibited by phosphorylation of CREB on serine 133","volume":"99","author":"Houglum","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmr.2025.100042_bib470","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0079-6603(01)69049-4","article-title":"PDE4 cAMP-specific phosphodiesterases","volume":"69","author":"Houslay","year":"2001","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib471","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tibs.2009.09.007","article-title":"Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown","volume":"35","author":"Houslay","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib472","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021698","article-title":"PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization","volume":"370","author":"Houslay","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmr.2025.100042_bib473","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nbt0110-38","article-title":"Putting the lid on phosphodiesterase 4","volume":"28","author":"Houslay","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmr.2025.100042_bib474","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1042\/BST0331333","article-title":"Beta-arrestin-recruited phosphodiesterase-4 desensitizes the AKAP79\/PKA-mediated switching of beta2-adrenoceptor signalling to activation of ERK","volume":"33","author":"Houslay","year":"2005","journal-title":"Biochemical Society transactions"},{"key":"10.1016\/j.pharmr.2025.100042_bib475","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/01.RES.0000261934.56938.38","article-title":"cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling","volume":"100","author":"Houslay","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib476","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S1359-6446(05)03622-6","article-title":"Keynote review: phosphodiesterase-4 as a therapeutic target","volume":"10","author":"Houslay","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.pharmr.2025.100042_bib477","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.4049\/jimmunol.2001026","article-title":"Phosphodiesterase 10A Is a Key Mediator of Lung Inflammation","volume":"206","author":"Hsu","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib478","doi-asserted-by":"crossref","first-page":"L1055","DOI":"10.1152\/ajplung.00021.2008","article-title":"Prolonged heterologous \u03b22-adrenoceptor desensitization promotes proasthmatic airway smooth muscle function via PKA\/ERK1\/2-mediated phosphodiesterase-4 induction","volume":"294","author":"Hu","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib479","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1111\/j.1460-9568.2004.03796.x","article-title":"Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A","volume":"20","author":"Hu","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib480","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120992","article-title":"The PDE5 inhibitor, vardenafil, ameliorates progressive pathological changes in a focal segmental glomerulosclerosis mouse model","volume":"309","author":"Hu","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib481","doi-asserted-by":"crossref","first-page":"13220","DOI":"10.1021\/bi034653e","article-title":"The crystal structure of AMP-bound PDE4 suggests a mechanism for phosphodiesterase catalysis","volume":"42","author":"Huai","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmr.2025.100042_bib482","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115194","article-title":"Advances in the development of phosphodiesterase 7 inhibitors","volume":"250","author":"Huang","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib483","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bmcl.2013.11.028","article-title":"Design, synthesis and evaluation of dual pharmacology \u03b22-adrenoceptor agonists and PDE4 inhibitors","volume":"24","author":"Huang","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib484","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/mol.115.099747","article-title":"Structural Asymmetry of Phosphodiesterase-9A and a Unique Pocket for Selective Binding of a Potent Enantiomeric Inhibitor","volume":"88","author":"Huang","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib485","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1021\/acs.jmedchem.2c00458","article-title":"Structural modifications of nimodipine lead to novel PDE1 inhibitors with anti-pulmonary fibrosis effects","volume":"65","author":"Huang","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib486","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1053\/j.gastro.2019.05.012","article-title":"Use of phosphodiesterase 5 inhibitors is associated with lower risk of colorectal cancer in men with benign colorectal neoplasms","volume":"157","author":"Huang","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmr.2025.100042_bib487","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1038\/s41467-020-17028-4","article-title":"Phosphodiesterase-5 inhibitors use and risk for mortality and metastases among male patients with colorectal cancer","volume":"11","author":"Huang","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2025.100042_bib488","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127097","article-title":"Novel PDE5 inhibitors derived from rutaecarpine for the treatment of Alzheimer's disease","volume":"30","author":"Huang","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib489","doi-asserted-by":"crossref","first-page":"15852","DOI":"10.1021\/acs.jmedchem.0c01573","article-title":"Rational design of 2-chloroadenine derivatives as highly selective phosphodiesterase 8A inhibitors","volume":"63","author":"Huang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib490","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1021\/acs.jmedchem.9b00224","article-title":"Validation of phosphodiesterase-10 as a novel target for pulmonary arterial hypertension via highly selective and subnanomolar inhibitors","volume":"62","author":"Huang","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib491","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00745-2017","article-title":"Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases: highlights from basic research to therapy","volume":"51","author":"Huertas","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmr.2025.100042_bib492","first-page":"293","article-title":"Studies on prostate cancer I: effects of castration, of estrogen, and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"1","author":"Huggins","year":"1941","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib493","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.bmcl.2011.01.043","article-title":"Discovery of muscarinic acetylcholine receptor antagonist and \u03b22-adrenoceptor agonist (MABA) dual pharmacology molecules","volume":"21","author":"Hughes","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib494","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/thoraxjnl-2015-207170","article-title":"The molecular targets of approved treatments for pulmonary arterial hypertension","volume":"71","author":"Humbert","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.pharmr.2025.100042_bib495","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmr.2025.100042_bib496","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib497","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1242\/jcs.03106","article-title":"Helix-1 of the cAMP-specific phosphodiesterase PDE4A1 regulates its phospholipase-D-dependent redistribution in response to release of Ca2+","volume":"119","author":"Huston","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib498","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1529\/biophysj.106.095356","article-title":"Compartmentation of cAMP signaling in cardiac myocytes: a computational study","volume":"92","author":"Iancu","year":"2007","journal-title":"Biophys J"},{"key":"10.1016\/j.pharmr.2025.100042_bib499","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089516","article-title":"Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study","volume":"9","author":"Ihara","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.pharmr.2025.100042_bib500","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nm0797-775","article-title":"Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury","volume":"3","author":"Indolfi","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib501","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bjp.0703287","article-title":"Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double-injury model","volume":"130","author":"Inoue","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib502","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1476-5381.2012.01847.x","article-title":"cAMP and Epac in the regulation of tissue fibrosis","volume":"166","author":"Insel","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib503","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature12000","article-title":"Conformational biosensors reveal GPCR signalling from endosomes","volume":"495","author":"Irannejad","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100042_bib504","doi-asserted-by":"crossref","first-page":"19486","DOI":"10.1074\/jbc.RA119.011002","article-title":"The molecular architecture of photoreceptor phosphodiesterase 6 (PDE6) with activated G protein elucidates the mechanism of visual excitation","volume":"294","author":"Irwin","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib505","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0021-9150(98)00147-6","article-title":"Effects of a single local administration of cilostazol on neointimal formation in balloon-injured rat carotid artery","volume":"142","author":"Ishizaka","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmr.2025.100042_bib506","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1158\/1940-6207.CAPR-17-0015","article-title":"Sildenafil suppresses inflammation-driven colorectal cancer in mice","volume":"10","author":"Islam","year":"2017","journal-title":"Cancer Prevent Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib507","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41440-021-00733-y","article-title":"Regulation of myosin light-chain phosphorylation and its roles in cardiovascular physiology and pathophysiology","volume":"45","author":"Ito","year":"2022","journal-title":"Hypertens Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib508","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12890-021-01710-4","article-title":"Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats","volume":"21","author":"Ito","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib509","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.21873\/anticanres.15005","article-title":"Over-expression of PDE5 in oral squamous cell carcinoma\u2014effect of sildenafil citrate","volume":"41","author":"Iwasaki","year":"2021","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib510","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1124\/jpet.108.148742","article-title":"Effects of roflumilast, a phosphodiesterase-4 inhibitor, on hypoxia- and monocrotaline-induced pulmonary hypertension in rats","volume":"330","author":"Izikki","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib511","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1074\/jbc.M111.263806","article-title":"Activation of PDE10 and PDE11 phosphodiesterases","volume":"287","author":"Jager","year":"2012","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.pharmr.2025.100042_bib512","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1039\/C2MD20242E","article-title":"On the origins of polypharmacology","volume":"4","author":"Jalencas","year":"2013","journal-title":"Med Chem Commun"},{"key":"10.1016\/j.pharmr.2025.100042_bib513","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1017\/S1047951114002698","article-title":"The effect of milrinone on right and left ventricular function when used as a rescue therapy for term infants with pulmonary hypertension","volume":"26","author":"James","year":"2016","journal-title":"Cardiol Young"},{"key":"10.1016\/j.pharmr.2025.100042_bib514","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/NDT.S2006","article-title":"Current approaches to the treatment of Parkinson\u2019s disease","volume":"4","author":"Jankovic","year":"2008","journal-title":"Neuropsychiat Dis Treat"},{"key":"10.1016\/j.pharmr.2025.100042_bib515","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2174\/0929867324666170116125159","article-title":"PDE7-Selective and dual inhibitors: advances in chemical and biological research","volume":"24","author":"Jankowska","year":"2017","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib516","first-page":"390","article-title":"Crisaborole topical ointment, 2%: a nonsteroidal, topical, anti-inflammatory phosphodiesterase 4 inhibitor in clinical development for the treatment of atopic dermatitis","volume":"15","author":"Jarnagin","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.pharmr.2025.100042_bib517","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1164\/ajrccm.164.supplement_2.2106061","article-title":"Remodeling in asthma and chronic obstructive lung disease","volume":"164","author":"Jeffery","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib518","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00005344-199808000-00007","article-title":"Phosphodiesterase III and V inhibitors on pulmonary artery from pulmonary hypertensive rats: differences between early and established pulmonary hypertension","volume":"32","author":"Jeffery","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib519","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03159935","article-title":"Pathology of Parkinson\u2019s disease: changes other than the nigrostriatal pathway","volume":"14","author":"Jellinger","year":"1991","journal-title":"Mol Chem Neuropathol"},{"key":"10.1016\/j.pharmr.2025.100042_bib520","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1073\/pnas.93.20.11236","article-title":"Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells","volume":"93","author":"Jiang","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib521","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02737809","article-title":"Expression and regulation of mRNA for distinct isoforms of cAMP-specific PDE-4 in mitogen-stimulated and leukemic human lymphocytes","volume":"28","author":"Jiang","year":"1998","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.pharmr.2025.100042_bib522","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.cellsig.2004.04.002","article-title":"Effect of phosphodiesterase 4 inhibitors on NFAT-dependent cyclooxygenase-2 expression in human T lymphocytes","volume":"16","author":"Jimenez","year":"2004","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib523","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-3565(24)29287-9","article-title":"Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation","volume":"299","author":"Jimenez","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib524","doi-asserted-by":"crossref","first-page":"19672","DOI":"10.1074\/jbc.273.31.19672","article-title":"Subcellular localization of rolipram-sensitive, cAMP-specific phosphodiesterases. Differential targeting and activation of the splicing variants derived from the PDE4D gene","volume":"273","author":"Jin","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib525","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1073\/pnas.122041599","article-title":"Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses","volume":"99","author":"Jin","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib526","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jaci.2010.08.014","article-title":"Phosphodiesterase 4B is essential for T(H)2-cell function and development of airway hyperresponsiveness in allergic asthma","volume":"126","author":"Jin","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib527","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4049\/jimmunol.175.3.1523","article-title":"Specific Role of Phosphodiesterase 4B in Lipopolysaccharide-Induced Signaling in Mouse Macrophages","volume":"175","author":"Jin","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib528","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1165\/rcmb.2017-0294OC","article-title":"PDE8 is expressed in human airway smooth muscle and selectively regulates cAMP signaling by beta2AR-AC6","volume":"58","author":"Johnstone","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib529","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1165\/rcmb.2017-0294OC","article-title":"PDE8 Is expressed in human airway smooth muscle and selectively regulates cAMP signaling by \u03b2(2)-adrenergic receptors and adenylyl cyclase 6","volume":"58","author":"Johnstone","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib530","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pupt.2004.10.001","article-title":"The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vitro","volume":"18","author":"Jones","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib531","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pupt.2005.11.010","article-title":"Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD","volume":"20","author":"Jones","year":"2007","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib532","doi-asserted-by":"crossref","first-page":"30","DOI":"10.14309\/ajg.0000000000002572","article-title":"ACG clinical guideline: alcohol-associated liver disease","volume":"119","author":"Jophlin","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pharmr.2025.100042_bib533","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1111\/bph.13087","article-title":"The long-acting \u03b22-adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor-mediated transcription in human airway epithelial cells in a gene- and agonist-dependent manner","volume":"172","author":"Joshi","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib534","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1124\/jpet.116.237743","article-title":"GS-5759, a bifunctional \u03b22-adrenoceptor agonist and phosphodiesterase 4 inhibitor for chronic obstructive pulmonary disease with a unique mode of action: effects on gene expression in human airway epithelial cells","volume":"360","author":"Joshi","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib535","first-page":"1839","article-title":"Clinical impact and mechanisms of non-atherosclerotic vascular aging: the new kid to be blocked","volume":"39","author":"Jouabadi","year":"2023","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib536","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1073\/pnas.93.1.295","article-title":"cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists","volume":"93","author":"Jurevicius","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib537","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121570","article-title":"The action of phosphodiesterase-5 inhibitors on beta-amyloid pathology and cognition in experimental Alzheimer's disease: a systematic review","volume":"320","author":"Justo","year":"2023","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib539","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2009.04.014","article-title":"ASB16165, a phosphodiesterase 7A inhibitor, reduces cutaneous TNFa level and ameliorates skin edema in phorbol ester 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation model in mice","volume":"613","author":"Kadoshima-Yamaoka","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib540","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.intimp.2008.10.005","article-title":"Effect of phosphodiesterase 7 inhibitor ASB16165 on development and function of cytotoxic T lymphocyte","volume":"9","author":"Kadoshima-Yamaoka","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib541","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.imlet.2009.01.004","article-title":"ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFN-gamma production by mouse activated T lymphocytes","volume":"122","author":"Kadoshima-Yamaoka","year":"2009","journal-title":"Immunol Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib542","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.imlet.2009.01.004","article-title":"ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFNg production by mouse activated T lymphocytes","volume":"122","author":"Kadoshima-Yamaoka","year":"2009","journal-title":"Immunol Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib543","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/2152-7806.76145","article-title":"Cilostazol improves symptomatic intracranial artery stenosis\u2014Evaluation of cerebral blood flow with single photon emission computed tomography","volume":"2","author":"Kai","year":"2011","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.pharmr.2025.100042_bib544","article-title":"Cardiac gene therapy with PDE2A limits remodeling and arrhythmias in mouse models of heart failure induced by catecholamines","author":"Kamel","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.pharmr.2025.100042_bib545","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1006\/jmbi.2001.4813","article-title":"Molecular organization of bovine rod cGMP-phosphodiesterase 6","volume":"310","author":"Kameni Tcheudji","year":"2001","journal-title":"J Mol Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib546","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neurobiolaging.2014.09.029","article-title":"Accumulation of carboxy-terminal fragments of APP increases phosphodiesterase 8B","volume":"36","author":"Kametani","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmr.2025.100042_bib547","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0006-2952(01)00688-8","article-title":"Regulatory roles of adenylate cyclase and cyclic nucleotide phosphodiesterases 1 and 4 in interleukin-13 production by activated human T cells","volume":"62","author":"Kanda","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib549","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuroscience.2006.09.026","article-title":"Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity","volume":"144","author":"Kanes","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmr.2025.100042_bib550","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13195-022-01034-3","article-title":"Phosphodiesterase 5 inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by multimodal actions","volume":"14","author":"Kang","year":"2022","journal-title":"Alzheimer's Res Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib551","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/CIRCULATIONAHA.119.042573","article-title":"Cardiac overexpression of PDE4B blunts \u03b2-adrenergic response and maladaptive remodeling in heart failure","volume":"142","author":"Karam","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib552","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104766","article-title":"Precision medicine advances in idiopathic pulmonary fibrosis","volume":"95","author":"Karampitsakos","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.pharmr.2025.100042_bib553","article-title":"Ensifentrine: Newly Approved for Maintenance Treatment in Patients with Chronic Obstructive Pulmonary Disease","author":"Kariya","year":"2024","journal-title":"NEJM"},{"key":"10.1016\/j.pharmr.2025.100042_bib554","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1358\/mf.1998.20.5.485701","article-title":"Effect of rolipram on age-related changes in cyclic AMP-selective phosphodiesterase in the rat brain: an autoradiographic study","volume":"20","author":"Kato","year":"1998","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib555","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/01.CIR.0000153349.77489.CF","article-title":"Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure","volume":"111","author":"Katz","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib556","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00210-009-0445-5","article-title":"Phosphodiesterases do not limit \u00df1-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1-5 in rats","volume":"380","author":"Kaumann","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib557","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1124\/mol.107.040121","article-title":"Long-acting \u03b22-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells","volume":"73","author":"Kaur","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib558","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/14756366.2016.1250756","article-title":"Investigation of PDE5\/PDE6 and PDE5\/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development","volume":"32","author":"Kayik","year":"2017","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib559","series-title":"Cyclic Nucleotide Phosphodiesterases in Health and Disease","first-page":"607","article-title":"Structure, catalytic mechanism, and inhibitor selectivity of cyclic nucleotide phosphodiesterases","author":"Ke","year":"2006"},{"key":"10.1016\/j.pharmr.2025.100042_bib560","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2174\/156802607779941242","article-title":"Crystal structures of phosphodiesterases and implications on substrate specificity and inhibitor selectivity","volume":"7","author":"Ke","year":"2007","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib561","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-3-642-17969-3_4","article-title":"Structural insight into the substrate specificity of phosphodiesterases","volume":"204","author":"Ke","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib562","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12664-020-01131-x","article-title":"Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis- A randomized pilot study","volume":"40","author":"Kedarisetty","year":"2021","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.pharmr.2025.100042_bib563","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2012.05.039","article-title":"Evaluating the significance of cyclic adenosine monophosphate-mediated signaling in human prostate: a functional and biochemical study","volume":"80","author":"Kedia","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.pharmr.2025.100042_bib564","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrd1609","article-title":"Multicomponent therapeutics for networked systems","volume":"4","author":"Keith","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmr.2025.100042_bib565","series-title":"Cyclic Nucleotide Phosphodiesterases in the Central Nervous System: From Biology to Disease","first-page":"47","article-title":"Putting together the pieces of phosphodiesterase distribution patterns in the brain: a jigsaw puzzle of cyclic nucleotide regulation","author":"Kelly","year":"2014"},{"key":"10.1016\/j.pharmr.2025.100042_bib566","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2174\/1381612820666140826114941","article-title":"Does phosphodiesterase 11A (PDE11A) hold promise as a future therapeutic target?","volume":"21","author":"Kelly","year":"2015","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.pharmr.2025.100042_bib567","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cellsig.2017.11.004","article-title":"Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain","volume":"42","author":"Kelly","year":"2018","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib568","series-title":"Encyclopedia of Signaling Molecules","first-page":"1","article-title":"Pde11a","author":"Kelly","year":"2018"},{"key":"10.1016\/j.pharmr.2025.100042_bib569","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cellsig.2013.10.007","article-title":"Select 3',5'-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain","volume":"26","author":"Kelly","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib570","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101799","article-title":"Genetic manipulation of cyclic nucleotide signaling during hippocampal neuroplasticity and memory formation","volume":"190","author":"Kelly","year":"2020","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib571","doi-asserted-by":"crossref","first-page":"8457","DOI":"10.1073\/pnas.1000730107","article-title":"Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes","volume":"107","author":"Kelly","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib572","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/2159-8290.CD-22-1066","article-title":"Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer","volume":"13","author":"Kemp","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.pharmr.2025.100042_bib573","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000025738","article-title":"Cyclic nucleotide hydrolysis in bovine aortic endothelial cells in culture: differential regulation in cobblestone and spindle phenotypes","volume":"37","author":"Keravis","year":"2000","journal-title":"J Vasc Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib574","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1476-5381.2011.01729.x","article-title":"Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments","volume":"165","author":"Keravis","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib575","first-page":"63","article-title":"Assessment of phosphodiesterase isozyme contribution in cell and tissue extracts","volume":"307","author":"Keravis","year":"2005","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib576","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0005-2744(80)90198-9","article-title":"Cyclic nucleotide phosphodiesterase activities from pig coronary arteries. Lack of interconvertibility of major forms","volume":"613","author":"Keravis","year":"1980","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2025.100042_bib577","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/1074248409333266","article-title":"The cyclic GMP modulators YC-1 and zaprinast reduce vessel remodeling through antiproliferative and proapoptotic effects","volume":"14","author":"Keswani","year":"2009","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib578","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1161\/hc4401.098432","article-title":"Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance","volume":"104","author":"Kim","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib579","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.exphem.2016.02.002","article-title":"Effect of roflumilast, novel phosphodiesterase-4 inhibitor, on lung chronic graft-versus-host disease in mice","volume":"44","author":"Kim","year":"2016","journal-title":"Exp Hematol"},{"key":"10.1016\/j.pharmr.2025.100042_bib580","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.bbrc.2013.06.002","article-title":"Sildenafil prevents the up-regulation of transient receptor potential canonical channels in the development of cardiomyocyte hypertrophy","volume":"436","author":"Kiso","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2025.100042_bib581","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2332\/allergolint.08-OA-0053","article-title":"Effects of KF19514, a phosphodiesterase 4 and 1 Inhibitor, on bronchial inflammation and remodeling in a murine model of chronic asthma","volume":"58","author":"Kita","year":"2009","journal-title":"Allergol Int"},{"key":"10.1016\/j.pharmr.2025.100042_bib582","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/jnnp.37.4.427","article-title":"Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias","volume":"37","author":"Klawans","year":"1974","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"10.1016\/j.pharmr.2025.100042_bib1297","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.amjcard.2017.06.012","article-title":"The nitric oxide pathway in pulmonary vascular disease","volume":"120","author":"Klinger","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib583","doi-asserted-by":"crossref","first-page":"E7116","DOI":"10.1073\/pnas.1607728113","article-title":"PDE1C deficiency antagonizes pathological cardiac remodeling and dysfunction","volume":"113","author":"Knight","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib584","first-page":"71","article-title":"Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis","volume":"58","author":"Knorr","year":"2008","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.pharmr.2025.100042_bib585","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-1119(03)00809-6","article-title":"Molecular comparison of rat cyclic nucleotide phosphodiesterase 8 family: unique expression of PDE8B in rat brain","volume":"319","author":"Kobayashi","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.pharmr.2025.100042_bib586","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.jid.2016.06.619","article-title":"PDE4 Inhibition as potential treatment of epidermolysis bullosa acquisita","volume":"136","author":"Koga","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.pharmr.2025.100042_bib587","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1165\/ajrcmb.26.6.4743","article-title":"PDE4 inhibitors attenuate fibroblast chemotaxis and contraction of native collagen gels","volume":"26","author":"Kohyama","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib588","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.yjmcc.2009.11.015","article-title":"Cyclic GMP\/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition","volume":"48","author":"Koitabashi","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib589","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-pharmtox-010716-104756","article-title":"Nanodomain regulation of cardiac cyclic nucleotide signaling by phosphodiesterases","volume":"57","author":"Kokkonen","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmr.2025.100042_bib590","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa1811737","article-title":"Nintedanib plus sildenafil in patients with idiopathic pulmonary fibrosis","volume":"379","author":"Kolb","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib591","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12931-019-1022-1","article-title":"The natural history of progressive fibrosing interstitial lung diseases","volume":"20","author":"Kolb","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib592","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1091\/mbc.e09-01-0019","article-title":"Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4","volume":"20","author":"Kolosionek","year":"2009","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib593","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00005344-198908000-00005","article-title":"Differential sensitivity to cardiotonic drugs of cyclic AMP phosphodiesterases isolated from canine ventricular and sinoatrial-enriched tissues","volume":"14","author":"Komas","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib594","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1080\/17460441.2019.1659242","article-title":"PROTACs- a game-changing technology","volume":"14","author":"Konstantinidou","year":"2019","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.pharmr.2025.100042_bib595","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910372","article-title":"Cyclic GMP in liver cirrhosis-role in pathophysiology of portal hypertension and therapeutic implications","volume":"22","author":"Kreisel","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib596","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.3390\/ijms21176223","article-title":"Phosphodiesterases in the liver as potential therapeutic targets of cirrhotic portal hypertension","volume":"21","author":"Kreisel","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib597","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1517\/13543784.16.1.109","article-title":"Phosphodiesterase-4 inhibitors as a novel approach for the treatment of respiratory disease: cilomilast","volume":"16","author":"Kroegel","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmr.2025.100042_bib598","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.neurobiolaging.2014.03.023","article-title":"PDE9A inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition","volume":"35","author":"Kroker","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmr.2025.100042_bib599","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/15287390590935897","article-title":"Perspectives on air quality policy issues in Europe and North America","volume":"68","author":"Krzyzanowski","year":"2005","journal-title":"J Toxicol Environ Health A"},{"key":"10.1016\/j.pharmr.2025.100042_bib600","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.biopha.2017.01.059","article-title":"Inhibitor of Phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer's Type","volume":"88","author":"Kumar","year":"2017","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.pharmr.2025.100042_bib601","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1741-7015-11-96","article-title":"Phosphodiesterase 4-targeted treatments for autoimmune diseases","volume":"11","author":"Kumar","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib602","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fmicb.2013.00293","article-title":"Virus-induced exacerbations in asthma and COPD","volume":"4","author":"Kurai","year":"2013","journal-title":"Front Microbiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib603","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/biomedicines9010057","article-title":"Endothelial dysfunction in pulmonary hypertension: cause or consequence?","volume":"9","author":"Kurakula","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.pharmr.2025.100042_bib604","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.748798","article-title":"Upregulation of Phosphodiesterase 2A Augments T Cell Activation by Changing cGMP\/cAMP Cross-Talk","volume":"12","author":"Kurelic","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011464","article-title":"A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice","volume":"5","author":"Kurz","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.pharmr.2025.100042_bib606","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cellsig.2006.07.011","article-title":"Androgen dependent regulation of protein kinase A subunits in prostate cancer cells","volume":"19","author":"Kvissel","year":"2007","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib607","doi-asserted-by":"crossref","first-page":"133","DOI":"10.31083\/j.fbl2807133","article-title":"Short PDE4 isoforms as drug targets in disease","volume":"28","author":"Kyurkchieva","year":"2023","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.pharmr.2025.100042_bib608","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ccm.2013.08.005","article-title":"World Health Organization group 5 pulmonary hypertension","volume":"34","author":"Lahm","year":"2013","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib609","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/2045893217710639","article-title":"Combination therapy in pulmonary arterial hypertension: recent accomplishments and future challenges","volume":"7","author":"Lajoie","year":"2017","journal-title":"Pulm Circ"},{"key":"10.1016\/j.pharmr.2025.100042_bib610","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12028-021-01331-z","article-title":"Intravenous milrinone for cerebral vasospasm in subarachnoid hemorrhage: the MILRISPASM controlled before-after study","volume":"35","author":"Lakhal","year":"2021","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.pharmr.2025.100042_bib611","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuropharm.2010.05.004","article-title":"Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues","volume":"59","author":"Lakics","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib612","first-page":"4256","article-title":"Effect of VEGF on retinal microvascular endothelial hydraulic conductivity: the role of NO","volume":"41","author":"Lakshminarayanan","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib613","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0006-8993(01)03023-2","article-title":"Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey","volume":"920","author":"Lamontagne","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib614","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/j.1600-0854.2012.01401.x","article-title":"Sensitive and high resolution localization and tracking of membrane proteins in live cells with BRET","volume":"13","author":"Lan","year":"2012","journal-title":"Traffic"},{"key":"10.1016\/j.pharmr.2025.100042_bib615","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1479-5876-7-67","article-title":"Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure","volume":"7","author":"Lanfear","year":"2009","journal-title":"J Transl Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib616","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1111\/bph.13868","article-title":"Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats","volume":"174","author":"Laursen","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib617","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.amjmed.2003.07.010","article-title":"Is airway remodeling clinically relevant in asthma?","volume":"115","author":"Lazaar","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib618","doi-asserted-by":"crossref","first-page":"35980","DOI":"10.1074\/jbc.M204832200","article-title":"Cyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells. Identification and characterization of a novel PDE4D5 promoter","volume":"277","author":"Le Jeune","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib619","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12931-015-0268-5","article-title":"Bronchoabsorption; a novel bronchoscopic technique to improve biomarker sampling of the airway","volume":"16","author":"Leaker","year":"2015","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib620","article-title":"A Non-Systemic Phosphodiesterase-5 Inhibitor Suppresses Colon Proliferation in Mice","volume":"24","author":"Lee","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib621","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature14332","article-title":"Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease","volume":"519","author":"Lee","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100042_bib622","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49416","article-title":"Inhibition of IRF4 in dendritic cells by PRR-independent and -dependent signals inhibit Th2 and promote Th17 responses","volume":"9","author":"Lee","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.pharmr.2025.100042_bib623","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.18632\/oncotarget.6705","article-title":"\u03b2-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmr.2025.100042_bib624","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/1940-6207.CAPR-21-0208","article-title":"Suppression of colon tumorigenesis in mutant Apc mice by a novel PDE10 inhibitor that reduces oncogenic \u03b2-catenin","volume":"14","author":"Lee","year":"2021","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.pharmr.2025.100042_bib625","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4155\/fmc.12.216","article-title":"Targeting protein-protein interactions within the cyclic AMP signaling system as a therapeutic strategy for cardiovascular disease","volume":"5","author":"Lee","year":"2013","journal-title":"Future Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib626","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0898-6568(01)00250-9","article-title":"PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMP","volume":"14","author":"Lee","year":"2002","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib627","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1378\/chest.91.5.662","article-title":"Reduction in pulmonary hypertension and in airway resistances by enoximone (MDL 17,043) in decompensated COPD","volume":"91","author":"Leeman","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.pharmr.2025.100042_bib628","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1083\/jcb.201303159","article-title":"The inner and outer compartments of mitochondria are sites of distinct cAMP\/PKA signaling dynamics","volume":"202","author":"Lefkimmiatis","year":"2013","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib629","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cell.2005.07.030","article-title":"Phosphodiesterase 4D deficiency in the ryanodine receptor complex promotes heart failure and arrhythmias","volume":"123","author":"Lehnart","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib630","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050761","article-title":"Molecular mechanisms of pulmonary vascular remodeling in pulmonary arterial hypertension","volume":"17","author":"Leopold","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib631","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/BJ20051368","article-title":"Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies","volume":"393","author":"Lerner","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmr.2025.100042_bib632","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.107.167817","article-title":"Spatiotemporal dynamics of beta-adrenergic cAMP signals and L-type Ca2+ channel regulation in adult rat ventricular myocytes: role of phosphodiesterases","volume":"102","author":"Leroy","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib633","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1172\/JCI44747","article-title":"Phosphodiesterase 4B in the cardiac L-type Ca2+ channel complex regulates Ca2+ current and protects against ventricular arrhythmias","volume":"121","author":"Leroy","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmr.2025.100042_bib634","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.576723","article-title":"Phosphodiesterase PDE4D is decreased in frontal cortex of aged rats and positively correlated with working memory performance and inversely correlated with PKA phosphorylation of tau","volume":"12","author":"Leslie","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib635","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.3390\/biomedicines11102808","article-title":"Extracellular vesicles as therapeutic and diagnostic tools for chronic liver diseases","volume":"11","author":"Leszczynska","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.pharmr.2025.100042_bib636","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.nbd.2012.11.016","article-title":"Phosphodiesterase 10A (PDE10A) localization in the R6\/2 mouse model of Huntington's disease","volume":"52","author":"Leuti","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib637","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/HYPERTENSIONAHA.121.18882","article-title":"Abnormal cyclic nucleotide signaling at the outer mitochondrial membrane in sympathetic neurons during the early stages of hypertension","volume":"79","author":"Li","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmr.2025.100042_bib638","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib639","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.brainres.2016.04.011","article-title":"Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-beta peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer's disease","volume":"1642","author":"Li","year":"2016","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib640","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00535-008-2180-y","article-title":"Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies","volume":"43","author":"Li","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.pharmr.2025.100042_bib641","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1039\/D2CS00193D","article-title":"PROTACs: past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib642","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.283.5403.848","article-title":"CD3- and CD28-dependent induction of PDE7 required for T cell activation","volume":"283","author":"Li","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2025.100042_bib643","article-title":"Suppression of \u03b2-catenin\/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmr.2025.100042_bib644","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/onc.2014.94","article-title":"Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and \u03b2-catenin-dependent TCF transcriptional activity","volume":"34","author":"Li","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmr.2025.100042_bib645","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1158\/1535-7163.MCT-13-0048","article-title":"Sulindac selectively inhibits colon tumor cell growth by activating the cGMP\/PKG pathway to suppress Wnt\/\u03b2-catenin signaling","volume":"12","author":"Li","year":"2013","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.pharmr.2025.100042_bib646","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1021\/acs.jmedchem.5b01751","article-title":"Discovery of potent and selective inhibitors of phosphodiesterase 1 for the treatment of cognitive impairment associated with neurodegenerative and neuropsychiatric diseases","volume":"59","author":"Li","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib647","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1523\/JNEUROSCI.5236-10.2011","article-title":"Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling","volume":"31","author":"Li","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib648","article-title":"Phosphodiesterase type 10A inhibitor attenuates lung fibrosis by targeting myofibroblast activation","volume":"26","author":"Li","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.pharmr.2025.100042_bib649","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1021\/acs.jmedchem.0c00060","article-title":"Discovery and optimization of alpha-mangostin derivatives as novel PDE4 inhibitors for the treatment of vascular dementia","volume":"63","author":"Liang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib650","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/1078-0432.CCR-08-0106","article-title":"Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors","volume":"14","author":"Libe","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib651","doi-asserted-by":"crossref","first-page":"E208","DOI":"10.1210\/jc.2010-1704","article-title":"Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype","volume":"96","author":"Libe","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmr.2025.100042_bib652","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1039\/D2BM01521H","article-title":"Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via the Ly6 antigen for psoriasiform dermatitis alleviation","volume":"11","author":"Lin","year":"2023","journal-title":"Biomater Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib653","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41589-023-01381-8","article-title":"Cardiac contraction and relaxation are regulated by distinct subcellular cAMP pools","volume":"20","author":"Lin","year":"2023","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib654","first-page":"129","article-title":"Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation","volume":"28","author":"Lincoln","year":"1991","journal-title":"Blood Vessels"},{"key":"10.1016\/j.pharmr.2025.100042_bib655","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuropharm.2012.06.032","article-title":"Dual inhibitor of PDE7 and GSK-3-VP1.15 acts as antipsychotic and cognitive enhancer in C57BL\/6J mice","volume":"64","author":"Lipina","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib656","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.bmcl.2012.11.058","article-title":"Hybrids consisting of the pharmacophores of salmeterol and roflumilast or phthalazinone: dual \u03b2\u2082-adrenoceptor agonists-PDE4 inhibitors for the treatment of COPD","volume":"23","author":"Liu","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib657","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98694","article-title":"Phosphodiesterase 2A as a therapeutic target to restore cardiac neurotransmission during sympathetic hyperactivity","volume":"3","author":"Liu","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmr.2025.100042_bib658","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bbrc.2010.11.116","article-title":"FRET-based direct detection of dynamic protein kinase A activity on the sarcoplasmic reticulum in cardiomyocytes","volume":"404","author":"Liu","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2025.100042_bib659","article-title":"Pulmonary hypertension: linking inflammation and pulmonary arterial stiffening","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib660","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1124\/mol.106.028951","article-title":"cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1\/2 and Smad signaling in cardiac fibroblasts","volume":"70","author":"Liu","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib661","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pharmtox-040623-115054","article-title":"G protein-coupled receptor signaling: new insights define cellular nanodomains","volume":"64","author":"Lohse","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmr.2025.100042_bib662","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.RES.0000102042.83024.CA","article-title":"What is the role of \u00df-adrenergic signaling in heart failure?","volume":"93","author":"Lohse","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib663","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.gastro.2018.05.011","article-title":"Corticosteroids reduce risk of death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo-a meta-analysis of individual data from controlled trials","volume":"155","author":"Louvet","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmr.2025.100042_bib664","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00213-015-4129-1","article-title":"Cyclic GMP-mediated memory enhancement in the object recognition test by inhibitors of phosphodiesterase-2 in mice","volume":"233","author":"Lueptow","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmr.2025.100042_bib665","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pharmthera.2005.07.003","article-title":"Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents","volume":"109","author":"Lugnier","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib666","first-page":"639","article-title":"Cross talk between NO and cyclic nucleotide phosphodiesterases in the modulation of signal transduction in blood vessel","volume":"50","author":"Lugnier","year":"1999","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib667","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0304-4165(99)00145-2","article-title":"Characterization of cyclic nucleotide phosphodiesterase isoforms associated to isolated cardiac nuclei","volume":"1472","author":"Lugnier","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2025.100042_bib668","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0022-3565(25)38240-6","article-title":"Characterization of indolidan- and rolipram-sensitive cyclic nucleotide phosphodiesterases in canine and human cardiac microsomal fractions","volume":"265","author":"Lugnier","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib669","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0006-2952(90)90650-A","article-title":"Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells","volume":"39","author":"Lugnier","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib670","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/0006-2952(86)90333-3","article-title":"Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta","volume":"35","author":"Lugnier","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib671","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-18-1942","article-title":"WNT\/beta-catenin pathway activation correlates with immune exclusion across human cancers","volume":"25","author":"Luke","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib672","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.3390\/pharmaceutics14091894","article-title":"Nanoparticle delivery of novel PDE4B inhibitor for the treatment of alcoholic liver disease","volume":"14","author":"Ma","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharmr.2025.100042_bib673","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.3","article-title":"Novel, primate-specific PDE10A isoform highlights gene expression complexity in human striatum with implications on the molecular pathology of bipolar disorder","volume":"6","author":"MacMullen","year":"2016","journal-title":"Translational psychiatry"},{"key":"10.1016\/j.pharmr.2025.100042_bib674","doi-asserted-by":"crossref","first-page":"14597","DOI":"10.1021\/acs.jmedchem.3c01088","article-title":"First optimization of novel, potent, selective PDE11A4 inhibitors for age-related cognitive decline","volume":"66","author":"Mahmood","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib675","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1124\/pr.111.004770","article-title":"Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn","volume":"64","author":"Majed","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib676","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1139\/O07-140","article-title":"Activated pericyte attenuates endothelial functions: nitric oxide-cGMP rescues activated pericyte-associated endothelial dysfunctions","volume":"85","author":"Majumder","year":"2007","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib677","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/acn3.79","article-title":"Phosphodiesterase III inhibitor promotes drainage of cerebrovascular beta-amyloid","volume":"1","author":"Maki","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.pharmr.2025.100042_bib678","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/carcin\/19.8.1353","article-title":"Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone)","volume":"19","author":"Malkinson","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pharmr.2025.100042_bib679","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1378\/chest.130.4.1203","article-title":"How viral infections cause exacerbation of airway diseases","volume":"130","author":"Mallia","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.pharmr.2025.100042_bib680","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1006\/pupt.1999.0224","article-title":"The inhaled administration of KF19514, a phosphodiesterase 4 and 1 inhibitor, prevents antigen-induced lung inflammation in guinea pigs","volume":"13","author":"Manabe","year":"2000","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib681","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(97)01063-7","article-title":"Anti-inflammatory and bronchodilator properties of KF19514, a phosphodiesterase 4 and 1 inhibitor","volume":"332","author":"Manabe","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib682","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0022-3565(25)12367-7","article-title":"Prolonged \u03b2\u2212adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B","volume":"276","author":"Manning","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib683","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/jcph.1988","article-title":"Update on cilostazol: a critical review of its antithrombotic and cardiovascular actions and its clinical applications","volume":"62","author":"Manolis","year":"2022","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib684","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/0891988716686833","article-title":"Negative bias in the perception and memory of emotional information in Alzheimer disease","volume":"30","author":"Maria","year":"2017","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.pharmr.2025.100042_bib685","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCRESAHA.112.274548","article-title":"S-Nitrosation of beta-catenin and p120 catenin: a novel regulatory mechanism in endothelial hyperpermeability","volume":"111","author":"Marin","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib686","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10585-014-9667-0","article-title":"Identification and validation of genes with expression patterns inverse to multiple metastasis suppressor genes in breast cancer cell lines","volume":"31","author":"Marino","year":"2014","journal-title":"Clin Exp Metast"},{"key":"10.1016\/j.pharmr.2025.100042_bib687","article-title":"Granulocyte colony-stimulating factor for alcoholic hepatitis: a systematic review and meta-analysis of randomised controlled trials","volume":"2","author":"Marot","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.pharmr.2025.100042_bib688","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1034\/j.1399-3003.2000.16b25.x","article-title":"The contribution of airway smooth muscle to airway narrowing and airway hyperresponsiveness in disease","volume":"16","author":"Martin","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmr.2025.100042_bib689","doi-asserted-by":"crossref","first-page":"13260","DOI":"10.1073\/pnas.192374899","article-title":"The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding","volume":"99","author":"Martinez","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib690","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0021-9258(19)68134-2","article-title":"Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues","volume":"257","author":"Martins","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib691","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/jpet.109.156729","article-title":"Anxiolytic effects of phosphodiesterase-2 inhibitors associated with increased cGMP signaling","volume":"331","author":"Masood","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib692","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1073\/pnas.1303920110","article-title":"PDE8A runs interference to limit PKA inhibition of Raf-1","volume":"110","author":"Maurice","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib693","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmr.2025.100042_bib694","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.cellsig.2005.04.003","article-title":"In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal region","volume":"17","author":"McCahill","year":"2005","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib695","first-page":"4","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmr.2025.100042_bib696","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1106955","article-title":"Small-airway obstruction and emphysema in chronic obstructive pulmonary disease","volume":"365","author":"McDonough","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib697","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/npp.2015.240","article-title":"Specific inhibition of phosphodiesterase-4B results in anxiolysis and facilitates memory acquisition","volume":"41","author":"McGirr","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib698","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archneur.64.3.456","article-title":"Changes in PDE4D isoforms in the hippocampus of a patient with advanced Alzheimer disease","volume":"64","author":"McLachlan","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmr.2025.100042_bib699","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib700","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108720","article-title":"Attenuated NMDAR signaling on fast-spiking interneurons in prefrontal cortex contributes to age-related decline of cognitive flexibility","volume":"197","author":"McQuail","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib701","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnmol.2019.00021","article-title":"Phosphodiesterase 1b (PDE1B) regulates spatial and contextual memory in hippocampus","volume":"12","author":"McQuown","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib702","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1126\/science.abi5200","article-title":"The spectrum of inflammatory responses","volume":"374","author":"Medzhitov","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2025.100042_bib703","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.jacc.2013.05.057","article-title":"Phoshodiesterase-2 is upregulated in human failing hearts and blunts \u00df-adrenergic responses in cardiomyocytes","volume":"62","author":"Mehel","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib704","first-page":"3311","article-title":"Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo","volume":"5","author":"Mei","year":"2015","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib705","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev-immunol-061020-053734","article-title":"Tissue Homeostasis and Inflammation","volume":"39","author":"Meizlish","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib706","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/978-3-642-38664-0_18","article-title":"Anti-inflammatory and immunosuppressive agents in PAH","volume":"218","author":"Meloche","year":"2013","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib707","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.600178","article-title":"PDE10A inhibitors\u2014clinical failure or window into antipsychotic drug action?","volume":"14","author":"Menniti","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib708","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cellsig.2010.08.017","article-title":"Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: cross-talk with the androgen receptor","volume":"23","author":"Merkle","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib709","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0026-895X(25)10036-9","article-title":"Erythro-9-(2-hydroxy-3-nonyl) adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes","volume":"48","author":"M\u00e9ry","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib710","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1111\/bph.13192","article-title":"PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis","volume":"172","author":"Mestre","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib711","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/archneur.56.11.1383","article-title":"Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study","volume":"56","author":"Metman","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmr.2025.100042_bib712","doi-asserted-by":"crossref","first-page":"17111","DOI":"10.1073\/pnas.1108121108","article-title":"Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model","volume":"108","author":"Meyer","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib713","doi-asserted-by":"crossref","first-page":"12925","DOI":"10.1016\/S0021-9258(18)31474-1","article-title":"Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae","volume":"268","author":"Michaeli","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib714","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1161\/01.CIR.0000099502.17776.C2","article-title":"Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension","volume":"108","author":"Michelakis","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib715","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0898-6568(95)02032-2","article-title":"Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram","volume":"8","author":"Michie","year":"1996","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib716","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF02737810","article-title":"Upregulation of cAMP-specific PDE-4 activity following ligation of the TCR complex on thymocytes is blocked by selective inhibitors of protein kinase C and tyrosyl kinases","volume":"28","author":"Michie","year":"1998","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.pharmr.2025.100042_bib717","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yjmcc.2019.05.025","article-title":"Synergic PDE3 and PDE4 control intracellular cAMP and cardiac excitation-contraction coupling in a porcine model","volume":"133","author":"Mika","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib718","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/cvr\/cvt193","article-title":"Differential regulation of cardiac excitation-contraction coupling by cAMP phosphodiesterase subtypes","volume":"100","author":"Mika","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib719","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.yjmcc.2011.08.016","article-title":"PDEs create local domains of cAMP signaling","volume":"52","author":"Mika","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib720","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1248\/cpb.c17-00564","volume":"65","author":"Mikami","year":"2017","journal-title":"Chem Pharmaceut Bull"},{"key":"10.1016\/j.pharmr.2025.100042_bib721","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1021\/acs.jmedchem.7b00807","volume":"60","author":"Mikami","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib722","doi-asserted-by":"crossref","first-page":"7658","DOI":"10.1021\/acs.jmedchem.7b00709","article-title":"Discovery of an orally bioavailable, brain-penetrating, in vivo active phosphodiesterase 2A inhibitor lead series for the treatment of cognitive disorders","volume":"60","author":"Mikami","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib723","first-page":"21","article-title":"Phosphodiesterase-4 inhibition in psoriasis","volume":"11","author":"Milakovic","year":"2021","journal-title":"Psoriasis (Auckl)"},{"key":"10.1016\/j.pharmr.2025.100042_bib724","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1476-5381.2012.01929.x","article-title":"Roflumilast N-oxide, a PDE4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smoke in vitro","volume":"166","author":"Milara","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib725","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib726","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00395-011-0228-2","article-title":"Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart","volume":"106","author":"Miller","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib727","first-page":"956","article-title":"Role of Ca2+\/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy","volume":"105","author":"Miller","year":"2009","journal-title":"CircRes"},{"key":"10.1016\/j.pharmr.2025.100042_bib728","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3233\/JHD-140129","article-title":"Comparison of phosphodiesterase 10A, dopamine receptors D1 and D2 and dopamine transporter ligand binding in the striatum of the R6\/2 and BACHD mouse models of Huntington's disease","volume":"3","author":"Miller","year":"2014","journal-title":"J Huntington's Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib729","first-page":"213","article-title":"Promoter methylation of candidate genes associated with familial testicular cancer","volume":"3","author":"Mirabello","year":"2012","journal-title":"Int J Mol Epidemiol Gen"},{"key":"10.1016\/j.pharmr.2025.100042_bib730","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1183\/09031936.00118912","article-title":"Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice","volume":"41","author":"Miravitlles","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmr.2025.100042_bib731","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.mayocp.2018.05.026","article-title":"COPD guidelines: a review of the 2018 GOLD Report","volume":"93","author":"Mirza","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pharmr.2025.100042_bib732","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148798","article-title":"Inhibition of phosphodiesterase type 9 reduces obesity and cardiometabolic syndrome in mice","volume":"131","author":"Mishra","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmr.2025.100042_bib733","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/jscd.2001.24657","article-title":"Effects of cilostazol on cerebral blood flow, P300, and serum lipid levels in the chronic stage of cerebral infarctionJ","volume":"10","author":"Mochizuki","year":"2001","journal-title":"Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib734","doi-asserted-by":"crossref","first-page":"111.e111","DOI":"10.1016\/j.urolonc.2016.10.002","article-title":"Observed correlation between the expression levels of catalytic subunit, Cbeta2, of cyclic adenosine monophosphate-dependent protein kinase and prostate cancer aggressiveness","volume":"35","author":"Moen","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.pharmr.2025.100042_bib735","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3390\/genes12060899","article-title":"Drugging the undruggable: advances on RAS targeting in cancer","volume":"12","author":"Molina-Arcas","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.pharmr.2025.100042_bib736","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.jacc.2012.01.060","article-title":"Cyclic adenosine monophosphate phosphodiesterase type 4 protects against atrial arrhythmias","volume":"59","author":"Molina","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib737","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s12325-009-0064-z","article-title":"Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension","volume":"26","author":"Montani","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib738","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1183\/09059180.00003313","article-title":"Drug-induced pulmonary arterial hypertension: a recent outbreak","volume":"22","author":"Montani","year":"2013","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib739","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.21374","article-title":"PDE2A2 regulates mitochondria morphology and apoptotic cell death via local modulation of cAMP\/PKA signalling","volume":"6","author":"Monterisi","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.pharmr.2025.100042_bib740","first-page":"1321","article-title":"Dysregulated cyclic nucleotide metabolism in alcohol-associated steatohepatitis: implications for novel targeted therapies","volume":"12","author":"Montoya-Durango","year":"2023","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.pharmr.2025.100042_bib741","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.brainresbull.2004.10.011","article-title":"Validation of the l-dopa-induced dyskinesia in the 6-OHDA model and evaluation of the effects of selective dopamine receptor agonists and antagonists","volume":"68","author":"Monville","year":"2005","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmr.2025.100042_bib742","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1124\/mol.112.083493","volume":"83","author":"Moodley","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib743","first-page":"589","article-title":"Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia","volume":"8","author":"Moon","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib744","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.neurobiolaging.2014.10.008","article-title":"Silencing phosphodiesterase 7B gene by lentiviral-shRNA interference attenuates neurodegeneration and motor deficits in hemiparkinsonian mice","volume":"36","author":"Morales-Garcia","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmr.2025.100042_bib745","doi-asserted-by":"crossref","first-page":"564","DOI":"10.5966\/sctm.2014-0277","article-title":"Phosphodiesterase 7 inhibition induces dopaminergic neurogenesis in hemiparkinsonian rats","volume":"4","author":"Morales-Garcia","year":"2015","journal-title":"Stem Cells Tran Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib746","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/stem.2480","article-title":"Phosphodiesterase7 inhibition activates adult neurogenesis in hippocampus and subventricular zone in vitro and in vivo","volume":"35","author":"Morales-Garcia","year":"2017","journal-title":"Stem Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib747","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/cn400166d","article-title":"Crosstalk between phosphodiesterase 7 and glycogen synthase kinase-3: two relevant therapeutic targets for neurological disorders","volume":"5","author":"Morales-Garcia","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib748","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchemneu.2010.03.004","article-title":"The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D","volume":"40","author":"Mori","year":"2010","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.pharmr.2025.100042_bib749","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib750","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01899-2018","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"53","author":"Morrell","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmr.2025.100042_bib751","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.cellsig.2010.11.018","article-title":"Cyclic AMP-mediated immune regulation\u2014overview of mechanisms of action in T cells","volume":"23","author":"Mosenden","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib752","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/molpharm.120.000146","article-title":"Transcriptome-level interactions between budesonide and formoterol provide insight into the mechanism of action of inhaled corticosteroid\/long-acting \u03b22-adrenoceptor agonist combination therapy in asthma","volume":"99","author":"Mostafa","year":"2021","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib753","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.coph.2011.09.001","article-title":"PDE3 inhibition in dilated cardiomyopathy","volume":"11","author":"Movsesian","year":"2011","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib754","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1071-9164(03)00135-0","article-title":"PDE3 inhibition in dilated cardiomyopathy: reasons to reconsider","volume":"9","author":"Movsesian","year":"2003","journal-title":"J Card Fail"},{"key":"10.1016\/j.pharmr.2025.100042_bib755","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm8780","article-title":"Therapeutic KRAS(G12C) inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers","volume":"8","author":"Mugarza","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.pharmr.2025.100042_bib756","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCRESAHA.121.319828","article-title":"PDE1 inhibition modulates Ca(v)1.2 channel to stimulate cardiomyocyte contraction","volume":"129","author":"Muller","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib757","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0022-3565(25)09591-6","article-title":"Paradoxical blockade of beta adrenergically mediated inhibition of stimulated eosinophil secretion by salmeterol","volume":"273","author":"Mu\u00f1oz","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib758","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1080\/09168451.2019.1584520","article-title":"Improvement of pulmonary arterial hypertension, inflammatory response, and epithelium injury by dual activation of cAMP\/cGMP pathway in a rat model of monocrotaline-induced pulmonary hypertension","volume":"83","author":"Muraki","year":"2019","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.pharmr.2025.100042_bib759","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/sj.bjp.0704984","article-title":"Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension","volume":"137","author":"Murray","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib760","doi-asserted-by":"crossref","first-page":"L294","DOI":"10.1152\/ajplung.00190.2006","article-title":"Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1","volume":"292","author":"Murray","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib761","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2125.2003.01760.x","article-title":"Bronchodilator effects of intravenous olprinone, a phosphodiesterase 3 inhibitor, with and without aminophylline in asthmatic patients","volume":"55","author":"Myou","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib762","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1164\/ajrccm.160.3.9812065","article-title":"Bronchodilator effect of inhaled olprinone, a phosphodiesterase 3 inhibitor, in asthmatic patients","volume":"160","author":"Myou","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib763","first-page":"250","article-title":"Pulmonary hypertension and right heart failure in COPD","volume":"59","author":"Naeije","year":"2003","journal-title":"Monaldi Arch Chest Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib764","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1016\/j.bmcl.2009.04.121","article-title":"Discovery of selective PDE4B inhibitors","volume":"19","author":"Naganuma","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib765","first-page":"380","article-title":"Sustained soluble guanylate cyclase stimulation offsets nitric-oxide synthase inhibition to restore acute cardiac modulation by sildenafil","volume":"326","author":"Nagayama","year":"2008","journal-title":"J PharmacolExpTher"},{"key":"10.1016\/j.pharmr.2025.100042_bib766","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/01.RES.0000215576.27615.fd","article-title":"Role of nuclear Ca2+\/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival","volume":"98","author":"Nagel","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib767","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/CIRCULATIONAHA.106.655266","article-title":"Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility","volume":"116","author":"Nagendran","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib768","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1172\/JCI80275","article-title":"Prevention of PKG1alpha oxidation augments cardioprotection in the stressed heart","volume":"125","author":"Nakamura","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmr.2025.100042_bib769","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004740","article-title":"Prevention of PKG-1alpha oxidation suppresses antihypertrophic\/antifibrotic effects from PDE5 inhibition but not sGC stimulation","volume":"11","author":"Nakamura","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pharmr.2025.100042_bib770","article-title":"TAK-915, a phosphodiesterase 2A inhibitor, ameliorates the cognitive impairment associated with aging in rodent models","volume":"376","author":"Nakashima","year":"2019","journal-title":"BehavBrain Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib771","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1365-2249.2002.01856.x","article-title":"Potential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitors","volume":"128","author":"Nakata","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib772","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/FJC.0000000000000652","article-title":"Contrasting effects of inhibition of phosphodiesterase 3 and 5 on cardiac function and interstitial fibrosis in rats with isoproterenol-induced cardiac dysfunction","volume":"73","author":"Nakata","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib773","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/17512433.2018.1507734","article-title":"Adult atopic dermatitis: new and emerging therapies","volume":"11","author":"Napolitano","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib774","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1158\/1078-0432.CCR-07-0744","article-title":"Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence","volume":"13","author":"Narayanan","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib775","doi-asserted-by":"crossref","first-page":"19900","DOI":"10.1074\/jbc.271.33.19900","article-title":"Activation of the human androgen receptor through a protein kinase A signaling pathway","volume":"271","author":"Nazareth","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib776","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/s11064-021-03327-9","article-title":"Drotaverine inhibitor of PDE4: reverses the streptozotocin induced Alzheimer's disease in mice","volume":"46","author":"Nazir","year":"2021","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib777","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/mol.104.004853","article-title":"Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis","volume":"67","author":"Netherton","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib778","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/CIRCRESAHA.106.146159","article-title":"Both protein kinase A and exchange protein activated by cAMP coordinate adhesion of human vascular endothelial cells","volume":"101","author":"Netherton","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib779","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejphar.2013.05.035","article-title":"Anti-inflammatory glucocorticoids: changing concepts","volume":"724","author":"Newton","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib780","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1111\/bph.13628","article-title":"Understanding how long-acting \u03b22-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma\u2014an update","volume":"173","author":"Newton","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib781","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fphys.2015.00294","article-title":"Fine particulate matter in acute exacerbation of COPD","volume":"6","author":"Ni","year":"2015","journal-title":"Front Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib782","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/jpet.110.173641","article-title":"In vivo characterization of GSK256066, a high-affinity inhaled phosphodiesterase 4 inhibitor","volume":"337","author":"Nials","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib783","doi-asserted-by":"crossref","first-page":"37215","DOI":"10.1074\/jbc.C400302200","article-title":"Novel single chain cAMP sensors for receptor-induced signal propagation","volume":"279","author":"Nikolaev","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib784","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1185988","article-title":"\u03b22-Adrenergic receptor redistribution in heart failure changes cAMP compartmentation","volume":"327","author":"Nikolaev","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2025.100042_bib785","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1523\/JNEUROSCI.2518-08.2008","article-title":"Distinct roles of PDE4 and PDE10A in the regulation of cAMP\/PKA signaling in the striatum","volume":"28","author":"Nishi","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib786","first-page":"13244","article-title":"Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition","volume":"285","author":"Nishida","year":"2010","journal-title":"JBiolChem"},{"key":"10.1016\/j.pharmr.2025.100042_bib787","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cellimm.2006.09.001","article-title":"Phosphodiesterase 7A1 is expressed in human CD4+ naive T cells at higher levels than in CD4+ memory cells and is not required during their CD3\/CD28-dependent activation","volume":"242","author":"Nueda","year":"2006","journal-title":"Cell Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib788","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.792798","article-title":"Cyclic GMP, and PKG signaling in heart failure","volume":"13","author":"Numata","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib789","article-title":"Levodopa-induced dyskinesia: review, observations, and speculations","volume":"40","author":"Nutt","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.pharmr.2025.100042_bib790","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2019.103449","article-title":"Inhibition of calcium-calmodulin-dependent phosphodiesterase (PDE1) suppresses inflammatory responses","volume":"102","author":"O'Brien","year":"2020","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib791","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1074\/jbc.M116.768853","article-title":"In vivo knockdown of pathogenic proteins via specific and nongenetic inhibitor of apoptosis protein (IAP)-dependent protein erasers (SNIPERs)","volume":"292","author":"Ohoka","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib792","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yjmcc.2013.08.003","article-title":"Cyclic nucleotide phosphodiesterase 3A1 protects the heart against ischemia-reperfusion injury","volume":"64","author":"Oikawa","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib793","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1756-0500-4-28","article-title":"Novel human genetic variants associated with extrapulmonary tuberculosis: a pilot genome wide association study","volume":"4","author":"Oki","year":"2011","journal-title":"BMC research notes"},{"key":"10.1016\/j.pharmr.2025.100042_bib794","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1212\/WNL.0b013e318199068b","article-title":"Can we achieve neuroprotection with currently available anti-parkinsonian interventions?","volume":"72","author":"Olanow","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.pharmr.2025.100042_bib795","doi-asserted-by":"crossref","first-page":"13320","DOI":"10.1073\/pnas.1822113116","article-title":"Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases","volume":"116","author":"Omar","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib796","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2011.03.018","article-title":"Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model","volume":"33","author":"Orejana","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmr.2025.100042_bib797","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2567.2008.02850.x","article-title":"Altered editing in cyclic nucleotide phosphodiesterase 8A1 gene transcripts of systemic lupus erythematosus T lymphocytes","volume":"125","author":"Orlowski","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.pharmr.2025.100042_bib798","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s002100000215","article-title":"\u03b2\u2212Adrenoceptor stimulation up-regulates phosphodiesterase 4 activity and reduces prostaglandin E2-inhibitory effects in human neutrophils","volume":"361","author":"Ortiz","year":"2000","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib799","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature12796","article-title":"K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions","volume":"503","author":"Ostrem","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100042_bib800","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group","volume":"325","author":"Packer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib801","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neurobiolaging.2020.10.004","article-title":"Increased isoform-specific phosphodiesterase 4D expression is associated with pathology and cognitive impairment in Alzheimer's disease","volume":"97","author":"Paes","year":"2021","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmr.2025.100042_bib802","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1124\/pharmrev.120.000273","article-title":"The molecular biology of phosphodiesterase 4 enzymes as pharmacological targets: an interplay of isoforms, conformational states, and inhibitors","volume":"73","author":"Paes","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib803","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00018-023-04804-w","article-title":"Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-beta pathology","volume":"80","author":"Paes","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib804","doi-asserted-by":"crossref","first-page":"9411","DOI":"10.1074\/jbc.M606936200","article-title":"Protein kinase A phosphorylation of human phosphodiesterase 3B promotes 14-3-3 protein binding and inhibits phosphatase-catalyzed inactivation","volume":"282","author":"Palmer","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib805","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2012.10.060","article-title":"Inhibition of phosphodiesterase-5 rescues age-related impairment of synaptic plasticity and memory","volume":"240","author":"Palmeri","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib806","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1440-1843.2009.01606.x","article-title":"Rolipram attenuates bleomycin A5-induced pulmonary fibrosis in rats","volume":"14","author":"Pan","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.pharmr.2025.100042_bib807","doi-asserted-by":"crossref","first-page":"18225","DOI":"10.1073\/pnas.0907635106","article-title":"Mechanism for the allosteric regulation of phosphodiesterase 2A deduced from the X-ray structure of a near full-length construct","volume":"106","author":"Pandit","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib808","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neurobiolaging.2018.01.019","article-title":"Identification of new PDE9A isoforms and how their expression and subcellular compartmentalization in the brain change across the life span","volume":"65","author":"Patel","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmr.2025.100042_bib809","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1530\/ERC-15-0034","article-title":"Rare inactivating PDE11A variants associated with testicular germ cell tumors","volume":"22","author":"Pathak","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.pharmr.2025.100042_bib810","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/mp.2016.155","article-title":"PDE11A negatively regulates lithium responsivity","volume":"22","author":"Pathak","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100042_bib811","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/mp.2016.155","article-title":"PDE11A negatively regulates lithium responsivity","volume":"22","author":"Pathak","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmr.2025.100042_bib812","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.yjmcc.2010.03.016","article-title":"Phosphodiesterase 8A (PDE8A) regulates excitation-contraction coupling in ventricular myocytes","volume":"49","author":"Patrucco","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib813","article-title":"Testing the cognitive effects of tadalafil. Neuropsychological secondary outcomes from the PASTIS trial","volume":"5","author":"Pauls","year":"2023","journal-title":"Cereb Circ Cogn Behav"},{"key":"10.1016\/j.pharmr.2025.100042_bib814","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tem.2016.10.007","article-title":"GPCR signaling and trafficking: the long and short of it","volume":"28","author":"Pavlos","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.pharmr.2025.100042_bib815","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/glia.22986","article-title":"PDE4B as a microglia target to reduce neuroinflammation","volume":"64","author":"Pearse","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.pharmr.2025.100042_bib816","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1111\/bph.14350","article-title":"Targeting the dopamine D1 receptor or its downstream signalling by inhibiting phosphodiesterase-1 improves cognitive performance","volume":"175","author":"Pekcec","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib817","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bone.2008.02.021","article-title":"Effects of phosphodiesterase 7 inhibition by RNA interference on the gene expression and differentiation of human mesenchymal stem cell-derived osteoblasts","volume":"43","author":"Pekkinen","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.pharmr.2025.100042_bib818","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/CIRCULATIONAHA.117.031855","article-title":"Quantifying importance of major risk factors for coronary heart disease","volume":"139","author":"Pencina","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib819","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1085\/jgp.201611654","article-title":"Exploring cells with targeted biosensors","volume":"149","author":"Pendin","year":"2017","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib820","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1091\/mbc.e09-08-0655","article-title":"Compartmentalized cyclic adenosine 3',5'-monophosphate at the plasma membrane clusters PDE3A and cystic fibrosis transmembrane conductance regulator into microdomains","volume":"21","author":"Penmatsa","year":"2010","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib821","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0107-2016","article-title":"Medical management of chronic thromboembolic pulmonary hypertension","volume":"26","author":"Pepke-Zaba","year":"2017","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib822","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1378\/chest.07-0592","article-title":"Sildenafil improves health-related quality of life in patients with pulmonary arterial hypertension","volume":"133","author":"Pepke-Zaba","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.pharmr.2025.100042_bib823","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/CIRCRESAHA.116.306082","article-title":"Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of beta-adrenoceptor-stimulated contractility in early cardiac hypertrophy","volume":"116","author":"Perera","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib824","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.neurobiolaging.2013.03.011","article-title":"Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease","volume":"34","author":"Perez-Gonzalez","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmr.2025.100042_bib825","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0014-4886(03)00042-6","article-title":"Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization","volume":"182","author":"Perez-Torres","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharmr.2025.100042_bib826","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0531-5131(03)00104-3","article-title":"cAMP-specific phosphodiesterases expression in Alzheimer's disease brains","volume":"1251","author":"Perez-Torres","year":"2003","journal-title":"Int Cong Ser"},{"key":"10.1016\/j.pharmr.2025.100042_bib827","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0891-0618(00)00097-1","article-title":"Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and [3H]rolipram binding autoradiography. Comparison with monkey and rat brain","volume":"20","author":"P\u00e9rez-Torres","year":"2000","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.pharmr.2025.100042_bib828","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.4049\/jimmunol.178.8.4820","article-title":"Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: predominant role of PDE4D","volume":"178","author":"Peter","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib829","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/cvr\/cvab240","article-title":"Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology","volume":"118","author":"Petraina","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib830","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0165-5728(99)00088-0","article-title":"Differential effects of phosphodiesterase type 4-specific inhibition on human autoreactive myelin-specific T cell clones","volume":"98","author":"Pette","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib831","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-09-0677","article-title":"Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients","volume":"161","author":"Peverelli","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pharmr.2025.100042_bib832","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1073\/pnas.1303302110","article-title":"Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment","volume":"110","author":"Phan","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib833","article-title":"Clinical outcomes and gut microbiota analysis of severe alcohol-associated hepatitis patients undergoing healthy donor fecal transplant or pentoxifylline therapy: single-center experience from Kerala","volume":"10","author":"Philips","year":"2022","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.pharmr.2025.100042_bib834","first-page":"209","article-title":"Bifunctional compounds for the treatment of COPD","volume":"47","author":"Phillips","year":"2012","journal-title":"Ann Rev Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib835","first-page":"2909","article-title":"Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels","volume":"57","author":"Piazza","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib836","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1158\/1940-6207.CAPR-09-0001","article-title":"A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity","volume":"2","author":"Piazza","year":"2009","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.pharmr.2025.100042_bib837","first-page":"3961","article-title":"Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis","volume":"61","author":"Piazza","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib838","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/brain\/awq342","article-title":"Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia","volume":"134","author":"Picconi","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.pharmr.2025.100042_bib839","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in L-DOPA\u2013induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib840","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neurobiolaging.2023.07.008","article-title":"Biologic that disrupts PDE11A4 homodimerization in hippocampus CA1 reverses age-related cognitive decline of social memories in mice","volume":"131","author":"Pilarzyk","year":"2023","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmr.2025.100042_bib841","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.749628","article-title":"The role of PDE11A4 in social isolation-induced changes in intracellular signaling and neuroinflammation","volume":"12","author":"Pilarzyk","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib842","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.cub.2019.06.018","article-title":"Loss of function of phosphodiesterase 11A4 shows that recent and remote long-term memories can be uncoupled","volume":"29","author":"Pilarzyk","year":"2019","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib843","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13687","article-title":"Conserved age-related increases in hippocampal PDE11A4 cause unexpected proteinopathies and cognitive decline of social associative memories","volume":"21","author":"Pilarzyk","year":"2022","journal-title":"Aging cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib844","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0898-6568(95)00042-N","article-title":"Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine","volume":"7","author":"Podzuweit","year":"1995","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib845","doi-asserted-by":"crossref","DOI":"10.1038\/srep44584","article-title":"Phosphodiesterase-5 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR-22 and BMP7","volume":"7","author":"Pofi","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2025.100042_bib846","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/CIRCULATIONAHA.108.822072","article-title":"Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice","volume":"119","author":"Pokreisz","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib847","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hup.308","article-title":"Cognitive effects of a Ginkgo biloba\/vinpocetine compound in normal adults: systematic assessment of perception, attention and memory","volume":"16","author":"Polich","year":"2001","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib848","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.yjmcc.2019.04.028","article-title":"Phosphodiesterase type 3A (PDE3A), but not type 3B (PDE3B), contributes to the adverse cardiac remodeling induced by pressure overload","volume":"132","author":"Polidovitch","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib849","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1523\/JNEUROSCI.14-03-01251.1994","article-title":"Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation","volume":"14","author":"Polli","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib850","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.embor.7400290","article-title":"Detecting cAMP-induced activation by fluorescence resonance energy transfer: epac as a novel cAMP indicator","volume":"5","author":"Ponsioen","year":"2004","journal-title":"EMBO Rep"},{"key":"10.1016\/j.pharmr.2025.100042_bib851","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12974-021-02252-6","article-title":"Aging triggers an upregulation of a multitude of cytokines in the male and especially the female rodent hippocampus but more discrete changes in other brain regions","volume":"18","author":"Porcher","year":"2021","journal-title":"J Neuroinf"},{"key":"10.1016\/j.pharmr.2025.100042_bib852","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1164\/ajrccm.158.supplement_2.13tac170","article-title":"Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease","volume":"158","author":"Postma","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib853","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1513\/pats.200601-006AW","article-title":"Remodeling in asthma and chronic obstructive pulmonary disease","volume":"3","author":"Postma","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.pharmr.2025.100042_bib854","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/BJ20051103","article-title":"Phosphodiesterase 3A binds to 14-3-3 proteins in response to PMA-induced phosphorylation of Ser428","volume":"392","author":"Pozuelo Rubio","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmr.2025.100042_bib855","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10557-020-06959-1","article-title":"Cardiac cyclic nucleotide phosphodiesterases: roles and therapeutic potential in heart failure","volume":"34","author":"Preedy","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib856","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/13543784.2017.1364360","article-title":"Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer\u2019s disease","volume":"26","author":"Prickaerts","year":"2017","journal-title":"Exp Opin Invest Drugs"},{"key":"10.1016\/j.pharmr.2025.100042_bib857","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.bmcl.2006.01.006","article-title":"First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives","volume":"16","author":"Provins","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib858","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1016\/j.bmcl.2007.03.047","article-title":"Dual M3 antagonists-PDE4 inhibitors. Part 2: synthesis and SAR of 3-substituted azetidinyl derivatives","volume":"17","author":"Provins","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib859","series-title":"Molecular Mechanisms in Visual Transduction","first-page":"183","article-title":"Phototransduction in vertebrate rods and cones: molecular mechanisms of amplification, recovery and light adaptation","author":"Pugh","year":"2000"},{"key":"10.1016\/j.pharmr.2025.100042_bib860","doi-asserted-by":"crossref","first-page":"L229","DOI":"10.1152\/ajplung.00238.2014","article-title":"The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes","volume":"308","author":"Pugliese","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib861","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1200\/JCO.2003.02.114","article-title":"Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer","volume":"21","author":"Pusztai","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pharmr.2025.100042_bib862","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.neurobiolaging.2013.09.002","article-title":"Effect of phosphodiesterase-5 inhibition on apoptosis and beta amyloid load in aged mice","volume":"35","author":"Puzzo","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmr.2025.100042_bib863","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1523\/JNEUROSCI.0864-09.2009","article-title":"Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model","volume":"29","author":"Puzzo","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib864","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ccr.2012.04.024","article-title":"Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia","volume":"21","author":"Pylayeva-Gupta","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib865","doi-asserted-by":"crossref","first-page":"8458","DOI":"10.1016\/S0021-9258(18)42466-0","article-title":"In vitro isoprenylation and membrane association of mouse rod photoreceptor cGMP phosphodiesterase alpha and beta subunits expressed in bacteria","volume":"267","author":"Qin","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib866","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bmc.2017.11.022","article-title":"Discovery of novel purine nucleoside derivatives as phosphodiesterase 2 (PDE2) inhibitors: structure-based virtual screening, optimization and biological evaluation","volume":"26","author":"Qiu","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib867","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cell.2018.06.039","article-title":"Genomic hallmarks and structural variation in metastatic prostate cancer","volume":"174","author":"Quigley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib868","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1476-5381.2011.01218.x","article-title":"Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease","volume":"163","author":"Rabe","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib869","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(05)67100-0","article-title":"Roflumilast\u2014an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial","volume":"366","author":"Rabe","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pharmr.2025.100042_bib870","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0014-2999(93)90466-U","article-title":"Salmeterol is a competitive antagonist at \u03b2-adrenoceptors mediating inhibition of respiratory burst in guinea-pig eosinophils","volume":"231","author":"Rabe","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib871","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S2213-2600(14)70101-8","article-title":"Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11","volume":"2","author":"Raghu","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib872","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib873","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fimmu.2016.00123","article-title":"The cAMP pathway as therapeutic target in autoimmune and inflammatory diseases","volume":"7","author":"Raker","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib874","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0021-9258(19)77422-5","article-title":"Formation of a cyclic adenine ribonucleotide by tissue particles","volume":"232","author":"Rall","year":"1958","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib875","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0896-6273(03)00694-9","article-title":"Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline.[see comment]","volume":"40","author":"Ramos","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2025.100042_bib876","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41586-019-0895-y","article-title":"PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress","volume":"566","author":"Ranek","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100042_bib877","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1038\/s41467-020-18980-x","article-title":"CHIP phosphorylation by protein kinase G enhances protein quality control and attenuates cardiac ischemic injury","volume":"11","author":"Ranek","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2025.100042_bib878","first-page":"1451","article-title":"Modulation of glucocorticoid receptor function by protein kinase A","volume":"6","author":"Rangarajan","year":"1992","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmr.2025.100042_bib879","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1080\/17512433.2020.1826304","article-title":"An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer","volume":"13","author":"Rappaport","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib880","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa","volume":"342","author":"Rascol","year":"2000","journal-title":"Nw Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib881","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1098-3597(05)80048-1","article-title":"The efficacy and safety of PDE5 inhibitors","volume":"7","author":"Rashid","year":"2005","journal-title":"Clin Cornerstone"},{"key":"10.1016\/j.pharmr.2025.100042_bib882","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jconrel.2017.02.003","article-title":"Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH)","volume":"250","author":"Rashid","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.pharmr.2025.100042_bib883","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.cgh.2014.01.040","article-title":"Lack of efficacy of an inhibitor of PDE4 in phase 1 and 2 trials of patients with nonalcoholic steatohepatitis","volume":"12","author":"Ratziu","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.pharmr.2025.100042_bib884","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12872-018-0822-4","article-title":"Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database","volume":"18","author":"Real","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.pharmr.2025.100042_bib885","article-title":"GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents","volume":"53","author":"Reddel","year":"2019","journal-title":"Eur Respirat J"},{"key":"10.1016\/j.pharmr.2025.100042_bib886","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/COPD.S230188","article-title":"Glucocorticoid receptor \u03b1 mediates roflumilast's ability to restore dexamethasone sensitivity in COPD","volume":"15","author":"Reddy","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib887","first-page":"3387","article-title":"Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process","volume":"59","author":"Reddy","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib888","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.pharmr.2025.100042_bib889","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1021\/jm201720d","article-title":"Effect of phosphodiesterase 7 (PDE7) inhibitors in experimental autoimmune encephalomyelitis mice. Discovery of a new chemically diverse family of compounds","volume":"55","author":"Redondo","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib890","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1523\/JNEUROSCI.22-12-05188.2002","article-title":"Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning","volume":"22","author":"Reed","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib891","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1042\/bj2410535","article-title":"The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors","volume":"241","author":"Reeves","year":"1987","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmr.2025.100042_bib892","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/01902148.2017.1349210","article-title":"MiR-541-5p regulates lung fibrosis by targeting cyclic nucleotide phosphodiesterase 1A","volume":"43","author":"Ren","year":"2017","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib893","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/0269881113477747","article-title":"The effects of the phosphodiesterase type 5 inhibitor vardenafil on cognitive performance in healthy adults: a behavioral-electroencephalography study","volume":"27","author":"Reneerkens","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib894","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00213-012-2817-7","article-title":"The PDE5 inhibitor vardenafil does not affect auditory sensory gating in rats and humans","volume":"225","author":"Reneerkens","year":"2013","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib895","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/0003495-200868002-00002","article-title":"The efficacy and safety of cilomilast in COPD","volume":"68","author":"Rennard","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.pharmr.2025.100042_bib896","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1465-9921-12-18","article-title":"Reduction of exacerbations by the PDE4 inhibitor roflumilast\u2014the importance of defining different subsets of patients with COPD","volume":"12","author":"Rennard","year":"2011","journal-title":"Respirat Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib897","doi-asserted-by":"crossref","first-page":"L686","DOI":"10.1152\/ajplung.00417.2007","article-title":"Role of vasodilator-stimulated phosphoprotein in cGMP-mediated protection of human pulmonary artery endothelial barrier function","volume":"294","author":"Rentsendorj","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib898","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1111\/j.1460-9568.2007.05589.x","article-title":"Expression of the cGMP-specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains","volume":"25","author":"Reyes-Irisarri","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib899","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.neuroscience.2005.01.050","article-title":"Neuronal expression of cAMP-specific phosphodiesterase 7B mRNA in the rat brain","volume":"132","author":"Reyes-Irisarri","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmr.2025.100042_bib900","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/ph14010058","article-title":"A perspective on natural and nature-inspired small molecules targeting phosphodiesterase 9 (PDE9): chances and challenges against neurodegeneration","volume":"14","author":"Ribaudo","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.pharmr.2025.100042_bib901","doi-asserted-by":"crossref","DOI":"10.1038\/srep46320","article-title":"Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer's disease","volume":"7","author":"Ricciarelli","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2025.100042_bib902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.soc.2023.06.004","article-title":"Changing epidemiology of hepatocellular carcinoma within the United States and worldwide","volume":"33","author":"Rich","year":"2024","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.pharmr.2025.100042_bib903","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/cvr\/cvw080","article-title":"Intracellular tortuosity underlies slow cAMP diffusion in adult ventricular myocytes","volume":"110","author":"Richards","year":"2016","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib904","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa2201737","article-title":"Trial of a preferential phosphodiesterase 4B inhibitor for idiopathic pulmonary fibrosis","volume":"386","author":"Richeldi","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib905","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0074-2018","article-title":"Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence","volume":"27","author":"Richeldi","year":"2018","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib906","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.emboj.7601968","article-title":"Signaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4","volume":"27","author":"Richter","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmr.2025.100042_bib907","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00395-010-0138-8","article-title":"Conserved expression and functions of PDE4 in rodent and human heart","volume":"106","author":"Richter","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib908","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/19390211.2011.569514","article-title":"Cognitex supplementation in elderly adults with memory complaints: an uncontrolled open label trial","volume":"8","author":"Richter","year":"2011","journal-title":"J Diet Suppl"},{"key":"10.1016\/j.pharmr.2025.100042_bib909","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1124\/mol.118.112755","article-title":"Long-acting \u03b22-adrenoceptor agonists enhance glucocorticoid receptor (GR)-mediated transcription by gene-specific mechanisms rather than generic effects via GR","volume":"94","author":"Rider","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib910","doi-asserted-by":"crossref","first-page":"11476","DOI":"10.1021\/acs.jmedchem.3c01012","article-title":"Optimization of M3 antagonist-PDE4 inhibitor (MAPI) dual pharmacology molecules for the treatment of COPD","volume":"66","author":"Rizzi","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib911","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0028-3908(00)00142-8","article-title":"PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway","volume":"40","author":"Robichaud","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib912","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI0215506","article-title":"Deletion of phosphodiesterase 4D in mice shortens a2-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis","volume":"110","author":"Robichaud","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmr.2025.100042_bib913","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0028-3908(98)00190-7","article-title":"Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret","volume":"38","author":"Robichaud","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib914","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0006-2952(91)90047-9","article-title":"Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes","volume":"42","author":"Robicsek","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib915","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0006-291X(89)92173-6","article-title":"High pressure liquid chromatography of cyclic nucleotide phosphodiesterase from purified human T-lymphocytes","volume":"163","author":"Robicsek","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmr.2025.100042_bib916","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/hep.30761","article-title":"Phosphodiesterase 4 inhibition as a therapeutic target for alcoholic liver disease: from bedside to bench","volume":"70","author":"Rodriguez","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmr.2025.100042_bib917","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.1995.tb14984.x","article-title":"No evidence for a role of muscarinic M2 receptors in functional antagonism in bovine trachea","volume":"115","author":"Roffel","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib918","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110251","article-title":"Phosphodiesterase-1 in the cardiovascular system","volume":"92","author":"Roks","year":"2022","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib919","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1124\/jpet.119.260059","article-title":"The novel phosphodiesterase 9A inhibitor BI 409306 increases cyclic guanosine monophosphate levels in the brain, promotes synaptic plasticity, and enhances memory function in rodents","volume":"371","author":"Rosenbrock","year":"2019","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.pharmr.2025.100042_bib920","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension","volume":"37","author":"Rosenkranz","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmr.2025.100042_bib921","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-1119(97)00046-2","article-title":"Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase","volume":"191","author":"Rosman","year":"1997","journal-title":"Gene"},{"key":"10.1016\/j.pharmr.2025.100042_bib922","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3389\/fncel.2019.00432","article-title":"Phosphodiesterase-2 inhibitor bay 60-7550 ameliorates abeta-induced cognitive and memory impairment via regulation of the HPA axis","volume":"13","author":"Ruan","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib923","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fimmu.2016.00216","article-title":"Regulatory T-cell-mediated suppression of conventional T-cells and dendritic cells by different cAMP intracellular pathways","volume":"7","author":"Rueda","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib924","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and treatment of pulmonary arterial hypertension: a review","volume":"327","author":"Ruopp","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.pharmr.2025.100042_bib925","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jamaneurol.2014.1954","article-title":"The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease","volume":"71","author":"Russell","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.pharmr.2025.100042_bib926","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1212\/WNL.0000000000002391","article-title":"Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging","volume":"86","author":"Russell","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.pharmr.2025.100042_bib927","first-page":"801","article-title":"Differential inhibitory effect of isoproterenol on contractions of canine airways","volume":"57","author":"Russell","year":"1984","journal-title":"J Appl Physiol Respir Environ Exerc Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib928","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1460-9568.2008.06349.x","article-title":"Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D) mice","volume":"28","author":"Rutten","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib929","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuropharm.2011.03.020","article-title":"Enhanced long-term depression and impaired reversal learning in phosphodiesterase 4B-knockout (PDE4B-\/-) mice","volume":"61","author":"Rutten","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib930","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1124\/jpet.114.214155","article-title":"GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species","volume":"350","author":"Rutter","year":"2014","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.pharmr.2025.100042_bib931","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1172\/JCI119805","article-title":"Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype","volume":"100","author":"Rybalkin","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmr.2025.100042_bib932","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/hh0202.104108","article-title":"Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation","volume":"90","author":"Rybalkin","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib933","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pupt.2010.02.004","article-title":"A phosphodiesterase 4 inhibitor, roflumilast N-oxide, inhibits human lung fibroblast functions in vitro","volume":"23","author":"Sabatini","year":"2010","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib934","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.027","article-title":"Efficacy of cilostazol in prevention of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a meta-analysis","volume":"27","author":"Saber","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib935","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2018.02.037","article-title":"Profound tissue specificity in proliferation control underlies cancer drivers and aneuploidy patterns","volume":"173","author":"Sack","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib936","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T cell states associated with response to checkpoint immunotherapy in melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib937","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207462","article-title":"Therapeutic implications for PDE2 and cGMP\/cAMP mediated crosstalk in cardiovascular diseases","volume":"21","author":"Sadek","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib938","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1111\/bph.15621","article-title":"Lung pharmacokinetics of inhaled and systemic drugs: a clinical evaluation","volume":"178","author":"Sadiq","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib939","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.2174\/0929867324666170530093902","article-title":"Phosphodiesterase 4 inhibitors in immune-mediated diseases: mode of action, clinical applications, current and future perspectives","volume":"24","author":"Sakkas","year":"2017","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib940","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1447-0594.2012.00866.x","article-title":"Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: a pilot study","volume":"13","author":"Sakurai","year":"2013","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.pharmr.2025.100042_bib941","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.46","article-title":"The in vivo efficacy and side effect pharmacology of GS-5759, a novel bifunctional phosphodiesterase 4 inhibitor and long-acting \u03b22-adrenoceptor agonist in preclinical animal species","volume":"2","author":"Salmon","year":"2014","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.pharmr.2025.100042_bib942","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/mds.27286","article-title":"A homozygous loss-of-function mutation in PDE2A associated to early-onset hereditary chorea","volume":"33","author":"Salpietro","year":"2018","journal-title":"Move Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib943","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev-pharmtox-040122-034745","article-title":"Beyond erectile dysfunction: cGMP-specific phosphodiesterase 5 inhibitors for other clinical disorders","volume":"63","author":"Samidurai","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmr.2025.100042_bib944","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/01.CIR.0000133390.12306.C7","article-title":"Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C","volume":"110","author":"Sanada","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib945","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/hc3201.092216","article-title":"Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors -The role of protein kinase A and p38 mitogen-activated protein kinase","volume":"104","author":"Sanada","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib946","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib947","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1471-4159.2007.05152.x","article-title":"Increased social interaction in mice deficient of the striatal medium spiny neuron-specific phosphodiesterase 10A2","volume":"105","author":"Sano","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100042_bib948","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.bjp.0707428","article-title":"Roflumilast inhibits leukocyte-endothelial cell interactions, expression of adhesion molecules and microvascular permeability","volume":"152","author":"Sanz","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib949","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2002-01-0075","article-title":"Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells","volume":"101","author":"Sarfati","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.pharmr.2025.100042_bib950","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2012.08.019","article-title":"Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer","volume":"32","author":"Sarwar","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.pharmr.2025.100042_bib951","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0014-2999(95)00278-S","article-title":"Suppression of oro-facial movements by rolipram, a cAMP phosphodiesterase inhibitor, in rats chronically treated with haloperidol","volume":"282","author":"Sasaki","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib952","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1172\/JCI70731","article-title":"PDE5 inhibitor efficacy is estrogen dependent in female heart disease","volume":"124","author":"Sasaki","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmr.2025.100042_bib953","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1471-4159.2004.02354.x","article-title":"Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP\/cyclic AMP-dependent protein kinase\/cyclic AMP-response element binding protein pathway in primary striatal neurons","volume":"89","author":"Sasaki","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2025.100042_bib954","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0004-2018","article-title":"Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era","volume":"27","author":"Savale","year":"2018","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib955","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/01.RES.0000209516.84815.3e","article-title":"Soluble adenylyl cyclase reveals the significance of cAMP compartmentation on pulmonary microvascular endothelial cell barrier","volume":"98","author":"Sayner","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib956","article-title":"The sleep quality- and myopia-linked PDE11A-Y727C variant impacts neural physiology by reducing catalytic activity and altering subcellular compartmentalization of the enzyme","author":"Sbornova","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.pharmr.2025.100042_bib957","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1358\/dot.2006.42.4.973582","article-title":"Cilomilast","volume":"42","author":"Schachter","year":"2006","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.pharmr.2025.100042_bib958","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40268-019-00284-1","article-title":"Apremilast normalizes gene expression of inflammatory mediators in human keratinocytes and reduces antigen-induced atopic dermatitis in mice","volume":"19","author":"Schafer","year":"2019","journal-title":"Drugs R D"},{"key":"10.1016\/j.pharmr.2025.100042_bib959","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cellsig.2014.05.014","article-title":"Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity","volume":"26","author":"Schafer","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib960","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1476-5381.2009.00559.x","article-title":"Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis","volume":"159","author":"Schafer","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib961","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.3748\/wjg.v24.i38.4356","article-title":"Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension","volume":"24","author":"Schaffner","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pharmr.2025.100042_bib962","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1164\/ajrccm.160.5.9901102","article-title":"Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension","volume":"160","author":"Schermuly","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib963","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanisms of disease: pulmonary arterial hypertension","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib964","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1164\/ajrccm.164.9.2105060","article-title":"Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity","volume":"164","author":"Schermuly","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib965","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1161\/CIRCULATIONAHA.106.676809","article-title":"Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy","volume":"115","author":"Schermuly","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib966","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1759720X10381432","article-title":"Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases","volume":"2","author":"Schett","year":"2010","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib967","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031209","article-title":"Clinical Implication of Phosphodiesterase-4-Inhibition","volume":"23","author":"Schick","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib968","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.immuni.2016.07.011","article-title":"Tumor-specific t cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis","volume":"45","author":"Schietinger","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.pharmr.2025.100042_bib969","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094982","article-title":"The PDE4 inhibitor tanimilast restrains the tissue-damaging properties of human neutrophils","volume":"23","author":"Schioppa","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib970","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1124\/jpet.117.241646","article-title":"Upregulation of Epac-1 in Hepatic Stellate Cells by Prostaglandin E(2) in Liver Fibrosis Is Associated with Reduced Fibrogenesis","volume":"363","author":"Schippers","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib971","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/jpet.107.132910","article-title":"Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia","volume":"325","author":"Schmidt","year":"2008","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.pharmr.2025.100042_bib972","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-3-540-68964-5_14","article-title":"NO- and haem-independent soluble guanylate cyclase activators","volume":"191","author":"Schmidt","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib973","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/brain\/123.11.2297","article-title":"Dyskinesias and motor fluctuations in Parkinson's disease: a community-based study","volume":"123","author":"Schrag","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.pharmr.2025.100042_bib974","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1183\/09031936.95.08071179","article-title":"PDE isoenzymes as targets for anti-asthma drugs","volume":"8","author":"Schudt","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmr.2025.100042_bib975","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/PL00007092","article-title":"Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials","volume":"19","author":"Schultheiss","year":"2001","journal-title":"World J Urol"},{"key":"10.1016\/j.pharmr.2025.100042_bib976","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-3-540-68964-5_6","article-title":"Structural and biochemical aspects of tandem GAF domains","volume":"191","author":"Schultz","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib977","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2174\/1567205011666140505100858","article-title":"A multicenter, double-blind, placebo-controlled trial of the PDE9A inhibitor, PF-04447943, in Alzheimer's disease","volume":"11","author":"Schwam","year":"2014","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib978","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-pharmtox-011112-140204","article-title":"Creating order from chaos: cellular regulation by kinase anchoring","volume":"53","author":"Scott","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmr.2025.100042_bib979","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jchf.2022.11.006","article-title":"Augmentation of natriuretic peptide bioactivity via combined inhibition of neprilysin and phosphodiesterase-9 in heart failure","volume":"11","author":"Scott","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.pharmr.2025.100042_bib980","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jacc.2019.05.067","article-title":"Hemodynamic, hormonal, and renal actions of phosphodiesterase-9 inhibition in experimental heart failure","volume":"74","author":"Scott","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib981","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neurobiolaging.2005.03.024","article-title":"The cAMP-specific phosphodiesterase 4B mediates Abeta-induced microglial activation","volume":"27","author":"Sebastiani","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmr.2025.100042_bib982","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129327","article-title":"Cigarette smoke-induced emphysema and pulmonary hypertension can be prevented by phosphodiesterase 4 and 5 inhibition in mice","volume":"10","author":"Seimetz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2025.100042_bib983","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1002\/jcp.22529","article-title":"The differential impact of PDE4 subtypes in human lung fibroblasts on cytokine-induced proliferation and myofibroblast conversion","volume":"226","author":"Selige","year":"2011","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib984","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcp.22037","article-title":"Cytokine-dependent balance of mitogenic effects in primary human lung fibroblasts related to cyclic AMP signaling and phosphodiesterase 4 inhibition","volume":"223","author":"Selige","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib985","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1084\/jem.20061104","article-title":"Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function","volume":"203","author":"Serafini","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib986","doi-asserted-by":"crossref","first-page":"20575","DOI":"10.1074\/jbc.273.32.20575","article-title":"Induction of phosphodiesterases 3B, 4A4, 4D1, 4D2, and 4D3 in Jurkat T-cells and in human peripheral blood T-lymphocytes by 8-bromo-cAMP and Gs-coupled receptor agonists. Potential role in beta2-adrenoreceptor desensitization","volume":"273","author":"Seybold","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib987","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood-2004-07-2729","article-title":"Tumor necrosis factor-alpha-dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability","volume":"105","author":"Seybold","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pharmr.2025.100042_bib988","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12931-018-0730-2","article-title":"Idiopathic pulmonary fibrosis: pathogenesis and management","volume":"19","author":"Sgalla","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib989","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.bmcl.2012.01.013","article-title":"Dual \u03b22-adrenoceptor agonists-PDE4 inhibitors for the treatment of asthma and COPD","volume":"22","author":"Shan","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib990","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/CIRCHEARTFAILURE.111.961706","article-title":"Differential expression of PDE5 in failing and nonfailing human myocardium","volume":"5","author":"Shan","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pharmr.2025.100042_bib991","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1158\/1940-6207.CAPR-17-0267","article-title":"Cyclic-GMP-elevating agents suppress polyposis in Apc(Min) mice by targeting the preneoplastic epithelium","volume":"11","author":"Sharman","year":"2018","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.pharmr.2025.100042_bib992","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112512","article-title":"The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of amyloid beta (abeta) peptide","volume":"383","author":"Shekarian","year":"2020","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib993","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12868-023-00790-8","article-title":"Neuroprotective effects of vinpocetine, as a phosphodiesterase 1 inhibitor, on long-term potentiation in a rat model of Alzheimer's disease","volume":"24","author":"Shekarian","year":"2023","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib994","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2016.09.020","article-title":"Proteome-scale investigation of protein allosteric regulation perturbed by somatic mutations in 7,000 cancer genomes","volume":"100","author":"Shen","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmr.2025.100042_bib995","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bjp.0705770","article-title":"Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937 cells","volume":"142","author":"Shepherd","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib996","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1365-2141.1997.4803282.x","article-title":"Cyclic AMP phosphodiesterases in human lymphocytes","volume":"99","author":"Sheth","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pharmr.2025.100042_bib997","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.794458","article-title":"Baicalein ameliorates A\u03b2-induced memory deficits and neuronal atrophy via inhibition of PDE2 and PDE4","volume":"12","author":"Shi","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib998","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.722580","article-title":"Phosphodiesterase-4D knockdown in the prefrontal cortex alleviates memory deficits and synaptic failure in mouse model of Alzheimer's disease","volume":"13","author":"Shi","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib999","doi-asserted-by":"crossref","first-page":"E5685","DOI":"10.1073\/pnas.1611424113","article-title":"SCAP\/SREBP pathway is required for the full steroidogenic response to cyclic AMP","volume":"113","author":"Shimizu-Albergine","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib1000","first-page":"222","article-title":"Cellular pathways promoting pulmonary vascular remodeling by hypoxia","volume":"35","author":"Shimoda","year":"2020","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.pharmr.2025.100042_bib1001","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00109-013-0998-0","article-title":"Vascular remodeling in pulmonary hypertension","volume":"91","author":"Shimoda","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.pharmr.2025.100042_bib1002","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/JCP.0b013e31822c94fd","article-title":"Effects of add-on cilostazol on cognition in patients with schizophrenia: an open-label pilot trial","volume":"31","author":"Shirayama","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1003","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/cmdc.201100101","article-title":"Design strategies for bivalent ligands targeting GPCRs","volume":"6","author":"Shonberg","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1004","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jaad.2022.12.029","article-title":"Guidelines of care for the management of atopic dermatitis in adults with topical therapies","volume":"89","author":"Sidbury","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1(+)PD-1(+)CD8(+) T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.pharmr.2025.100042_bib1006","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1164\/rccm.202307-1164ED","article-title":"A new treatment for chronic obstructive pulmonary disease: ensifentrine moves closer","volume":"208","author":"Singh","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib1007","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12931-019-1142-7","article-title":"Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD","volume":"20","author":"Singh","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1008","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12931-020-01512-y","article-title":"Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study","volume":"21","author":"Singh","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1009","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12931-020-1307-4","article-title":"A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD","volume":"21","author":"Singh","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1010","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.4049\/jimmunol.0900826","volume":"183","author":"Singh","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1011","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13753","article-title":"Phosphodiesterase 4 inhibition reduces lung fibrosis following targeted type II alveolar epithelial cell injury","volume":"6","author":"Sisson","year":"2018","journal-title":"Physiol Rep"},{"key":"10.1016\/j.pharmr.2025.100042_bib1012","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.neuropharm.2006.04.013","article-title":"Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis","volume":"51","author":"Siuciak","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1013","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-007-0727-x","article-title":"Antipsychotic profile of rolipram: efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4B (PDE4B) enzyme","volume":"192","author":"Siuciak","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1014","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.neuropharm.2006.01.012","article-title":"Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function","volume":"51","author":"Siuciak","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00213-007-1014-6","article-title":"Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme","volume":"197","author":"Siuciak","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1016","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.neuropharm.2007.10.009","article-title":"Behavioral characterization of mice deficient in the phosphodiesterase-10A (PDE10A) enzyme on a C57\/Bl6N congenic background","volume":"54","author":"Siuciak","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1017","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuropharm.2007.04.009","article-title":"Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-1B (PDE1B) enzyme","volume":"53","author":"Siuciak","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1018","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/cells12111543","article-title":"CRISPR\/Cas9 knock-out in primary neonatal and adult cardiomyocytes reveals distinct cAMP dynamics regulation by various PDE2A and PDE3A isoforms","volume":"12","author":"Skryabin","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.pharmr.2025.100042_bib1019","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11901-012-0158-y","article-title":"Alcoholic hepatitis: steroids vs. pentoxifylline","volume":"12","author":"Smart","year":"2013","journal-title":"Curr Hepat Rep"},{"key":"10.1016\/j.pharmr.2025.100042_bib1020","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1038\/s41380-021-01237-4","article-title":"A genetic basis for friendship? Homophily for membrane-associated PDE11A-cAMP-CREB signaling in CA1 of hippocampus dictates mutual social preference in male and female mice","volume":"26","author":"Smith","year":"2021","journal-title":"Molecular psychiatry"},{"key":"10.1016\/j.pharmr.2025.100042_bib1021","first-page":"240","article-title":"Vinpocetine monograph","volume":"7","author":"Smith","year":"2002","journal-title":"Alter Med Review"},{"key":"10.1016\/j.pharmr.2025.100042_bib1022","doi-asserted-by":"crossref","first-page":"L279","DOI":"10.1152\/ajplung.00170.2002","article-title":"Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells","volume":"284","author":"Smith","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1023","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1124\/mol.104.002246","article-title":"Discovery of BRL 50481 [3-(N, N-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages, and CD8+ T-lymphocytes","volume":"66","author":"Smith","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1024","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1007\/s00213-016-4346-2","article-title":"Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats","volume":"233","author":"Snyder","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1025","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.1073\/pnas.95.15.8991","article-title":"Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase","volume":"95","author":"Soderling","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib1026","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0165-5728(97)00111-2","article-title":"Therapeutic potential of phosphodiesterase type 4 inhibition in chronic autoimmune demyelinating disease","volume":"79","author":"Sommer","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1027","doi-asserted-by":"crossref","first-page":"17655","DOI":"10.1016\/S0021-9258(19)47421-8","article-title":"Molecular cloning of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase cDNA. Identification and distribution of isozyme variants","volume":"266","author":"Sonnenburg","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1028","first-page":"6178","article-title":"Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines","volume":"59","author":"Soriano","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1029","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/ehjcvp\/pvae029","article-title":"Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysis","volume":"10","author":"Soulaidopoulos","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.pharmr.2025.100042_bib1030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fmed.2018.00148","article-title":"The management of patients with idiopathic pulmonary fibrosis","volume":"5","author":"Spagnolo","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.pharmr.2025.100042_bib1031","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/CIRCULATIONAHA.117.033383","article-title":"Endothelial C-type natriuretic peptide acts on pericytes to regulate microcirculatory flow and blood pressure","volume":"138","author":"Spiranec","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib1032","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100042_bib1033","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-residing batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib1034","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40425-015-0089-6","article-title":"A new paradigm for tumor immune escape: beta-catenin-driven immune exclusion","volume":"3","author":"Spranger","year":"2015","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.pharmr.2025.100042_bib1035","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1038\/ncomms7965","article-title":"In vivo model with targeted cAMP biosensor reveals changes in receptor-microdomain communication in cardiac disease","volume":"6","author":"Sprenger","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2025.100042_bib1036","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/postgradmedj-2018-135967","article-title":"Pharmacological interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis","volume":"94","author":"Sridharan","year":"2018","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.pharmr.2025.100042_bib1037","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/mol.117.111062","article-title":"G protein-coupled receptors as targets for approved drugs: how many targets and how many drugs?","volume":"93","author":"Sriram","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1038","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0306-3623(91)90237-Z","article-title":"Age-related changes of cyclic AMP phosphodiesterase activity in rat brain regions and a new phosphodiesterase inhibitor\u2014nootropic agent adafenoxate","volume":"22","author":"Stancheva","year":"1991","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1039","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/mol.110.069120","article-title":"THRX-198321 is a bifunctional muscarinic receptor antagonist and \u03b22-adrenoceptor agonist (MABA) that binds in a bimodal and multivalent manner","volume":"79","author":"Steinfeld","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1040","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nrd1752","article-title":"Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab","volume":"4","author":"Steinman","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmr.2025.100042_bib1041","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-4615-4149-3_5","article-title":"Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis","volume":"470","author":"Stoner","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1042","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/BF00544068","article-title":"Psychopharmacological effects of vinpocetine in normal healthy volunteers","volume":"28","author":"Subhan","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1043","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCRESAHA.122.321448","article-title":"Integrated proteomics unveils nuclear PDE3A2 as a regulator of cardiac myocyte hypertrophy","volume":"132","author":"Subramaniam","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1044","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0006-2952(99)00346-9","article-title":"Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity","volume":"59","author":"Sudo","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166626","article-title":"RAS-mitogen-activated protein kinase signal is required for enhanced PD-l1 expression in human lung cancers","volume":"11","author":"Sumimoto","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2025.100042_bib1046","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/CIRCRESAHA.107.154229","article-title":"Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3","volume":"101","author":"Surapisitchat","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1047","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15031","article-title":"FRET biosensor uncovers cAMP nano-domains at beta-adrenergic targets that dictate precise tuning of cardiac contractility","volume":"8","author":"Surdo","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2025.100042_bib1048","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1052932","article-title":"Tumors induce immune tolerance through activation of beta-catenin\/TCF4 signaling in dendritic cells: a novel therapeutic target for cancer immunotherapy","volume":"4","author":"Suryawanshi","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1049","doi-asserted-by":"crossref","first-page":"E1800","DOI":"10.1073\/pnas.1418716112","article-title":"Cross-talk between PKA-Cbeta and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi","volume":"112","author":"Susuki-Miyata","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib1050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.177.4047.401","article-title":"Studies on the mechanism of hormone action","volume":"177","author":"Sutherland","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2025.100042_bib1051","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0021-9258(19)77423-7","article-title":"Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles","volume":"232","author":"Sutherland","year":"1958","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1052","first-page":"171","article-title":"Formation of adenosine-3,5-phosphate (cyclic adenylate) and its relation to the action of several neurohormones or hormones","volume":"34","author":"Sutherland","year":"1960","journal-title":"Acta Endocrinol Suppl (Copenh)"},{"key":"10.1016\/j.pharmr.2025.100042_bib1053","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1254\/jphs.13103FP","article-title":"Evaluation of the therapeutic index of a novel phosphodiesterase 4B-selective inhibitor over phosphodiesterase 4D in mice","volume":"123","author":"Suzuki","year":"2013","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib1054","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1007\/s11030-022-10504-7","article-title":"Combined ligand-based and structure-based design of PDE 9A inhibitors against Alzheimer's disease","volume":"26","author":"Swetha","year":"2022","journal-title":"Mol Divers"},{"key":"10.1016\/j.pharmr.2025.100042_bib1055","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.32478","article-title":"IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis","volume":"76","author":"Szabo","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1056","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003119","article-title":"Vinpocetine for cognitive impairment and dementia","author":"Szatmari","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib1057","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.3390\/ijms21176118","article-title":"Role of phosphodiesterase 7 (PDE7) in T cell activity. Effects of selective PDE7 inhibitors and dual PDE4\/7 inhibitors on T cell functions","volume":"21","author":"Szczypka","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib1058","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/a-1345-7832","article-title":"Tadalafil reversed H-89\u2014and scopolamine\u2014induced spatial learning impairments in male rats","volume":"71","author":"Tabrizian","year":"2021","journal-title":"Drug Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1059","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/psyg.12021","article-title":"Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis","volume":"13","author":"Taguchi","year":"2013","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.pharmr.2025.100042_bib1060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12883-017-0800-y","article-title":"Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study","volume":"17","author":"Tai","year":"2017","journal-title":"BMC Neurol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1061","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s13311-017-0512-4","article-title":"Cilostazol use is associated with reduced risk of dementia: a nationwide cohort study","volume":"14","author":"Tai","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pharmr.2025.100042_bib1062","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1523\/JNEUROSCI.19-02-00610.1999","article-title":"Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms","volume":"19","author":"Takahashi","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib1063","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.RES.0000152262.22968.72","article-title":"cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism","volume":"96","author":"Takimoto","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1064","first-page":"408","article-title":"RGS2 mediates cardiac compensation to pressure-overload and anti-hypertrophic effects of PDE5 inhibition","volume":"119","author":"Takimoto","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmr.2025.100042_bib1065","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/2045893217728261","article-title":"Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension","volume":"7","author":"Tang","year":"2017","journal-title":"Pulm Circ"},{"key":"10.1016\/j.pharmr.2025.100042_bib1066","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1124\/jpet.113.210997","article-title":"The in vitro pharmacology of GS-5759, a novel bifunctional phosphodiesterase 4 inhibitor and long acting \u03b22-adrenoceptor agonist","volume":"349","author":"Tannheimer","year":"2014","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.pharmr.2025.100042_bib1067","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1465-9921-13-28","article-title":"Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts","volume":"13","author":"Tannheimer","year":"2012","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1068","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1069","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2021.102114","article-title":"Targeted protein degradation: emerging concepts and protein state-specific targeting principles","volume":"67","author":"Tao","year":"2022","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41419-023-05792-2","article-title":"Genetic deletion of phosphodiesterase 4D in the liver improves kidney damage in high-fat fed mice: liver-kidney crosstalk","volume":"14","author":"Tao","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib1071","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106004","article-title":"Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF-beta1 pathway: therapeutic role of roflumilast","volume":"175","author":"Tao","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1072","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3892\/ol.2012.851","article-title":"Endogenous cGMP-dependent protein kinase reverses EGF-induced MAPK\/ERK signal transduction through phosphorylation of VASP at Ser239","volume":"4","author":"Tao","year":"2012","journal-title":"Oncol Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib1073","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.pbb.2005.06.013","article-title":"Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat","volume":"81","author":"Taylor","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmr.2025.100042_bib1074","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/art.40040","article-title":"Genome-wide association analysis reveals genetic heterogeneity of sjogren's syndrome according to ancestry","volume":"69","author":"Taylor","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1075","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1124\/jpet.105.092544","article-title":"Differential effects of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, and tadalafil in rat aorta","volume":"316","author":"Teixeira","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib1076","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1073\/pnas.1916398117","article-title":"Chorea-related mutations in PDE10A result in aberrant compartmentalization and functionality of the enzyme","volume":"117","author":"Tejeda","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib1077","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/cvr\/cvad108","article-title":"Pathophysiology of the right ventricle in health and disease: an update","volume":"119","author":"Tello","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1078","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1021\/acs.jmedchem.1c01832","article-title":"Development of PDE6D and CK1alpha Degraders through Chemical Derivatization of FPFT-2216","volume":"65","author":"Teng","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1079","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-3-642-17969-3_3","article-title":"Pharmacology, clinical efficacy, and tolerability of phosphodiesterase-4 inhibitors: impact of human pharmacokinetics","volume":"204","author":"Tenor","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1080","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2222.1995.tb01110.x","article-title":"Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophages","volume":"25","author":"Tenor","year":"1995","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.pharmr.2025.100042_bib1081","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1365-2222.1995.tb01109.x","article-title":"Cyclic nucleotide phosphodiesterases from purified human CD4+ and CD8+ T lymphocytes","volume":"25","author":"Tenor","year":"1995","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.pharmr.2025.100042_bib1082","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1038\/npp.2013.183","article-title":"Acute effects of Sceletium tortuosum (Zembrin), a dual 5-HT reuptake and PDE4 inhibitor, in the human amygdala and its connection to the hypothalamus","volume":"38","author":"Terburg","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1083","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1083\/jcb.200605050","article-title":"PGE(1) stimulation of HEK293 cells generates multiple contiguous domains with different [cAMP]: role of compartmentalized phosphodiesterases","volume":"175","author":"Terrin","year":"2006","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1084","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/14656566.2018.1465929","article-title":"Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy options","volume":"19","author":"Teschke","year":"2018","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pharmr.2025.100042_bib1085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1532-5415.1989.tb05682.x","article-title":"The safety and lack of efficacy of vinpocetine in Alzheimer's disease","volume":"37","author":"Thal","year":"1989","journal-title":"J Am Geriat Soc"},{"key":"10.1016\/j.pharmr.2025.100042_bib1086","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/01.PCC.0000124021.25393.2D","article-title":"Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance following inhaled nitric oxide withdrawal in lambs","volume":"5","author":"Thelitz","year":"2004","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib1087","first-page":"267","article-title":"Sulfone metabolite of sulindac inhibits mammary carcinogenesis","volume":"57","author":"Thompson","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1088","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/bi00778a018","article-title":"Multiple cyclic nucleotide phosphodiesterase activities from rat brain","volume":"10","author":"Thompson","year":"1971","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmr.2025.100042_bib1089","first-page":"3338","article-title":"Exisulind induction of apoptosis involves guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin","volume":"60","author":"Thompson","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1090","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib1091","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018136","article-title":"Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling","volume":"6","author":"Tian","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2025.100042_bib1092","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yjmcc.2022.01.001","article-title":"Phosphodiesterase type 4 anchoring regulates cAMP signaling to Popeye domain-containing proteins","volume":"165","author":"Tibbo","year":"2022","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1093","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/mol.62.3.497","article-title":"Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivo","volume":"62","author":"Tilley","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1094","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1158\/1940-6207.CAPR-11-0095","article-title":"Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt\/\u03b2-catenin-mediated transcription in human breast tumor cells","volume":"4","author":"Tinsley","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.pharmr.2025.100042_bib1095","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1158\/1535-7163.MCT-09-0758","article-title":"Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G","volume":"8","author":"Tinsley","year":"2009","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.pharmr.2025.100042_bib1096","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1940-6207.CAPR-10-0030","article-title":"Colon tumor cell growth-inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibition","volume":"3","author":"Tinsley","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.pharmr.2025.100042_bib1097","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/cancers15030646","article-title":"Novel non-cyclooxygenase inhibitory derivative of sulindac inhibits breast cancer cell growth in vitro and reduces mammary tumorigenesis in rats","volume":"15","author":"Tinsley","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pharmr.2025.100042_bib1098","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1510\/icvts.2009.205849","article-title":"Aortic dissection due to sildenafil abuse","volume":"9","author":"Tiryakioglu","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.pharmr.2025.100042_bib1099","doi-asserted-by":"crossref","first-page":"L959","DOI":"10.1152\/ajplung.00508.2007","article-title":"PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-beta1-stimulated fibroblasts","volume":"296","author":"Togo","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1100","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1248\/bpb.19.300","article-title":"Influence of aging on rolipram-sensitive phosphodiesterase activity and [3H]rolipram binding in the rat brain","volume":"19","author":"Tohda","year":"1996","journal-title":"Biol Pharmaceut Bull"},{"key":"10.1016\/j.pharmr.2025.100042_bib1101","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0014-2999(84)90580-6","article-title":"Differential relaxant effects of isoproterenol on methacholine- versus leukotriene D4-induced contraction in the guinea-pig trachea","volume":"102","author":"Torphy","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1102","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1164\/ajrccm.157.2.9708012","article-title":"Phosphodiesterase isozymes: molecular targets for novel antiasthma agents","volume":"157","author":"Torphy","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib1103","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/pupt.1999.0181","article-title":"Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic","volume":"12","author":"Torphy","year":"1999","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib1104","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0022-3565(25)22186-3","article-title":"Inhibition of the low km cyclic AMP phosphodiesterase in intact canine trachealis by SK&F 94836: mechanical and biochemical responses","volume":"246","author":"Torphy","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib1105","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0022-3565(25)22103-6","article-title":"Functional antagonism in canine tracheal smooth muscle: inhibition by methacholine of the mechanical and biochemical responses to isoproterenol","volume":"227","author":"Torphy","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib1106","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/thx.46.7.512","article-title":"Phosphodiesterase inhibitors: new opportunities for the treatment of asthma","volume":"46","author":"Torphy","year":"1991","journal-title":"Thorax"},{"key":"10.1016\/j.pharmr.2025.100042_bib1107","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0022-3565(25)38243-1","article-title":"Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle","volume":"265","author":"Torphy","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib1108","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0022-3565(25)10457-6","article-title":"Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity","volume":"263","author":"Torphy","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib1109","doi-asserted-by":"crossref","first-page":"23598","DOI":"10.1074\/jbc.270.40.23598","article-title":"Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of \u03b2-adrenoceptor agonists","volume":"270","author":"Torphy","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajhg.2013.12.016","article-title":"Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci","volume":"94","author":"Tragante","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmr.2025.100042_bib1111","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/jpet.110.173690","article-title":"GSK256066, an exceptionally high-affinity and selective inhibitor of phosphodiesterase 4 suitable for administration by inhalation: in vitro, kinetic, and in vivo characterization","volume":"337","author":"Tralau-Stewart","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib1112","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1055\/s-0032-1321861","article-title":"Regulation of adrenal steroidogenesis by the high-affinity phosphodiesterase 8 family","volume":"44","author":"Tsai","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1113","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1601-183X.2012.00836.x","article-title":"Inactivation of Pde8b enhances memory, motor performance, and protects against age-induced motor coordination decay","volume":"11","author":"Tsai","year":"2012","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.pharmr.2025.100042_bib1114","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1124\/mol.110.069104","article-title":"The high affinity cAMP-specific phosphodiesterase 8B (PDE8B) controls steroidogenesis in the mouse adrenal gland","volume":"79","author":"Tsai","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2022.09.001","article-title":"Apremilast ameliorates acute respiratory distress syndrome by inhibiting neutrophil-induced oxidative stress","volume":"46","author":"Tsai","year":"2023","journal-title":"Biomed J"},{"key":"10.1016\/j.pharmr.2025.100042_bib1116","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1042\/bj3290505","article-title":"Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation","volume":"329","author":"Turko","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmr.2025.100042_bib1117","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/jpet.120.000080","article-title":"The phosphodiesterase inhibitor ensifentrine reduces production of proinflammatory mediators in well differentiated bronchiale epithelial cells by inhibiting PDE4","volume":"375","author":"Turner","year":"2020","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.pharmr.2025.100042_bib1118","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/S0022-5347(05)65621-2","article-title":"Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate","volume":"166","author":"Uckert","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1119","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2005.12.050","article-title":"Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate","volume":"49","author":"Uckert","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2466-10-26","article-title":"Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice","volume":"10","author":"Udalov","year":"2010","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib1121","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/nan.12203","article-title":"Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease","volume":"41","author":"Ugarte","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1122","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1161\/ATVBAHA.117.309707","article-title":"Cilostazol attenuates angiotensin ii-induced abdominal aortic aneurysms but not atherosclerosis in apolipoprotein e-deficient mice","volume":"38","author":"Umebayashi","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1123","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1450","article-title":"Pulmonary hypertension therapy and a systematic review of efficacy and safety of PDE-5 inhibitors","volume":"139","author":"Unegbu","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.pharmr.2025.100042_bib1124","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00432-022-04092-0","article-title":"Combination therapy of doxorubicin and Sildenafil inhibits the growth of pediatric rhabdomyosarcoma","volume":"149","author":"Urla","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1125","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01897-2018","article-title":"Pulmonary hypertension due to left heart disease","volume":"53","author":"Vachiery","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmr.2025.100042_bib1126","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1073\/pnas.1009463108","article-title":"Regulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1)","volume":"108","author":"Vaeth","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib1127","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-pharmtox-010611-134514","article-title":"The best of both worlds? Bitopic orthosteric\/allosteric ligands of g protein-coupled receptors","volume":"52","author":"Valant","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1128","first-page":"115","article-title":"[Study of the effects of vinpocetin on cognitive functions]","volume":"65","author":"Valikovics","year":"2012","journal-title":"Ideggyogy Sz"},{"key":"10.1016\/j.pharmr.2025.100042_bib1129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1752-699X.2011.00249.x","article-title":"Small airway disease in asthma: a need for awareness in patients and doctors","volume":"5","author":"van den Berge","year":"2011","journal-title":"Clin Respir J"},{"key":"10.1016\/j.pharmr.2025.100042_bib1130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-2999(73)90027-7","article-title":"The model of functional interaction. II. Experimental verification of a new model: the antagonism of beta-adrenoceptor stimulants and other agonists","volume":"22","author":"van den Brink","year":"1973","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1131","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuropharm.2017.12.019","article-title":"Acute administration of roflumilast enhances immediate recall of verbal word memory in healthy young adults","volume":"131","author":"Van Duinen","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1132","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8107807","article-title":"The association of the long prostate cancer expressed PDE4D transcripts to poor patient outcome depends on the tumour's TMPRSS2-ERG fusion status","volume":"2019","author":"van Strijp","year":"2019","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.pharmr.2025.100042_bib1133","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5821616","article-title":"The prognostic PDE4D7 score in a diagnostic biopsy prostate cancer patient cohort with longitudinal biological outcomes","volume":"2018","author":"van Strijp","year":"2018","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.pharmr.2025.100042_bib1134","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1665-2681(19)31539-X","article-title":"Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial","volume":"10","author":"Van Wagner","year":"2011","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1135","first-page":"32749","article-title":"Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes","volume":"282","author":"Vandeput","year":"2007","journal-title":"J BiolChem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1136","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2016.00259","article-title":"Differential expression and function of PDE8 and PDE4 in effector T cells: implications for PDE8 as a drug target in inflammation","volume":"7","author":"Vang","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012011","article-title":"PDE8 regulates rapid Teff cell adhesion and proliferation independent of ICER","volume":"5","author":"Vang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2025.100042_bib1138","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/BJ20130064","article-title":"Regulatory T cells and cAMP suppress effector T cells independently of PKA-CREM\/ICER: a potential role for Epac","volume":"456","author":"Vang","year":"2013","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmr.2025.100042_bib1139","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/antiox10030460","article-title":"Rolipram prevents the formation of abdominal aortic aneurysm (AAA) in mice: PDE4B as a target in AAA","volume":"10","author":"Varona","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.pharmr.2025.100042_bib1140","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/bph.12106","article-title":"Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands","volume":"168","author":"Vauquelin","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1141","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature08488","article-title":"Sleep deprivation impairs cAMP signalling in the hippocampus","volume":"461","author":"Vecsey","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100042_bib1142","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/00005344-199612000-00018","article-title":"Antiplatelet and antiproliferative effects of SCH 51866, a novel type 1 and type 5 phosphodiesterase inhibitor","volume":"28","author":"Vemulapalli","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2013.10.010","article-title":"COPD: definition and phenotypes","volume":"35","author":"Vestbo","year":"2014","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib1144","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/CIRCRESAHA.116.310069","article-title":"Phosphodiesterase 2 protects against catecholamine-induced arrhythmias and preserves contractile function after myocardial infarction","volume":"120","author":"Vettel","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1145","doi-asserted-by":"crossref","first-page":"E2063","DOI":"10.1210\/jc.2012-2275","article-title":"Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors","volume":"97","author":"Vezzosi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmr.2025.100042_bib1146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085243","article-title":"Roflumilast N-oxide prevents cytokine secretion induced by cigarette smoke combined with LPS through JAK\/STAT and ERK1\/2 inhibition in airway epithelial cells","volume":"9","author":"Victoni","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2025.100042_bib1147","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1517\/13543784.16.10.1585","article-title":"Small-molecule inhibitors of PDE-IV and -VII in the treatment of respiratory diseases and chronic inflammation","volume":"16","author":"Vijayakrishnan","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmr.2025.100042_bib1148","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.114.220558","article-title":"CHF6001 II: a novel phosphodiesterase 4 inhibitor, suitable for topical pulmonary administration\u2014in vivo preclinical pharmacology profile defines a potent anti-inflammatory compound with a wide therapeutic window","volume":"352","author":"Villetti","year":"2015","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.pharmr.2025.100042_bib1149","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/cells10081951","article-title":"cAMP compartmentalization in cerebrovascular endothelial cells: new therapeutic opportunities in Alzheimer's disease","volume":"10","author":"Vina","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.pharmr.2025.100042_bib1150","article-title":"Exacerbations of COPD","volume":"27","author":"Viniol","year":"2018","journal-title":"Eur Respirat Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib1151","doi-asserted-by":"crossref","first-page":"63250","DOI":"10.1007\/s11356-021-15189-3","article-title":"Ameliorative role of rolipram, PDE-4 inhibitor, against sodium arsenite-induced vascular dementia in rats","volume":"28","author":"Virk","year":"2021","journal-title":"Environ Sci Pollut Res Int"},{"key":"10.1016\/j.pharmr.2025.100042_bib1152","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nbd.2008.11.010","article-title":"Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease","volume":"35","author":"Visanji","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib1153","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary","volume":"195","author":"Vogelmeier","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib1154","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(17)30293-X","article-title":"Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"5","author":"Vos","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib1155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jaut.2018.08.008","article-title":"Altered expression of microRNA-23a in psoriatic arthritis modulates synovial fibroblast pro-inflammatory mechanisms via phosphodiesterase 4B","volume":"96","author":"Wade","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.pharmr.2025.100042_bib1156","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.3390\/ijms22094816","article-title":"Cellular mechanisms of the anti-arrhythmic effect of cardiac PDE2 overexpression","volume":"22","author":"Wagner","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib1157","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cellsig.2018.06.005","article-title":"Role of cAMP and phosphodiesterase signaling in liver health and disease","volume":"49","author":"Wahlang","year":"2018","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib1158","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2010.04.035","article-title":"Expression of cAMP-dependent protein kinase isoforms in the human prostate: functional significance and relation to PDE4","volume":"76","author":"Waldkirch","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1159","series-title":"Drug Combinations of PDE3\/PDE4 Inhibitor and Muscarinic Receptor Antagonist","author":"Walker","year":"2017"},{"key":"10.1016\/j.pharmr.2025.100042_bib1160","series-title":"Drug Combinations of PDE4\/PDE4 Inhibitor and Muscarinic Receptor Antagonist","author":"Walker","year":"2019"},{"key":"10.1016\/j.pharmr.2025.100042_bib1161","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2567.2004.01810.x","article-title":"Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesis","volume":"111","author":"Walker","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1162","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/JCP.0000000000001128","article-title":"Phosphodiesterase 10A inhibitor monotherapy is not an effective treatment of acute schizophrenia","volume":"39","author":"Walling","year":"2019","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1163","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0898-6568(03)00042-1","article-title":"Cloning and characterization of novel PDE4D isoforms PDE4D6 and PDE4D7","volume":"15","author":"Wang","year":"2003","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib1164","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2004.047100","article-title":"Prostaglandins and cancer","volume":"55","author":"Wang","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.pharmr.2025.100042_bib1165","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/onc.2009.421","article-title":"The role of COX-2 in intestinal inflammation and colorectal cancer","volume":"29","author":"Wang","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmr.2025.100042_bib1166","doi-asserted-by":"crossref","first-page":"21469","DOI":"10.1074\/jbc.M512527200","article-title":"Multiple conformations of phosphodiesterase-5: implications for enzyme function and drug development","volume":"281","author":"Wang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1167","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/BJ20070970","article-title":"Structures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitors","volume":"408","author":"Wang","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmr.2025.100042_bib1168","doi-asserted-by":"crossref","first-page":"12760","DOI":"10.1021\/bi801487x","article-title":"Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity","volume":"47","author":"Wang","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmr.2025.100042_bib1169","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1124\/mol.107.040212","article-title":"Conformational variations of both PDE5 and inhibitors provide the structural basis for the physiological effects of vardenafil and sildenafil","volume":"73","author":"Wang","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1170","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ijnp\/pyaa048","article-title":"The phosphodiesterase-4 inhibitor roflumilast, a potential treatment for the comorbidity of memory loss and depression in Alzheimer's disease: a preclinical study in APP\/PS1 transgenic mice","volume":"23","author":"Wang","year":"2020","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1171","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jmb.2007.05.060","article-title":"The molecular basis for different recognition of substrates by phosphodiesterase families 4 and 10","volume":"371","author":"Wang","year":"2007","journal-title":"JMB"},{"key":"10.1016\/j.pharmr.2025.100042_bib1172","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2021.719698","article-title":"microvascular sex- and age- dependent phosphodiesterase expression","volume":"2","author":"Wang","year":"2021","journal-title":"Front Aging"},{"key":"10.1016\/j.pharmr.2025.100042_bib1173","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.cellsig.2015.02.003","article-title":"UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy","volume":"27","author":"Wang","year":"2015","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib1174","article-title":"Inhibition of PDE2 reverses beta amyloid induced memory impairment through regulation of PKA\/PKG-dependent neuro-inflammatory and apoptotic pathways","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2025.100042_bib1175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-1119(01)00783-1","article-title":"Human phosphodiesterase 8A splice variants: cloning, gene organization, and tissue distribution","volume":"280","author":"Wang","year":"2001","journal-title":"Gene"},{"key":"10.1016\/j.pharmr.2025.100042_bib1176","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-1119(03)00733-9","article-title":"Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5). Differential tissue distribution and subcellular localization of PDE9A variants","volume":"314","author":"Wang","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.pharmr.2025.100042_bib1177","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106238","article-title":"Immunity and inflammation in pulmonary arterial hypertension: from pathophysiology mechanisms to treatment perspective","volume":"180","author":"Wang","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1178","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi0759","article-title":"Found in translation-Fibrosis in metabolic dysfunction-associated steatohepatitis (MASH)","volume":"15","author":"Wang","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib1179","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1126\/science.208147","article-title":"Rise and fall of cyclic AMP required for onset of lymphocyte DNA synthesis","volume":"201","author":"Wang","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2025.100042_bib1180","article-title":"Generation and phenotypic characterization of Pde1a mutant mice","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2025.100042_bib1181","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115037","article-title":"PROTACS: a technology with a gold rush-like atmosphere","volume":"247","author":"Wang","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1182","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jmoldx.2012.10.003","article-title":"Automated quantitative RNA in situ hybridization for resolution of equivocal and heterogeneous ERBB2 (HER2) status in invasive breast carcinoma","volume":"15","author":"Wang","year":"2013","journal-title":"J Mol Diagnost"},{"key":"10.1016\/j.pharmr.2025.100042_bib1183","article-title":"Phosphodiesterase-4D knock-down in the prefrontal cortex alleviates chronic unpredictable stress-induced depressive-like behaviors and memory deficits in mice","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2025.100042_bib1184","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/jdv.18812","article-title":"Oral orismilast: efficacy and safety in moderate-to-severe psoriasis and development of modified release tablets","volume":"37","author":"Warren","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1185","doi-asserted-by":"crossref","first-page":"38072","DOI":"10.1074\/jbc.M203647200","article-title":"Isoforms of cyclic nucleotide phosphodiesterase PDE3A in cardiac myocytes","volume":"277","author":"Wechsler","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1186","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41588-018-0086-z","article-title":"Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets","volume":"50","author":"Wedge","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmr.2025.100042_bib1187","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/COPD.S89849","article-title":"Roflumilast: a review of its use in the treatment of COPD","volume":"11","author":"Wedzicha","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib1188","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1158\/1078-0432.CCR-14-1711","article-title":"Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma","volume":"21","author":"Weed","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1189","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/jpet.109.156935","article-title":"Interactions between cyclic nucleotide phosphodiesterase 11 catalytic site and substrates or tadalafil and role of a critical Gln-869 hydrogen bond","volume":"331","author":"Weeks","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib1190","doi-asserted-by":"crossref","first-page":"10353","DOI":"10.1021\/bi7009629","article-title":"N-Terminal domain of phosphodiesterase-11A4 (PDE11A4) decreases affinity of the catalytic site for substrates and tadalafil, and is involved in oligomerization","volume":"46","author":"Weeks","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmr.2025.100042_bib1191","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fimmu.2016.00222","article-title":"Molecular mechanisms for cAMP-mediated immunoregulation in T cells\u2014role of anchored protein kinase A signaling units","volume":"7","author":"Wehbi","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1192","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/sj.leu.2401367","article-title":"Modulation of the immune response and tumor growth by activated Ras","volume":"13","author":"Weijzen","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.pharmr.2025.100042_bib1193","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1038\/s41467-018-06638-8","article-title":"A shear-dependent NO-cGMP-cGKI cascade in platelets acts as an auto-regulatory brake of thrombosis","volume":"9","author":"Wen","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2025.100042_bib1194","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-3-319-58811-7_13","article-title":"Phosphodiesterase 1: a unique drug target for degenerative diseases and cognitive dysfunction","volume":"17","author":"Wennogle","year":"2017","journal-title":"Adv Neurobiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1195","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1526-0542(03)00095-2","article-title":"Pathology of difficult asthma","volume":"4","author":"Wenzel","year":"2003","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib1196","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib1197","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0006-2952(00)00369-5","article-title":"Inhibition of a phosphodiesterase III in the lysis-sensitive target-induced elevation of cyclic AMP (cAMP) in human natural killer cells","volume":"60","author":"Whalen","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1198","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.200411-1587OC","article-title":"Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells","volume":"172","author":"Wharton","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib1199","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1200","first-page":"479","article-title":"Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival","volume":"2","author":"Whitehead","year":"2003","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.pharmr.2025.100042_bib1201","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/1940-6207.CAPR-11-0559","article-title":"A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and \u03b2-catenin transcriptional activity","volume":"5","author":"Whitt","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.pharmr.2025.100042_bib1202","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1152\/jappl.1990.69.3.849","article-title":"A model of the mechanics of airway narrowing","volume":"69","author":"Wiggs","year":"1990","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1203","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ccm.2020.10.004","article-title":"Personalized medicine for pulmonary hypertension: the future management of pulmonary hypertension requires a new taxonomy","volume":"42","author":"Wilkins","year":"2021","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib1204","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1183\/09031936.00124007","article-title":"Phosphodiesterase inhibitors for the treatment of pulmonary hypertension","volume":"32","author":"Wilkins","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmr.2025.100042_bib1205","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cellsig.2016.01.008","article-title":"Location, location, location: PDE4D5 function is directed by its unique N-terminal region","volume":"28","author":"Wills","year":"2016","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib1206","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jns.2016.07.033","article-title":"Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers","volume":"368","author":"Wilson","year":"2016","journal-title":"J Neurolog Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib1207","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.4049\/jimmunol.0902738","article-title":"Selective prostacyclin receptor agonism augments glucocorticoid-induced gene expression in human bronchial epithelial cells","volume":"183","author":"Wilson","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13555-013-0023-0","article-title":"Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases","volume":"3","author":"Wittmann","year":"2013","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib1209","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbamcr.2006.10.008","article-title":"Expression and activity of cGMP-dependent phosphodiesterases is up-regulated by lipopolysaccharide (LPS) in rat peritoneal macrophages","volume":"1773","author":"Witwicka","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmr.2025.100042_bib1210","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pupt.2005.09.002","article-title":"Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors","volume":"19","author":"Wollin","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib1211","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib1212","first-page":"L694","article-title":"Phosphodiesterase expression in human epithelial cells","volume":"275","author":"Wright","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1213","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10557-017-6719-0","article-title":"Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis","volume":"31","author":"Wu","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib1214","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1016\/j.apsb.2022.02.012","article-title":"Structure-based discovery of orally efficient inhibitors via unique interactions with H-pocket of PDE8 for the treatment of vascular dementia","volume":"12","author":"Wu","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.pharmr.2025.100042_bib1215","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.1021\/acs.jmedchem.0c00711","article-title":"Discovery of novel selective and orally bioavailable phosphodiesterase-1 inhibitors for the efficient treatment of idiopathic pulmonary fibrosis","volume":"63","author":"Wu","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1216","doi-asserted-by":"crossref","first-page":"9537","DOI":"10.1021\/acs.jmedchem.1c00862","article-title":"Discovery of potent phosphodiesterase-9 inhibitors for the treatment of hepatic fibrosis","volume":"64","author":"Wu","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1217","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1124\/mol.105.017608","article-title":"Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line","volume":"68","author":"Wunder","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1218","first-page":"H448","article-title":"ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells","volume":"274","author":"Wyatt","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1219","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1021\/acschemneuro.1c00762","article-title":"Discovery of novel 3-Amino-4-alkoxyphenylketones as PDE4 inhibitors with improved oral bioavailability and safety against spatial memory impairments","volume":"13","author":"Xia","year":"2022","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib1220","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1126\/science.288.5472.1822","article-title":"Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity","volume":"288","author":"Xu","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2025.100042_bib1221","article-title":"LncRNA GAS5 knockdown mitigates hepatic lipid accumulation via regulating MiR-26a-5p\/PDE4B to activate cAMP\/CREB pathway","volume":"13","author":"Xu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.pharmr.2025.100042_bib1222","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1017\/S146114571200065X","article-title":"Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP\/PKG dependent pathway","volume":"16","author":"Xu","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1223","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cellsig.2017.09.014","article-title":"AIPL1: a specialized chaperone for the phototransduction effector","volume":"40","author":"Yadav","year":"2017","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib1224","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejphar.2006.08.023","article-title":"Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models","volume":"550","author":"Yamamoto","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1225","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2006.05.007","article-title":"The effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related cytokine production in vitro and in vivo","volume":"541","author":"Yamamoto","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1226","doi-asserted-by":"crossref","first-page":"12526","DOI":"10.1016\/S0021-9258(17)44208-6","article-title":"Purification and characterization of cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from calf liver","volume":"258","author":"Yamamoto","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1227","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0021-5198(19)31351-4","article-title":"Rolipram, a selective inhibitor of phosphodiesterase type 4, pronouncedly enhanced the forskolin-induced promotion of dopamine biosynthesis in primary cultured rat mesencephalic neurons","volume":"75","author":"Yamashita","year":"1997","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1228","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1042\/CS20150605","article-title":"Cyclic nucleotide phosphodiesterase 1 and vascular aging","volume":"129","author":"Yan","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pharmr.2025.100042_bib1229","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1523\/JNEUROSCI.14-03-00973.1994","article-title":"Differential expression of the 61 kDa and 63 kDa calmodulin-dependent phosphodiesterases in the mouse brain","volume":"14","author":"Yan","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib1230","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.RES.0000258451.44949.d7","article-title":"Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart","volume":"100","author":"Yan","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1231","doi-asserted-by":"crossref","first-page":"25699","DOI":"10.1074\/jbc.271.41.25699","article-title":"The calmodulin-dependent phosphodiesterase gene PDE1C encodes several functionally different splice variants in a tissue-specific manner","volume":"271","author":"Yan","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1232","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109128","article-title":"Protective effects of phosphodiesterase 2 inhibitor against Abeta(1-42) induced neuronal toxicity","volume":"213","author":"Yan","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1233","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1031637","article-title":"Reversal of spatial memory impairment by phosphodiesterase 3 inhibitor cilostazol is associated with reduced neuroinflammation and increased cerebral glucose uptake in aged male mice","volume":"13","author":"Yanai","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1234","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuropharm.2016.12.006","article-title":"Long-term cilostazol administration ameliorates memory decline in senescence-accelerated mouse prone 8 (SAMP8) through a dual effect on cAMP and blood-brain barrier","volume":"116","author":"Yanai","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1235","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.4049\/jimmunol.171.12.6414","article-title":"Phosphodiesterase 7A-deficient mice have functional T cells","volume":"171","author":"Yang","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib538","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/bs.apha.2022.01.001","article-title":"Pharmacological developments in antihypertensive treatment through nitric oxide-cGMP modulation","volume":"94","author":"J\u00fcttner","year":"2022","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib548","series-title":"Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer\u2019s-Type Dementia","author":"Kane","year":"2017"},{"key":"10.1016\/j.pharmr.2025.100042_bib1236","unstructured":"Yang M, Sun Y, Li, W,Xu Z, Bao P, Gao J, Dong P, Hui H, JI X, and Luo Y (2023) Pharmaceutical composition of tricyclic PDE3\/PDE4 dual inhibitor compound. Patent application WO2021143841A1."},{"key":"10.1016\/j.pharmr.2025.100042_bib1237","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1007\/s12035-018-1446-5","article-title":"miRNA-27a-3p and miRNA-222-3p as novel modulators of phosphodiesterase 3a (PDE3A) in cerebral microvascular endothelial cells","volume":"56","author":"Yasmeen","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1238","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1162556","article-title":"Inflammation and immunity in the pathogenesis of hypoxic pulmonary hypertension","volume":"14","author":"Ye","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1239","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/356063a0","article-title":"Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin","volume":"356","author":"Yednock","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100042_bib1240","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.pupt.2009.11.002","article-title":"Phosphodiesterase-5 inhibition by sildenafil citrate in a rat model of bleomycin-induced lung fibrosis","volume":"23","author":"Yildirim","year":"2010","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib1241","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3892\/etm.2014.1700","article-title":"Protective effect of Xin Mai Jia ultrafiltration extract on human umbilical vein endothelial cell injury induced by hydrogen peroxide and the effect on the NO-cGMP signaling pathway","volume":"8","author":"Yin","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib1242","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1073\/pnas.0801490105","article-title":"The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals","volume":"105","author":"Yokoyama","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib1243","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2147\/IJGM.S295463","article-title":"Treating inflammation associated with pulmonary hypertension: an overview of the literature","volume":"15","author":"Yoo","year":"2022","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.pharmr.2025.100042_bib1244","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3109\/15412555.2014.898045","article-title":"Polymorphisms in PDE4D are associated with a risk of COPD in non-emphysematous Koreans","volume":"11","author":"Yoon","year":"2014","journal-title":"Copd"},{"key":"10.1016\/j.pharmr.2025.100042_bib1245","doi-asserted-by":"crossref","first-page":"31469","DOI":"10.1074\/jbc.M003041200","article-title":"Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression","volume":"275","author":"Yuasa","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1246","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/71345","article-title":"A genetically encoded, fluorescent indicator for cyclic AMP in living cells","volume":"2","author":"Zaccolo","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1247","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1126\/science.1069982","article-title":"Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes","volume":"295","author":"Zaccolo","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2025.100042_bib1248","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1124\/pharmrev.120.000086","article-title":"Subcellular organization of the cAMP signaling pathway","volume":"73","author":"Zaccolo","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmr.2025.100042_bib1249","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/1535370218824101","article-title":"Pulmonary arterial hypertension in connective tissue disorders: pathophysiology and treatment","volume":"244","author":"Zanatta","year":"2019","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.pharmr.2025.100042_bib1250","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1158\/2326-6066.CIR-15-0241","article-title":"Mutant KRAS conversion of conventional T cells into regulatory T cells","volume":"4","author":"Zdanov","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1251","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hep.25778","article-title":"Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism","volume":"56","author":"Zein","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1252","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/hep.24544","article-title":"Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial","volume":"54","author":"Zein","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1253","doi-asserted-by":"crossref","first-page":"12468","DOI":"10.1021\/acs.jmedchem.3c01044","article-title":"Identification of novel quinolin-2 (1 H)-ones as phosphodiesterase 1 inhibitors for the treatment of inflammatory bowel disease","volume":"66","author":"Zhang","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1254","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3233\/JAD-122236","article-title":"RNA interference-mediated knockdown of long-form phosphodiesterase-4D (PDE4D) enzyme reverses amyloid-beta42-induced memory deficits in mice","volume":"38","author":"Zhang","year":"2014","journal-title":"J Alzheimer's Dis"},{"key":"10.1016\/j.pharmr.2025.100042_bib1255","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-3-319-58811-7_12","article-title":"The role of phosphodiesterase-2 in psychiatric and neurodegenerative disorders","volume":"17","author":"Zhang","year":"2017","journal-title":"Adv Neurobiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1256","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1038\/s41386-018-0178-6","article-title":"Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice","volume":"43","author":"Zhang","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1257","article-title":"Comparison of the Pharmacological Profiles of Selective PDE4B and PDE4D Inhibitors in the Central Nervous System","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2025.100042_bib1258","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2174\/1381612820666140826115245","article-title":"The roles of phosphodiesterase 2 in the central nervous and peripheral systems","volume":"21","author":"Zhang","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmr.2025.100042_bib1259","article-title":"Cyclic nucleotide phosphodiesterase 1C contributes to abdominal aortic aneurysm","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib1260","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.2174\/138161209788168092","article-title":"Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs","volume":"15","author":"Zhang","year":"2009","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.pharmr.2025.100042_bib1261","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0076-6879(05)03005-3","article-title":"Assay and functional properties of PrBP (PDE\u03b4), a prenyl-binding protein interacting with multiple partners","volume":"403","author":"Zhang","year":"2005","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1262","article-title":"PDE1 inhibition facilitates proteasomal degradation of misfolded proteins and protects against cardiac proteinopathy","volume":"5","author":"Zhang","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.pharmr.2025.100042_bib1263","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/sj.npp.1301537","article-title":"Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B)","volume":"33","author":"Zhang","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1264","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3390\/brainsci13030422","article-title":"Moderate-intensity intermittent training alters the DNA methylation pattern of PDE4D gene in hippocampus to improve the ability of spatial learning and memory in aging rats reduced by D-galactose","volume":"13","author":"Zhang","year":"2023","journal-title":"Brain Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib1265","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbr.2013.05.017","article-title":"Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP\/PS1 transgenic mice","volume":"250","author":"Zhang","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1266","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.cell.2020.07.043","article-title":"Phase separation of a PKA regulatory subunit controls cAMP compartmentation and oncogenic signaling","volume":"182","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib1267","doi-asserted-by":"crossref","first-page":"19532","DOI":"10.1073\/pnas.0806152105","article-title":"Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2025.100042_bib1268","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.STR.0000158923.19956.73","article-title":"Functional recovery in aged and young rats after embolic stroke: treatment with a phosphodiesterase type 5 inhibitor","volume":"36","author":"Zhang","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.pharmr.2025.100042_bib1269","first-page":"1471","article-title":"beta-arrestin2 mediates beta-2 adrenergic receptor signaling inducing prostate cancer cell progression","volume":"26","author":"Zhang","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1016\/j.pharmr.2025.100042_bib1270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127254","article-title":"Design, synthesis and evaluation of pyrazolopyrimidinone derivatives as novel PDE9A inhibitors for treatment of Alzheimer's disease","volume":"30","author":"Zhang","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmr.2025.100042_bib1271","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1016\/j.jss.2011.01.017","article-title":"Suppression of experimental abdominal aortic aneurysm in a rat model by the phosphodiesterase 3 inhibitor cilostazol","volume":"167","author":"Zhang","year":"2011","journal-title":"J Surg Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1272","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/01.RES.0000056757.93432.8C","article-title":"Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat","volume":"92","author":"Zhang","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1273","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.1021\/acs.jmedchem.0c00983","article-title":"Discovery of evodiamine derivatives as highly selective PDE5 inhibitors targeting a unique allosteric pocket","volume":"63","author":"Zhang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1274","doi-asserted-by":"crossref","first-page":"29699","DOI":"10.1074\/jbc.M803948200","article-title":"Direct allosteric regulation between the gaf domain and catalytic domain of photoreceptor phosphodiesterase PDE6","volume":"283","author":"Zhang","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2025.100042_bib1275","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1167\/iovs.05-0257","article-title":"Efficacy and selectivity of phosphodiesterase-targeted drugs in inhibiting photoreceptor phosphodiesterase (PDE6) in retinal photoreceptors","volume":"46","author":"Zhang","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib1276","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fnmol.2017.00100","article-title":"The phosphodiesterase 10A inhibitor PF-2545920 enhances hippocampal excitability and seizure activity involving the upregulation of GluA1 and NR2A in post-synaptic densities","volume":"10","author":"Zhang","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.pharmr.2025.100042_bib1277","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/gerona\/glp132","article-title":"Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity","volume":"64","author":"Zhang","year":"2009","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.pharmr.2025.100042_bib1278","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1161\/CIRCULATIONAHA.118.034189","article-title":"Multiprotein complex with TRPC (transient receptor potential-canonical) channel, PDE1C (phosphodiesterase 1C), and A2R (adenosine a2 receptor) plays a critical role in regulating cardiomyocyte cAMP and survival","volume":"138","author":"Zhang","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100042_bib1279","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ccell.2022.07.005","article-title":"A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy","volume":"40","author":"Zhang","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmr.2025.100042_bib1280","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1040-7952(97)80022-5","article-title":"Recent advances in the study of Ca2+\/CaM-activated phosphodiesterases: expression and physiological functions","volume":"31","author":"Zhao","year":"1997","journal-title":"Adv Second Messenger Phosphoprotein Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1281","first-page":"1728","article-title":"Anti-inflammatory effect of ciclamilast in an allergic model involving the expression of PDE4B","volume":"19","author":"Zheng","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.pharmr.2025.100042_bib1282","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000231716","article-title":"The PDE1A-PKCalpha signaling pathway is involved in the upregulation of alpha-smooth muscle actin by TGF-beta1 in adventitial fibroblasts","volume":"47","author":"Zhou","year":"2010","journal-title":"J Vasc Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1283","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.apsb.2022.09.023","article-title":"Discovery of novel phosphodiesterase-1 inhibitors for curing vascular dementia: Suppression of neuroinflammation by blocking NF-kappaB transcription regulation and activating cAMP\/CREB axis","volume":"13","author":"Zhou","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.pharmr.2025.100042_bib1284","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.3390\/molecules26103034","article-title":"Design, synthesis, and evaluation of dihydropyranopyrazole derivatives as novel PDE2 inhibitors for the treatment of Alzheimer's disease","volume":"26","author":"Zhou","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.pharmr.2025.100042_bib1285","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bcp.2004.03.039","article-title":"Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells","volume":"68","author":"Zhu","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1286","doi-asserted-by":"crossref","first-page":"69264","DOI":"10.18632\/oncotarget.20566","article-title":"Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking beta-catenin and MAPK signaling","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmr.2025.100042_bib1287","doi-asserted-by":"crossref","first-page":"11708","DOI":"10.1021\/ja404449g","article-title":"X-ray crystal structure of phosphodiesterase 2 in complex with a highly selective, nanomolar inhibitor reveals a binding-induced pocket important for selectivity","volume":"135","author":"Zhu","year":"2013","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pharmr.2025.100042_bib1288","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146344","article-title":"Inhibition of PDE5 attenuates streptozotocin-induced neuroinflammation and tau hyperphosphorylation in a streptozotocin-treated rat model","volume":"1722","author":"Zhu","year":"2019","journal-title":"Brain research"},{"key":"10.1016\/j.pharmr.2025.100042_bib1289","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neuropharm.2019.04.022","article-title":"The antidepressant- and anxiolytic-like effects of resveratrol: involvement of phosphodiesterase-4D inhibition","volume":"153","author":"Zhu","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmr.2025.100042_bib1290","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/CIRCRESAHA.114.305892","article-title":"Cardiac hypertrophy is inhibited by a local pool of cAMP regulated by phosphodiesterase 2","volume":"117","author":"Zoccarato","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100042_bib1291","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/mol.65.2.267","article-title":"Properties and functions of GAF domains in cyclic nucleotide phosphodiesterases and other proteins","volume":"65","author":"Zoraghi","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1292","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110689","article-title":"Phosphodiesterase 7 as a therapeutic target\u2014Where are we now?","volume":"108","author":"Zorn","year":"2023","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100042_bib1293","series-title":"Development and use of biomarkers in clinical development of new therapies for chronic airway disease","author":"Zuiker","year":"2016"},{"key":"10.1016\/j.pharmr.2025.100042_bib1294","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pharmthera.2019.02.002","article-title":"Phosphodiesterases as therapeutic targets for respiratory diseases","volume":"197","author":"Zuo","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmr.2025.100042_bib1295","doi-asserted-by":"crossref","first-page":"L59","DOI":"10.1152\/ajplung.00319.2019","article-title":"Cigarette smoke exposure alters phosphodiesterases in human structural lung cells","volume":"318","author":"Zuo","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmr.2025.100042_bib1296","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1111\/bph.14347","article-title":"Cigarette smoke up-regulates PDE3 and PDE4 to decrease cAMP in airway cells","volume":"175","author":"Zuo","year":"2018","journal-title":"Br J Pharmacol"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699725073867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699725073867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:05:35Z","timestamp":1777435535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699725073867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":1297,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0031699725073867"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2025.100042","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclic nucleotide phosphodiesterases as drug targets","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2025.100042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100042"}}